{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 230925, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:11:15Z", "timestamp": 1574129475892}, "reference-count": 0, "publisher": "Georg Thieme Verlag KG", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Semin Liver Dis"], "published-print": {"date-parts": [[2004, 2]]}, "DOI": "10.1055/s-2004-828672", "type": "journal-article", "created": {"date-parts": [[2004, 6, 11]], "date-time": "2004-06-11T07:04:29Z", "timestamp": 1086937469000}, "page": "3-10", "source": "Crossref", "is-referenced-by-count": 115, "title": ["Molecular Virology of Hepatitis B Virus"], "prefix": "10.1055", "volume": "24", "author": [{"given": "Stephen", "family": "Locarnini", "sequence": "first", "affiliation": []}], "member": "194", "container-title": ["Seminars in Liver Disease"], "language": "de", "link": [{"URL": "http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2004-828672.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 22]], "date-time": "2017-05-22T21:56:19Z", "timestamp": 1495490179000}, "score": 40.93318, "issued": {"date-parts": [[2004, 2]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1055/s-2004-828672", "ISSN": ["0272-8087", "1098-8971"], "issn-type": [{"value": "0272-8087", "type": "print"}, {"value": "1098-8971", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T18:32:02Z", "timestamp": 1575225122070}, "publisher-location": "Singapore", "reference-count": 120, "publisher": "Springer Singapore", "isbn-type": [{"value": "9789811048425", "type": "print"}, {"value": "9789811048432", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2017, 9, 5]], "date-time": "2017-09-05T00:00:00Z", "timestamp": 1504569600000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2018]]}, "DOI": "10.1007/978-981-10-4843-2_1", "type": "book-chapter", "created": {"date-parts": [[2018, 1, 12]], "date-time": "2018-01-12T09:36:27Z", "timestamp": 1515749787000}, "page": "1-23", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Molecular Virology and Life Cycle"], "prefix": "10.1007", "author": [{"given": "Darren J.", "family": "Wong", "sequence": "first", "affiliation": []}, {"given": "Stephen A.", "family": "Locarnini", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2017, 9, 5]]}, "reference": [{"issue": "4", "key": "1_CR1", "doi-asserted-by": "crossref", "first-page": "1158", "DOI": "10.1002/hep.22790", "volume": "49", "author": "S Amini-Bavil-Olyaee", "year": "2009", "unstructured": "Amini-Bavil-Olyaee S, Herbers U, Sheldon J, Luedde T, Trautwein C, Tacke F. The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains. Hepatology. 2009;49(4):1158\u201365.", "journal-title": "Hepatology"}, {"issue": "2", "key": "1_CR2", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1016/S0016-5085(03)00939-9", "volume": "125", "author": "P Angus", "year": "2003", "unstructured": "Angus P, Vaughan R, Xiong S, Yang H, Delaney W, Gibbs C, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology. 2003;125(2):292\u20137.", "journal-title": "Gastroenterology"}, {"issue": "9", "key": "1_CR3", "doi-asserted-by": "crossref", "first-page": "3413", "DOI": "10.1002/j.1460-2075.1992.tb05420.x", "volume": "11", "author": "R Bartenschlager", "year": "1992", "unstructured": "Bartenschlager R, Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J. 1992;11(9):3413\u201320.", "journal-title": "EMBO J"}, {"issue": "1", "key": "1_CR4", "doi-asserted-by": "crossref", "first-page": "3", "DOI": "10.1002/rmv.400", "volume": "14", "author": "A Bartholomeusz", "year": "2004", "unstructured": "Bartholomeusz A, Schaefer S. Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol. 2004;14(1):3\u201316.", "journal-title": "Rev Med Virol"}, {"issue": "2", "key": "1_CR5", "first-page": "149", "volume": "9", "author": "A Bartholomeusz", "year": "2004", "unstructured": "Bartholomeusz A, Tehan BG, Chalmers DK. Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations. Antivir Ther. 2004;9(2):149\u201360.", "journal-title": "Antivir Ther"}, {"issue": "1", "key": "1_CR6", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.3748/wjg.v13.i1.48", "volume": "13", "author": "J Beck", "year": "2007", "unstructured": "Beck J, Nassal M. Hepatitis B virus replication. World J Gastroenterol. 2007;13(1):48\u201364.", "journal-title": "World J Gastroenterol"}, {"issue": "47", "key": "1_CR7", "doi-asserted-by": "crossref", "first-page": "19975", "DOI": "10.1073/pnas.0908365106", "volume": "106", "author": "L Belloni", "year": "2009", "unstructured": "Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A. 2009;106(47):19975\u20139.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "8", "key": "1_CR8", "doi-asserted-by": "crossref", "first-page": "4360", "DOI": "10.1128/JVI.02574-12", "volume": "87", "author": "S Benhenda", "year": "2013", "unstructured": "Benhenda S, Ducroux A, Riviere L, Sobhian B, Ward MD, Dion S, et al. Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription. J Virol. 2013;87(8):4360\u201371.", "journal-title": "J Virol"}, {"issue": "4", "key": "1_CR9", "first-page": "2376", "volume": "67", "author": "A Bertoletti", "year": "1993", "unstructured": "Bertoletti A, Chisari FV, Penna A, Guilhot S, Galati L, Missale G, et al. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol. 1993;67(4):2376\u201380.", "journal-title": "J Virol"}, {"issue": "3", "key": "1_CR10", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1007/BF01703079", "volume": "8", "author": "CT Bock", "year": "1994", "unstructured": "Bock CT, Schranz P, Schroder CH, Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes. 1994;8(3):215\u201329.", "journal-title": "Virus Genes"}, {"issue": "1", "key": "1_CR11", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1006/jmbi.2000.4481", "volume": "307", "author": "CT Bock", "year": "2001", "unstructured": "Bock CT, Schwinn S, Locarnini S, Fyfe J, Manns MP, Trautwein C, et al. Structural organization of the hepatitis B virus minichromosome. J Mol Biol. 2001;307(1):183\u201396.", "journal-title": "J Mol Biol"}, {"issue": "2", "key": "1_CR12", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1053/gast.2002.31015", "volume": "122", "author": "CT Bock", "year": "2002", "unstructured": "Bock CT, Tillmann HL, Torresi J, Klempnauer J, Locarnini S, Manns MP, et al. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology. 2002;122(2):264\u201373.", "journal-title": "Gastroenterology"}, {"issue": "6", "key": "1_CR13", "doi-asserted-by": "crossref", "first-page": "1391", "DOI": "10.1002/hep.20723", "volume": "41", "author": "M-N Brunelle", "year": "2005", "unstructured": "Brunelle M-N, Jacquard A-C, Pichoud C, Durantel D, Carrouee-Durantel S, Villeneuve J-P, et al. Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir. Hepatology. 2005;41(6):1391\u20138.", "journal-title": "Hepatology"}, {"issue": "1", "key": "1_CR14", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.3748/wjg.v13.i1.65", "volume": "13", "author": "V Bruss", "year": "2007", "unstructured": "Bruss V. Hepatitis B virus morphogenesis. World J Gastroenterol. 2007;13(1):65\u201373.", "journal-title": "World J Gastroenterol"}, {"issue": "8711", "key": "1_CR15", "doi-asserted-by": "crossref", "first-page": "325", "DOI": "10.1016/0140-6736(90)91874-A", "volume": "336", "author": "WF Carman", "year": "1990", "unstructured": "Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336(8711):325\u20139.", "journal-title": "Lancet"}, {"issue": "3", "key": "1_CR16", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1002/hep.510240304", "volume": "24", "author": "WF Carman", "year": "1996", "unstructured": "Carman WF, Trautwein C, van Deursen FJ, Colman K, Dornan E, McIntyre G, et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology. 1996;24(3):489\u201393.", "journal-title": "Hepatology"}, {"issue": "10", "key": "1_CR17", "doi-asserted-by": "crossref", "first-page": "2629", "DOI": "10.1111/j.1572-0241.2002.06065.x", "volume": "97", "author": "HL-Y Chan", "year": "2002", "unstructured": "Chan HL-Y, Tsang SW-C, Wong M-L, Tse C-H, Leung NW-Y, Chan FK-L, et al. Genotype B hepatitis B virus is associated with severe icteric flare-up of chronic hepatitis B virus infection in Hong Kong. Am J Gastroenterol. 2002a;97(10):2629\u201333.", "journal-title": "Am J Gastroenterol"}, {"issue": "2", "key": "1_CR18", "doi-asserted-by": "crossref", "first-page": "406", "DOI": "10.1111/j.1572-0241.2002.05478.x", "volume": "97", "author": "HL Chan", "year": "2002", "unstructured": "Chan HL, Tsang SW, Liew CT, Tse CH, Wong ML, Ching JY, et al. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection. Am J Gastroenterol. 2002b;97(2):406\u201312.", "journal-title": "Am J Gastroenterol"}, {"issue": "9", "key": "1_CR19", "first-page": "5682", "volume": "66", "author": "HS Chen", "year": "1992", "unstructured": "Chen HS, Kew MC, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, et al. The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host. J Virol. 1992;66(9):5682\u20134.", "journal-title": "J Virol"}, {"issue": "2", "key": "1_CR20", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1016/j.jcv.2009.11.024", "volume": "47", "author": "WI Cheung", "year": "2010", "unstructured": "Cheung WI, Chan HL, Leung VK, Tse CH, Fung K, Lin SY, et al. Reactivation of hepatitis B virus infection with persistently negative HBsAg on three HBsAg assays in a lymphoma patient undergoing chemotherapy. J Clin Virol. 2010;47(2):193\u20135.", "journal-title": "J Clin Virol"}, {"key": "1_CR21", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1146/annurev.iy.13.040195.000333", "volume": "13", "author": "FV Chisari", "year": "1995", "unstructured": "Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995;13:29\u201360.", "journal-title": "Annu Rev Immunol"}, {"issue": "1", "key": "1_CR22", "doi-asserted-by": "crossref", "first-page": "220", "DOI": "10.1016/0016-5085(87)90863-8", "volume": "92", "author": "CM Chu", "year": "1987", "unstructured": "Chu CM, Liaw YF. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. Gastroenterology. 1987;92(1):220\u20135.", "journal-title": "Gastroenterology"}, {"issue": "12", "key": "1_CR23", "first-page": "4376", "volume": "141", "author": "G Colucci", "year": "1988", "unstructured": "Colucci G, Beazer Y, Cantaluppi C, Tackney C. Identification of a major hepatitis B core antigen (HBcAg) determinant by using synthetic peptides and monoclonal antibodies. J Immunol. 1988;141(12):4376\u201380.", "journal-title": "J Immunol"}, {"issue": "6", "key": "1_CR24", "doi-asserted-by": "crossref", "first-page": "943", "DOI": "10.1016/0092-8674(94)90142-2", "volume": "77", "author": "RA Crowther", "year": "1994", "unstructured": "Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, Ose V, et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell. 1994;77(6):943\u201350.", "journal-title": "Cell"}, {"issue": "7594", "key": "1_CR25", "doi-asserted-by": "crossref", "first-page": "386", "DOI": "10.1038/nature17170", "volume": "531", "author": "A Decorsiere", "year": "2016", "unstructured": "Decorsiere A, Mueller H, van Breugel PC, Abdul F, Gerossier L, Beran RK, et al. Hepatitis B virus X protein identifies the Smc5/6 complex as a host restriction factor. Nature. 2016;531(7594):386\u20139.", "journal-title": "Nature"}, {"issue": "1", "key": "1_CR26", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1177/095632020101200101", "volume": "12", "author": "WE Delaney", "year": "2001", "unstructured": "Delaney WE, Locarnini S, Shaw T. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation. Antivir Chem Chemother. 2001;12(1):1\u201335.", "journal-title": "Antivir Chem Chemother"}, {"issue": "2", "key": "1_CR27", "first-page": "161", "volume": "13", "author": "CP Desmond", "year": "2008", "unstructured": "Desmond CP, Bartholomeusz A, Gaudieri S, Revill PA, Lewin SR. A systematic review of T-cell epitopes in hepatitis B virus: identification, genotypic variation and relevance to antiviral therapeutics. Antivir Ther. 2008;13(2):161\u201375.", "journal-title": "Antivir Ther"}, {"issue": "12", "key": "1_CR28", "doi-asserted-by": "crossref", "first-page": "861", "DOI": "10.1038/nrg3074", "volume": "12", "author": "M Esteller", "year": "2011", "unstructured": "Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.", "journal-title": "Nat Rev Genet"}, {"issue": "1", "key": "1_CR29", "doi-asserted-by": "crossref", "first-page": "214", "DOI": "10.1172/JCI115280", "volume": "88", "author": "C Ferrari", "year": "1991", "unstructured": "Ferrari C, Bertoletti A, Penna A, Cavalli A, Valli A, Missale G, et al. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest. 1991;88(1):214\u201322.", "journal-title": "J Clin Invest"}, {"issue": "6", "key": "1_CR30", "doi-asserted-by": "crossref", "first-page": "937", "DOI": "10.1016/j.jhep.2005.05.037", "volume": "43", "author": "SK Fung", "year": "2005", "unstructured": "Fung SK, Andreone P, Han SH, Rajender Reddy K, Regev A, Keeffe EB, et al. Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. J Hepatol. 2005;43(6):937\u201343.", "journal-title": "J Hepatol"}, {"issue": "1", "key": "1_CR31", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1046/j.1365-2893.2002.00304.x", "volume": "9", "author": "ML Funk", "year": "2002", "unstructured": "Funk ML, Rosenberg DM, Lok ASF. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepat. 2002;9(1):52\u201361.", "journal-title": "J Viral Hepat"}, {"key": "1_CR32", "first-page": "2923", "volume-title": "Fields virology", "author": "D Ganem", "year": "2001", "unstructured": "Ganem D, Schneider RJ. Hepadnaviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2923\u201369.", "edition": "4"}, {"issue": "2", "key": "1_CR33", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1006/viro.1995.0002", "volume": "213", "author": "P Gripon", "year": "1995", "unstructured": "Gripon P, Le Seyec J, Rumin S, Guguen-Guillouzo C. Myristoylation of the hepatitis B virus large surface protein is essential for viral infectivity. Virology. 1995;213(2):292\u20139.", "journal-title": "Virology"}, {"key": "1_CR34", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1016/S0065-3527(08)60298-5", "volume": "52", "author": "S Gunther", "year": "1999", "unstructured": "Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res. 1999;52:25\u20132137.", "journal-title": "Adv Virus Res"}, {"issue": "4", "key": "1_CR35", "doi-asserted-by": "crossref", "first-page": "1492", "DOI": "10.1016/j.bbrc.2014.07.019", "volume": "450", "author": "L Guo", "year": "2014", "unstructured": "Guo L, Wang X, Ren L, Zeng M, Wang S, Weng Y, et al. HBx affects CUL4-DDB1 function in both positive and negative manners. Biochem Biophys Res Commun. 2014;450(4):1492\u20137.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "1_CR36", "first-page": "7", "volume": "1", "author": "S Hadziyannis", "year": "1995", "unstructured": "Hadziyannis S. HBeAg-negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hepat Rev. 1995;1:7\u2013l5.", "journal-title": "Viral Hepat Rev"}, {"issue": "4 Pt 1", "key": "1_CR37", "doi-asserted-by": "crossref", "first-page": "617", "DOI": "10.1053/jhep.2001.27834", "volume": "34", "author": "SJ Hadziyannis", "year": "2001", "unstructured": "Hadziyannis SJ, Vassilopoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology. 2001;34(4 Pt 1):617\u201324.", "journal-title": "Hepatology"}, {"issue": "3", "key": "1_CR38", "doi-asserted-by": "crossref", "first-page": "546", "DOI": "10.1016/j.jhep.2015.03.020", "volume": "63", "author": "S Hayashi", "year": "2015", "unstructured": "Hayashi S, Murakami S, Omagari K, Matsui T, Iio E, Isogawa M, et al. Characterization of novel entecavir resistance mutations. J Hepatol. 2015;63(3):546\u201353.", "journal-title": "J Hepatol"}, {"issue": "1", "key": "1_CR39", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/j.virol.2012.01.021", "volume": "426", "author": "AJ Hodgson", "year": "2012", "unstructured": "Hodgson AJ, Hyser JM, Keasler VV, Cang Y, Slagle BL. Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication. Virology. 2012;426(1):73\u201382.", "journal-title": "Virology"}, {"issue": "9", "key": "1_CR40", "first-page": "7231", "volume": "73", "author": "Z Hu", "year": "1999", "unstructured": "Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, Liang TJ. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol. 1999;73(9):7231\u201340.", "journal-title": "J Virol"}, {"issue": "8", "key": "1_CR41", "first-page": "5582", "volume": "70", "author": "J Huang", "year": "1996", "unstructured": "Huang J, Kwong J, Sun EC, Liang TJ. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J Virol. 1996;70(8):5582\u201391.", "journal-title": "J Virol"}, {"issue": "5", "key": "1_CR42", "doi-asserted-by": "crossref", "first-page": "1037", "DOI": "10.1053/he.2000.6709", "volume": "31", "author": "CM Hunt", "year": "2000", "unstructured": "Hunt CM, McGill JM, Allen MI, Condreay LD. Clinical relevance of hepatitis B viral mutations. Hepatology. 2000;31(5):1037\u201344.", "journal-title": "Hepatology"}, {"key": "1_CR43", "unstructured": "Kann ML, Gerlich W. Chapter 10: Structure and molecular virology. In: Thomas H, Lemon S, Zuckerman A, editors. Viral hepatitis. Third ed. Oxford, UK: Blackwell Publishing Ltd; 2005.", "DOI": "10.1002/9780470987131.ch10", "doi-asserted-by": "crossref"}, {"issue": "6", "key": "1_CR44", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1046/j.1440-1746.2002.02737.x", "volume": "17", "author": "JH Kao", "year": "2002", "unstructured": "Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol. 2002;17(6):643\u201350.", "journal-title": "J Gastroenterol Hepatol"}, {"issue": "6", "key": "1_CR45", "first-page": "1916", "volume": "125", "author": "JH Kao", "year": "2003", "unstructured": "Kao JH, Chen DS. Clinical relevance of hepatitis B virus genotypes Ba and Bj in Taiwan. Gastroenterology. 2003;125(6):1916\u20137. author reply 7\u20138", "journal-title": "Gastroenterology"}, {"issue": "Suppl 1", "key": "1_CR46", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1159/000048273", "volume": "62", "author": "K Koike", "year": "2002", "unstructured": "Koike K, Tsutsumi T, Fujie H, Shintani Y, Kyoji M. Molecular mechanism of viral hepatocarcinogenesis. Oncology. 2002;62(Suppl 1):29\u201337.", "journal-title": "Oncology"}, {"issue": "40", "key": "1_CR47", "doi-asserted-by": "crossref", "first-page": "E4244", "DOI": "10.1073/pnas.1409986111", "volume": "111", "author": "C Koniger", "year": "2014", "unstructured": "Koniger C, Wingert I, Marsmann M, Rosler C, Beck J, Nassal M. Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses. Proc Natl Acad Sci U S A. 2014;111(40):E4244\u201353.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "6", "key": "1_CR48", "doi-asserted-by": "crossref", "first-page": "687", "DOI": "10.1086/368083", "volume": "36", "author": "CL Lai", "year": "2003", "unstructured": "Lai CL, Dienstag J, Schiff E, Leung NW, Atkins M, Hunt C, et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis. 2003;36(6):687\u201396.", "journal-title": "Clin Infect Dis"}, {"issue": "17", "key": "1_CR49", "doi-asserted-by": "crossref", "first-page": "9050", "DOI": "10.1128/JVI.00479-07", "volume": "81", "author": "C Lambert", "year": "2007", "unstructured": "Lambert C, Doring T, Prange R. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol. 2007;81(17):9050\u201360.", "journal-title": "J Virol"}, {"issue": "7", "key": "1_CR50", "doi-asserted-by": "crossref", "first-page": "4238", "DOI": "10.1128/JVI.79.7.4238-4245.2005", "volume": "79", "author": "O Leupin", "year": "2005", "unstructured": "Leupin O, Bontron S, Schaeffer C, Strubin M. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol. 2005;79(7):4238\u201345.", "journal-title": "J Virol"}, {"issue": "8", "key": "1_CR51", "doi-asserted-by": "crossref", "first-page": "2525", "DOI": "10.1128/AAC.46.8.2525-2532.2002", "volume": "46", "author": "S Levine", "year": "2002", "unstructured": "Levine S, Hernandez D, Yamanaka G, Zhang S, Rose R, Weinheimer S, et al. Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro. Antimicrob Agents Chemother. 2002;46(8):2525\u201332.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "3", "key": "1_CR52", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1016/j.jhep.2009.05.022", "volume": "51", "author": "M Levrero", "year": "2009", "unstructured": "Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J Hepatol. 2009;51(3):581\u201392.", "journal-title": "J Hepatol"}, {"issue": "15", "key": "1_CR53", "doi-asserted-by": "crossref", "first-page": "1521", "DOI": "10.1056/NEJMoa033364", "volume": "351", "author": "YF Liaw", "year": "2004", "unstructured": "Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351(15):1521\u201331.", "journal-title": "N Engl J Med"}, {"issue": "3", "key": "1_CR54", "doi-asserted-by": "crossref", "first-page": "328", "DOI": "10.1111/jvh.12298", "volume": "22", "author": "Y Liu", "year": "2015", "unstructured": "Liu Y, Li X, Xin S, Xu Z, Chen R, Yang J, et al. The rtA181S mutation of hepatitis B virus primarily confers resistance to adefovir dipivoxil. J Viral Hepat. 2015;22(3):328\u201334.", "journal-title": "J Viral Hepat"}, {"issue": "2", "key": "1_CR55", "doi-asserted-by": "crossref", "first-page": "113", "DOI": "10.1016/j.jcv.2004.10.002", "volume": "32", "author": "S Locarnini", "year": "2005", "unstructured": "Locarnini S, Shaw T, Dean J, Colledge D, Thompson A, Li K, et al. Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. J Clin Virol. 2005;32(2):113\u201321.", "journal-title": "J Clin Virol"}, {"issue": "6 Pt B", "key": "1_CR56", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.1016/j.semcancer.2013.08.006", "volume": "23", "author": "S Locarnini", "year": "2013", "unstructured": "Locarnini S, Littlejohn M, Aziz MN, Yuen L. Possible origins and evolution of the hepatitis B virus (HBV). Semin Cancer Biol. 2013;23(6 Pt B):561\u201375.", "journal-title": "Semin Cancer Biol"}, {"issue": "3", "key": "1_CR57", "doi-asserted-by": "crossref", "first-page": "661", "DOI": "10.1002/hep.23190", "volume": "50", "author": "AS Lok", "year": "2009", "unstructured": "Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661\u20132.", "journal-title": "Hepatology"}, {"issue": "9", "key": "1_CR58", "doi-asserted-by": "crossref", "first-page": "4077", "DOI": "10.1073/pnas.91.9.4077", "volume": "91", "author": "AS Lok", "year": "1994", "unstructured": "Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci U S A. 1994;91(9):4077\u201381.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "5", "key": "1_CR59", "doi-asserted-by": "crossref", "first-page": "996", "DOI": "10.1016/j.jhep.2011.02.015", "volume": "55", "author": "J Lucifora", "year": "2011", "unstructured": "Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, Levrero M, et al. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol. 2011;55(5):996\u20131003.", "journal-title": "J Hepatol"}, {"issue": "5", "key": "1_CR60", "first-page": "315", "volume": "21", "author": "S Martin-Vilchez", "year": "2011", "unstructured": "Martin-Vilchez S, Lara-Pezzi E, Trapero-Marugan M, Moreno-Otero R, Sanz-Cameno P. The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection. Rev Med Virol. 2011;21(5):315\u201329.", "journal-title": "Rev Med Virol"}, {"issue": "6", "key": "1_CR61", "doi-asserted-by": "crossref", "first-page": "863", "DOI": "10.1097/01.aids.0000218550.85081.59", "volume": "20", "author": "GV Matthews", "year": "2006", "unstructured": "Matthews GV, Bartholomeusz A, Locarnini S, Ayres A, Sasaduesz J, Seaberg E, et al. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. AIDS. 2006;20(6):863\u201370.", "journal-title": "AIDS"}, {"issue": "1", "key": "1_CR62", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1002/hep.26181", "volume": "58", "author": "A Meier", "year": "2013", "unstructured": "Meier A, Mehrle S, Weiss TS, Mier W, Urban S. Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytes. Hepatology. 2013;58(1):31\u201342.", "journal-title": "Hepatology"}, {"key": "1_CR63", "doi-asserted-by": "crossref", "first-page": "71", "DOI": "10.1111/j.1600-065X.1987.tb01173.x", "volume": "99", "author": "DR Milich", "year": "1987", "unstructured": "Milich DR. Genetic and molecular basis for T- and B-cell recognition of hepatitis B viral antigens. Immunol Rev. 1987;99:71\u2013103.", "journal-title": "Immunol Rev"}, {"issue": "12", "key": "1_CR64", "doi-asserted-by": "crossref", "first-page": "380", "DOI": "10.1016/0167-5699(88)91239-X", "volume": "9", "author": "DR Milich", "year": "1988", "unstructured": "Milich DR. T- and B-cell recognition of hepatitis B viral antigens. Immunol Today. 1988;9(12):380\u20136.", "journal-title": "Immunol Today"}, {"issue": "4704", "key": "1_CR65", "doi-asserted-by": "crossref", "first-page": "1195", "DOI": "10.1126/science.2408336", "volume": "228", "author": "DR Milich", "year": "1985", "unstructured": "Milich DR, Thornton GB, Neurath AR, Kent SB, Michel ML, Tiollais P, et al. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science. 1985;228(4704):1195\u20139.", "journal-title": "Science"}, {"issue": "1", "key": "1_CR66", "first-page": "315", "volume": "137", "author": "DR Milich", "year": "1986", "unstructured": "Milich DR, McLachlan A, Chisari FV, Kent SB, Thorton GB. Immune response to the pre-S(1) region of the hepatitis B surface antigen (HBsAg): a pre-S(1)-specific T cell response can bypass nonresponsiveness to the pre-S(2) and S regions of HBsAg. J Immunol. 1986;137(1):315\u201322.", "journal-title": "J Immunol"}, {"issue": "17", "key": "1_CR67", "doi-asserted-by": "crossref", "first-page": "6599", "DOI": "10.1073/pnas.87.17.6599", "volume": "87", "author": "DR Milich", "year": "1990", "unstructured": "Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A. 1990;87(17):6599\u2013603.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "11", "key": "1_CR68", "doi-asserted-by": "crossref", "first-page": "4683", "DOI": "10.3390/v6114683", "volume": "6", "author": "MM Minor", "year": "2014", "unstructured": "Minor MM, Slagle BL. Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system. Virus. 2014;6(11):4683\u2013702.", "journal-title": "Virus"}, {"issue": "3", "key": "1_CR69", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1084/jem.177.3.751", "volume": "177", "author": "G Missale", "year": "1993", "unstructured": "Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, et al. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med. 1993;177(3):751\u201362.", "journal-title": "J Exp Med"}, {"issue": "2", "key": "1_CR70", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1086/315238", "volume": "181", "author": "D Mutimer", "year": "2000", "unstructured": "Mutimer D, Pillay D, Cook P, Ratcliffe D, O\u2019Donnell K, Dowling D, et al. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy. J Infect Dis. 2000;181(2):713\u20136.", "journal-title": "J Infect Dis"}, {"issue": "6", "key": "1_CR71", "first-page": "3350", "volume": "69", "author": "JE Newbold", "year": "1995", "unstructured": "Newbold JE, Xin H, Tencza M, Sherman G, Dean J, Bowden S, et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol. 1995;69(6):3350\u20137.", "journal-title": "J Virol"}, {"issue": "4", "key": "1_CR72", "doi-asserted-by": "crossref", "first-page": "1070", "DOI": "10.1053/j.gastro.2013.12.024", "volume": "146", "author": "Y Ni", "year": "2014", "unstructured": "Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology. 2014;146(4):1070\u201383.", "journal-title": "Gastroenterology"}, {"issue": "3", "key": "1_CR73", "doi-asserted-by": "crossref", "first-page": "626", "DOI": "10.1002/hep.20580", "volume": "41", "author": "C Noguchi", "year": "2005", "unstructured": "Noguchi C, Ishino H, Tsuge M, Fujimoto Y, Imamura M, Takahashi S, et al. G to A hypermutation of hepatitis B virus. Hepatology. 2005;41(3):626\u201333.", "journal-title": "Hepatology"}, {"issue": "2", "key": "1_CR74", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1006/viro.1994.1060", "volume": "198", "author": "H Norder", "year": "1994", "unstructured": "Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology. 1994;198(2):489\u2013503.", "journal-title": "Virology"}, {"issue": "12", "key": "1_CR75", "first-page": "8102", "volume": "68", "author": "H Okamoto", "year": "1994", "unstructured": "Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, et al. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol. 1994;68(12):8102\u201310.", "journal-title": "J Virol"}, {"issue": "11", "key": "1_CR76", "doi-asserted-by": "publisher", "first-page": "1777", "DOI": "10.3201/eid1411.080437", "volume": "14", "author": "CM Olinger", "year": "2008", "unstructured": "Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Samountry B, Thammavong T, et al. Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis. 2008;14(11):1777\u201380. https://doi.org/10.3201/eid1411.080437 .", "journal-title": "Emerg Infect Dis"}, {"issue": "1", "key": "1_CR77", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1053/jhep.2001.20532", "volume": "33", "author": "E Orito", "year": "2001", "unstructured": "Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, et al. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology. 2001;33(1):218\u201323.", "journal-title": "Hepatology"}, {"issue": "3", "key": "1_CR78", "first-page": "355", "volume": "12", "author": "X Qi", "year": "2007", "unstructured": "Qi X, Xiong S, Yang H, Miller M, Delaney WE. In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents. Antivir Ther. 2007;12(3):355\u201362.", "journal-title": "Antivir Ther"}, {"issue": "17", "key": "1_CR79", "doi-asserted-by": "crossref", "first-page": "9849", "DOI": "10.1073/pnas.1730940100", "volume": "100", "author": "B Rabe", "year": "2003", "unstructured": "Rabe B, Vlachou A, Pante N, Helenius A, Kann M. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A. 2003;100(17):9849\u201354.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "2", "key": "1_CR80", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1002/jmv.1890360207", "volume": "36", "author": "MT Rossner", "year": "1992", "unstructured": "Rossner MT. Review: Hepatitis B virus X-gene product: a promiscuous transcriptional activator. J Med Virol. 1992;36(2):101\u201317.", "journal-title": "J Med Virol"}, {"issue": "2", "key": "1_CR81", "first-page": "798", "volume": "63", "author": "J Salfeld", "year": "1989", "unstructured": "Salfeld J, Pfaff E, Noah M, Schaller H. Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol. 1989;63(2):798\u2013808.", "journal-title": "J Virol"}, {"issue": "1", "key": "1_CR82", "first-page": "345", "volume": "71", "author": "PP Scaglioni", "year": "1997", "unstructured": "Scaglioni PP, Melegari M, Wands JR. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol. 1997;71(1):345\u201353.", "journal-title": "J Virol"}, {"key": "1_CR83", "author": "H-J Schlicht", "first-page": "171", "year": "1991", "unstructured": "Schlicht H-J, Bartenschlager R, Schaller H. Biosynthesis and enzymatic functions of the hepadnaviral reverse transcriptase. Molecular biology of the hepatitis B virus. Boca raton: CRC Press; 1991. p. 171\u201380.", "volume-title": "Biosynthesis and enzymatic functions of the hepadnaviral reverse transcriptase. Molecular biology of the hepatitis B virus"}, {"issue": "6", "key": "1_CR84", "doi-asserted-by": "crossref", "first-page": "1759", "DOI": "10.1002/hep.21896", "volume": "46", "author": "A Schulze", "year": "2007", "unstructured": "Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology. 2007;46(6):1759\u201368.", "journal-title": "Hepatology"}, {"issue": "6", "key": "1_CR85", "first-page": "727", "volume": "10", "author": "J Sheldon", "year": "2005", "unstructured": "Sheldon J, Camino N, Rodes B, Bartholomeusz A, Kuiper M, Tacke F, et al. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir Ther. 2005;10(6):727\u201334.", "journal-title": "Antivir Ther"}, {"issue": "7", "key": "1_CR86", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1111/j.1365-2893.2005.00713.x", "volume": "13", "author": "J Sheldon", "year": "2006", "unstructured": "Sheldon J, Rodes B, Zoulim F, Bartholomeusz A, Soriano V. Mutations affecting the replication capacity of the hepatitis B virus. J Viral Hepat. 2006;13(7):427\u201334.", "journal-title": "J Viral Hepat"}, {"issue": "Pt 2", "key": "1_CR87", "doi-asserted-by": "crossref", "first-page": "369", "DOI": "10.1099/0022-1317-81-2-369", "volume": "81", "author": "D Sobotta", "year": "2000", "unstructured": "Sobotta D, Sominskaya I, Jansons J, Meisel H, Schmitt S, Heermann KH, et al. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype. J Gen Virol. 2000;81(Pt 2):369\u201378.", "journal-title": "J Gen Virol"}, {"issue": "3", "key": "1_CR88", "doi-asserted-by": "crossref", "first-page": "e91279", "DOI": "10.1371/journal.pone.0091279", "volume": "9", "author": "JT Stieler", "year": "2014", "unstructured": "Stieler JT, Prange R. Involvement of ESCRT-II in hepatitis B virus morphogenesis. PLoS One. 2014;9(3):e91279.", "journal-title": "PLoS One"}, {"issue": "Pt 1", "key": "1_CR89", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1099/0022-1317-81-1-67", "volume": "81", "author": "L Stuyver", "year": "2000", "unstructured": "Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol. 2000;81(Pt 1):67\u201374.", "journal-title": "J Gen Virol"}, {"issue": "3", "key": "1_CR90", "doi-asserted-by": "crossref", "first-page": "751", "DOI": "10.1053/jhep.2001.22166", "volume": "33", "author": "LJ Stuyver", "year": "2001", "unstructured": "Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology. 2001;33(3):751\u20137.", "journal-title": "Hepatology"}, {"issue": "3", "key": "1_CR91", "doi-asserted-by": "crossref", "first-page": "985", "DOI": "10.1002/hep.26125", "volume": "57", "author": "C Sureau", "year": "2013", "unstructured": "Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology. 2013;57(3):985\u201394.", "journal-title": "Hepatology"}, {"issue": "3", "key": "1_CR92", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1016/j.biologicals.2007.11.002", "volume": "36", "author": "KF Tang", "year": "2008", "unstructured": "Tang KF, Xie J, Chen M, Liu Q, Zhou XY, Zeng W, et al. Knockdown of damage-specific DNA binding protein 1 (DDB1) enhances the HBx-siRNA-mediated inhibition of HBV replication. Biologicals. 2008;36(3):177\u201383.", "journal-title": "Biologicals"}, {"issue": "20", "key": "1_CR93", "doi-asserted-by": "publisher", "first-page": "10538", "DOI": "10.1128/JVI.00462-09", "volume": "83", "author": "K Tatematsu", "year": "2009", "unstructured": "Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009;83(20):10538\u201347. https://doi.org/10.1128/JVI.00462-09 . Epub 2009 Jul 29", "journal-title": "J Virol"}, {"issue": "9", "key": "1_CR94", "doi-asserted-by": "crossref", "first-page": "3498", "DOI": "10.1128/AAC.48.9.3498-3507.2004", "volume": "48", "author": "DJ Tenney", "year": "2004", "unstructured": "Tenney DJ, Levine SM, Rose RE, Walsh AW, Weinheimer SP, Discotto L, et al. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. Antimicrob Agents Chemother. 2004;48(9):3498\u2013507.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "5", "key": "1_CR95", "doi-asserted-by": "crossref", "first-page": "1503", "DOI": "10.1002/hep.22841", "volume": "49", "author": "DJ Tenney", "year": "2009", "unstructured": "Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology. 2009;49(5):1503\u201314.", "journal-title": "Hepatology"}, {"issue": "15", "key": "1_CR96", "doi-asserted-by": "crossref", "first-page": "2810", "DOI": "10.1128/MCB.00205-13", "volume": "33", "author": "Y Tian", "year": "2013", "unstructured": "Tian Y, Yang W, Song J, Wu Y, Ni B. Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis. Mol Cell Biol. 2013;33(15):2810\u20136.", "journal-title": "Mol Cell Biol"}, {"issue": "2", "key": "1_CR97", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1016/S1386-6532(02)00049-5", "volume": "25", "author": "J Torresi", "year": "2002", "unstructured": "Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol. 2002;25(2):97\u2013106.", "journal-title": "J Clin Virol"}, {"issue": "2", "key": "1_CR98", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1093/infdis/160.2.199", "volume": "160", "author": "F Tron", "year": "1989", "unstructured": "Tron F, Degos F, Brechot C, Courouce AM, Goudeau A, Marie FN, et al. Randomized dose range study of a recombinant hepatitis B vaccine produced in mammalian cells and containing the S and PreS2 sequences. J Infect Dis. 1989;160(2):199\u2013204.", "journal-title": "J Infect Dis"}, {"issue": "2", "key": "1_CR99", "doi-asserted-by": "crossref", "first-page": "292", "DOI": "10.1136/gutjnl-2014-306977", "volume": "64", "author": "TC Tseng", "year": "2015", "unstructured": "Tseng TC, Liu CJ, Yang HC, Chen CL, Yang WT, Tsai CS, et al. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 2015;64(2):292\u2013302.", "journal-title": "Gut"}, {"issue": "1", "key": "1_CR100", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1053/j.gastro.2014.04.030", "volume": "147", "author": "S Urban", "year": "2014", "unstructured": "Urban S, Bartenschlager R, Kubitz R, Zoulim F. Strategies to inhibit entry of HBV and HDV into hepatocytes. Gastroenterology. 2014;147(1):48\u201364.", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "1_CR101", "doi-asserted-by": "crossref", "first-page": "1253", "DOI": "10.1053/j.gastro.2006.08.013", "volume": "131", "author": "S Villet", "year": "2006", "unstructured": "Villet S, Pichoud C, Villeneuve JP, Trepo C, Zoulim F. Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient. Gastroenterology. 2006;131(4):1253\u201361.", "journal-title": "Gastroenterology"}, {"issue": "3", "key": "1_CR102", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1016/j.jhep.2006.11.016", "volume": "46", "author": "S Villet", "year": "2007", "unstructured": "Villet S, Ollivet A, Pichoud C, Barraud L, Villeneuve JP, Trepo C, et al. Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient. J Hepatol. 2007;46(3):531\u20138.", "journal-title": "J Hepatol"}, {"issue": "5", "key": "1_CR103", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1016/j.jhep.2008.01.027", "volume": "48", "author": "S Villet", "year": "2008", "unstructured": "Villet S, Pichoud C, Billioud G, Barraud L, Durantel S, Trepo C, et al. Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure. J Hepatol. 2008;48(5):747\u201355.", "journal-title": "J Hepatol"}, {"issue": "1", "key": "1_CR104", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1002/hep.21482", "volume": "45", "author": "K Visvanathan", "year": "2007", "unstructured": "Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology. 2007;45(1):102\u201310.", "journal-title": "Hepatology"}, {"issue": "3", "key": "1_CR105", "doi-asserted-by": "crossref", "first-page": "232", "DOI": "10.1016/j.chom.2013.08.012", "volume": "14", "author": "J Votteler", "year": "2013", "unstructured": "Votteler J, Sundquist WI. Virus budding and the ESCRT pathway. Cell Host Microbe. 2013;14(3):232\u201341.", "journal-title": "Cell Host Microbe"}, {"issue": "2", "key": "1_CR106", "doi-asserted-by": "crossref", "first-page": "e9195", "DOI": "10.1371/journal.pone.0009195", "volume": "5", "author": "AW Walsh", "year": "2010", "unstructured": "Walsh AW, Langley DR, Colonno RJ, Tenney DJ. Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir. PLoS One. 2010;5(2):e9195.", "journal-title": "PLoS One"}, {"issue": "24", "key": "1_CR107", "first-page": "6012", "volume": "55", "author": "XW Wang", "year": "1995", "unstructured": "Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, et al. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res. 1995;55(24):6012\u20136.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "1_CR108", "doi-asserted-by": "crossref", "first-page": "2441", "DOI": "10.1016/S0002-9440(10)63599-7", "volume": "163", "author": "HC Wang", "year": "2003", "unstructured": "Wang HC, Wu HC, Chen CF, Fausto N, Lei HY, Su IJ. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol. 2003;163(6):2441\u20139.", "journal-title": "Am J Pathol"}, {"issue": "1", "key": "1_CR109", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1002/hep.22295", "volume": "48", "author": "N Warner", "year": "2008", "unstructured": "Warner N, Locarnini S. The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology. 2008;48(1):88\u201398.", "journal-title": "Hepatology"}, {"issue": "15", "key": "1_CR110", "doi-asserted-by": "crossref", "first-page": "9369", "DOI": "10.1128/JVI.79.15.9369-9380.2005", "volume": "79", "author": "SF Wieland", "year": "2005", "unstructured": "Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol. 2005;79(15):9369\u201380.", "journal-title": "J Virol"}, {"issue": "3", "key": "1_CR111", "first-page": "904", "volume": "61", "author": "H Will", "year": "1987", "unstructured": "Will H, Reiser W, Weimer T, Pfaff E, Buscher M, Sprengel R, et al. Replication strategy of human hepatitis B virus. J Virol. 1987;61(3):904\u201311.", "journal-title": "J Virol"}, {"issue": "6", "key": "1_CR112", "doi-asserted-by": "crossref", "first-page": "3273", "DOI": "10.1128/JVI.03478-13", "volume": "88", "author": "H Yan", "year": "2014", "unstructured": "Yan H, Peng B, Liu Y, Xu G, He W, Ren B, et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J Virol. 2014;88(6):3273\u201384.", "journal-title": "J Virol"}, {"issue": "6", "key": "1_CR113", "doi-asserted-by": "crossref", "first-page": "1962", "DOI": "10.1002/hep.22889", "volume": "49", "author": "JC Yang", "year": "2009", "unstructured": "Yang JC, Teng CF, Wu HC, Tsai HW, Chuang HC, Tsai TF, et al. Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis. Hepatology. 2009;49(6):1962\u201371.", "journal-title": "Hepatology"}, {"issue": "6", "key": "1_CR114", "doi-asserted-by": "crossref", "first-page": "1318", "DOI": "10.1053/jhep.2000.7296", "volume": "31", "author": "CT Yeh", "year": "2000", "unstructured": "Yeh CT, Chien RN, Chu CM, Liaw YF. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology. 2000;31(6):1318\u201326.", "journal-title": "Hepatology"}, {"issue": "3", "key": "1_CR115", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1002/hep.21290", "volume": "44", "author": "HJ Yim", "year": "2006", "unstructured": "Yim HJ, Hussain M, Liu Y, Wong SN, Fung SK, Lok AS. Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology. 2006;44(3):703\u201312.", "journal-title": "Hepatology"}, {"issue": "3", "key": "1_CR116", "first-page": "182", "volume": "11", "author": "XD Zhang", "year": "2014", "unstructured": "Zhang XD, Wang Y, Ye LH. Hepatitis B virus X protein accelerates the development of hepatoma. Cancer Biol Med. 2014;11(3):182\u201390.", "journal-title": "Cancer Biol Med"}, {"issue": "8", "key": "1_CR117", "doi-asserted-by": "crossref", "first-page": "1947", "DOI": "10.1128/AAC.43.8.1947", "volume": "43", "author": "T Zhou", "year": "1999", "unstructured": "Zhou T, Saputelli J, Aldrich CE, Deslauriers M, Condreay LD, Mason WS. Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine. Antimicrob Agents Chemother. 1999;43(8):1947\u201354.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "1", "key": "1_CR118", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1002/hep.20016", "volume": "39", "author": "B Zollner", "year": "2004", "unstructured": "Zollner B, Petersen J, Puchhammer-Stockl E, Kletzmayr J, Sterneck M, Fischer L, et al. Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology. 2004;39(1):42\u201350.", "journal-title": "Hepatology"}, {"issue": "5", "key": "1_CR119", "doi-asserted-by": "crossref", "first-page": "1593", "DOI": "10.1053/j.gastro.2009.08.063", "volume": "137", "author": "F Zoulim", "year": "2009", "unstructured": "Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology. 2009;137(5):1593\u2013608 e1\u20132.", "journal-title": "Gastroenterology"}, {"issue": "1", "key": "1_CR120", "first-page": "6", "volume": "68", "author": "F Zoulim", "year": "1994", "unstructured": "Zoulim F, Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol. 1994;68(1):6\u201313.", "journal-title": "J Virol"}], "container-title": ["Hepatitis B Virus and Liver Disease"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-981-10-4843-2_1", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 10, 9]], "date-time": "2019-10-09T08:58:34Z", "timestamp": 1570611514000}, "score": 36.839268, "issued": {"date-parts": [[2017, 9, 5]]}, "ISBN": ["9789811048425", "9789811048432"], "references-count": 120, "URL": "http://dx.doi.org/10.1007/978-981-10-4843-2_1", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:48:19Z", "timestamp": 1574243299246}, "reference-count": 82, "publisher": "Wiley", "issue": "S2", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3196, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2006, 12]]}, "DOI": "10.1111/j.1478-3231.2006.01371.x", "type": "journal-article", "created": {"date-parts": [[2006, 11, 7]], "date-time": "2006-11-07T10:01:32Z", "timestamp": 1162893692000}, "page": "11-22", "source": "Crossref", "is-referenced-by-count": 11, "title": ["Molecular virology of hepatitis B virus and the development of antiviral drug resistance"], "prefix": "10.1111", "volume": "26", "author": [{"given": "Stephen", "family": "Locarnini", "sequence": "first", "affiliation": []}, {"given": "Masao", "family": "Omata", "sequence": "additional", "affiliation": []}], "member": "311", "reference": [{"key": "10.1111/j.1478-3231.2006.01371.x-BIB1", "unstructured": "1.\u2002 Chisari F , Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol 1995; 13: 29-60.", "DOI": "10.1146/annurev.iy.13.040195.000333", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB2", "unstructured": "2.\u2002 Hadziyannis S. Hepatitis B e antigen negative chronic hepatitis B: from clinical recognition to pathogenesis and treatment. Viral Hep Rev 1995; 1: 7-36."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB3", "unstructured": "3.\u2002 Bouchard M J , Schneider R J. The enigmatic X gene of hepatitis B virus. J Virol 2004; 78: 12725-34.", "DOI": "10.1128/JVI.78.23.12725-12734.2004", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB4", "unstructured": "4.\u2002 Bouchard M J , Wang L , Schneider R J. Activation of focal adhesion kinase by hepatitis B virus HBx protein: multiple functions in viral replication. J Virol 2006; 80: 4406-14.", "DOI": "10.1128/JVI.80.9.4406-4414.2006", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB5", "unstructured": "5.\u2002 Chen B F , Liu C J , Jow G M , Chen P J , Kao J H , Chen D S. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 2006; 130: 1153-68.", "DOI": "10.1053/j.gastro.2006.01.011", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB6", "unstructured": "6.\u2002 Chen C H , Lee C M , Lu S N , et al. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan. J Clin Microbiol 2005; 43: 6000-6.", "DOI": "10.1128/JCM.43.12.6000-6006.2005", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB7", "unstructured": "7.\u2002 Kao J H , Chen P J , Lai M Y , Chen D S. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 2003; 124: 327-34.", "DOI": "10.1053/gast.2003.50053", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB8", "unstructured": "8.\u2002 Lin C L , Liao L Y , Wang C S , et al. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver Int 2005; 25: 564-70.", "DOI": "10.1111/j.1478-3231.2005.01041.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB9", "unstructured": "9.\u2002 Song B C , Kim H , Kim S H , et al. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea. J Med Virol 2005; 75: 13-9.", "DOI": "10.1002/jmv.20230", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB10", "unstructured": "10.\u2002 Yotsuyanagi H , Hino K , Tomita E , et al. Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B. J Hepatol 2002; 37: 355-63.", "DOI": "10.1016/S0168-8278(02)00180-0", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB11", "unstructured": "11.\u2002 Bartholomeusz A , Locarnini S A. Antiviral drug resistance: clinical consequences and molecular aspects. Semin Liver Dis 2006; 26: 162-70.", "DOI": "10.1055/s-2006-939758", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB12", "unstructured": "12.\u2002 Locarnini S. Molecular virology and the development of resistant mutants: implications for therapy. Semin Liver Dis 2005; 25 (Suppl. 1): 9-19.", "DOI": "10.1055/s-2005-915645", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB13", "unstructured": "13.\u2002 De Meyer S , Gong Z , Suwandhi W , et al. Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes. J Viral Hepatol 1997; 4: 145-53.", "DOI": "10.1046/j.1365-2893.1997.00126.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB14", "unstructured": "14.\u2002 Rabe B , Vlachou A , Pante N , Helenius A , Kann M. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci USA 2003; 100: 9849-54.", "DOI": "10.1073/pnas.1730940100", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB15", "unstructured": "15.\u2002 Bock C T , Schranz P , Schroder C H , Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes 1994; 8: 215-29.", "DOI": "10.1007/BF01703079", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB16", "unstructured": "16.\u2002 Newbold J E , Xin H , Tencza M , et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minochromosomes. J Virol 1995; 69: 3350-7."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB17", "author": "Ganem", "first-page": "2923", "year": "2001", "volume-title": "Fields Virology"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB18", "unstructured": "18.\u2002 Bartenschlager R , Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J 1992; 11: 3413-20.", "DOI": "10.1002/j.1460-2075.1992.tb05420.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB19", "unstructured": "19.\u2002 Zoulim F , Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol 1994; 68: 6-13."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB20", "unstructured": "20.\u2002 Will H , Reiser W , Weimer T , et al. Replication strategy of human hepatitis B virus. J Virol 1987; 61: 904-11."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB21", "author": "Kann", "first-page": "77", "year": "1998", "volume-title": "Viral Hepatitis"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB22", "unstructured": "22.\u2002 Gerelsaikhan T , Tavis J E , Bruss V. Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis. J Virol 1996; 70: 4269-74."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB23", "unstructured": "23.\u2002 Stuyver L , De Gendt S , Van Geyt C , et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000; 81 (part 1): 67-74.", "DOI": "10.1099/0022-1317-81-1-67", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB24", "unstructured": "24.\u2002 Norder H , Courouce A M , Coursaget P , et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47: 289-309.", "DOI": "10.1159/000080872", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB25", "unstructured": "25.\u2002 Lewin S R , Ribeiro R M , Walters T , et al. Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology 2001; 34: 1012-20.", "DOI": "10.1053/jhep.2001.28509", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB26", "unstructured": "26.\u2002 Scaglioni P P , Melegari M , Wands J R. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol 1997; 71: 345-53."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB27", "unstructured": "27.\u2002 Hunt C M , McGill J M , Allen M I , Condreay L D. Clinical relevance of hepatitis B viral mutations. Hepatology 2000; 31: 1037-44.", "DOI": "10.1053/he.2000.6709", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB28", "unstructured": "28.\u2002 Locarnini S , Shaw T , Dean J , et al. Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells. J Clin Virol 2005; 32: 113-21.", "DOI": "10.1016/j.jcv.2004.10.002", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB29", "unstructured": "29.\u2002 Milich D R , Jones J E , Hughes J L , et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci USA 1990; 87: 6599-603."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB30", "unstructured": "30.\u2002 Omata M , Ehata T , Yokosuka O , Hosoda K , Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699-704.", "DOI": "10.1056/NEJM199106133242404", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB31", "unstructured": "31.\u2002 Bartholomeusz A , Schaefer S. Hepatitis B virus genotypes: comparison of genotyping methods. Rev Med Virol 2004; 14: 3-16.", "DOI": "10.1002/rmv.400", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB32", "unstructured": "32.\u2002 Lok A S , Akarca U , Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci USA 1994; 91: 4077-81.", "DOI": "10.1073/pnas.91.9.4077", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB33", "unstructured": "33.\u2002 Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987; 196: 947-50.", "DOI": "10.1016/0022-2836(87)90418-9", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB34", "unstructured": "34.\u2002 Ahn S H , Kramvis A , Kawai S , et al. Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production. Gastroenterology 2003; 125: 1370-8.", "DOI": "10.1016/j.gastro.2003.07.016", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB35", "unstructured": "35.\u2002 Takahashi K , Aoyama K , Ohno N , et al. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol 1995; 76 (part 12): 3159-64.", "DOI": "10.1099/0022-1317-76-12-3159", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB36", "unstructured": "36.\u2002 Hsia C C , Yuwen H , Tabor E. Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma. Lancet 1996; 348: 625-6.", "DOI": "10.1016/S0140-6736(05)64851-9", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB37", "unstructured": "37.\u2002 Fang Z L , Ling R , Wang S S , et al. HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China. J Med Virol 1998; 56: 18-24.", "DOI": "10.1002/(SICI)1096-9071(199809)56:1<18::AID-JMV4>3.0.CO;2-Q", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB38", "unstructured": "38.\u2002 Fang Z L , Yang J , Ge X. Core promoter mutations (A(1762)T and G(1764)A) and viral genotype in chronic hepatitis B and hepatocellular carcinoma in Guangxi, China. J Med Virol 2002; 68: 33-40.", "DOI": "10.1002/jmv.10167", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB39", "unstructured": "39.\u2002 Sendi H , Mehrab-Mohseni M , Zali M R , Norder H , Magnius L O. T1764G1766 core promoter double mutants are restricted to hepatitis B virus strains with an A1757 and are common in genotype D. J Gen Virol 2005; 86 (part 9): 2451-8.", "DOI": "10.1099/vir.0.81023-0", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB40", "unstructured": "40.\u2002 Ehata T , Omata M , Yokosuka O , Hosoda K , Ohto M. Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest 1992; 89: 332-8.", "DOI": "10.1172/JCI115581", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB41", "unstructured": "41.\u2002 Le Pogam S , Yuan T , Sahu G , Chatterjee S , Shih C. Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. J Virol 2000; 74: 9099-105.", "DOI": "10.1128/JVI.74.19.9099-9105.2000", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB42", "unstructured": "42.\u2002 Lohr H F , Gerken G , Schlicht H J , Meryer zum Buschenfelde K H , Fleischer B. Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B. J Infect Dis 1993; 68: 1133-9.", "DOI": "10.1093/infdis/168.5.1133", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB43", "unstructured": "43.\u2002 Jung M , Pape G. Immunology of hepatitis B infection. Lancet Infect Dis 2002; 2: 43-50.", "DOI": "10.1016/S1473-3099(01)00172-4", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB44", "unstructured": "44.\u2002 Gunther S , Fischer L , Pult I , Sterneck M , Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999; 52: 25-137.", "DOI": "10.1016/S0065-3527(08)60298-5", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB45", "unstructured": "45.\u2002 Akarca U S , Lok A S. Naturally occurring hepatitis B virus core gene mutations. Hepatology 1995; 22: 50-60."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB46", "unstructured": "46.\u2002 Carman W F , Zanetti A R , Karayiannis P , et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-9.", "DOI": "10.1016/0140-6736(90)91874-A", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB47", "unstructured": "47.\u2002 Carman W F , Trautwein C , van Deursen F J , et al. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology 1996; 24: 489-93.", "DOI": "10.1002/hep.510240304", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB48", "unstructured": "48.\u2002 Shaw T , Locarnini S. Entecavir for the treatment of chronic hepatitis B. Expert Rev Anti Infect Ther 2004; 2: 853-71.", "DOI": "10.1586/14789072.2.6.853", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB49", "unstructured": "49.\u2002 Locarnini S , Hatzakis A , Heathcote J , et al. Management of antiviral resistance in patients with chronic hepatitis B. Antivir Ther 2004; 9: 679-93."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB50", "unstructured": "50.\u2002 Domingo E. Quasispecies and the development of new antiviral strategies. Prog Drug Res 2003; 60: 133-58.", "DOI": "10.1007/978-3-0348-8012-1_4", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB51", "unstructured": "51.\u2002 Stuyver L J , Locarnini S A , Lok A , et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001; 33: 751-7.", "DOI": "10.1053/jhep.2001.22166", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB52", "unstructured": "52.\u2002 Yeh C T , Chien R N , Chu C M , Liau Y F. Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy. Hepatology 2000; 31: 1318-26.", "DOI": "10.1053/jhep.2000.7296", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB53", "unstructured": "53.\u2002 Ogata N , Fujii K , Takigawa S , et al. Novel patterns of amino acid mutations in the hepatitis B virus polymerase in association with resistance to lamivudine therapy in Japanese patients with chronic hepatitis B. J Med Virol 1999; 59: 270-6.", "DOI": "10.1002/(SICI)1096-9071(199911)59:3<270::AID-JMV2>3.0.CO;2-1", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB54", "unstructured": "54.\u2002 Tenney D J , Levine S M , Rose R E , et al. Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine. Antimicrob Agents Chemother 2004; 48: 3498-507.", "DOI": "10.1128/AAC.48.9.3498-3507.2004", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB55", "unstructured": "55.\u2002 Delaney W E IV , Yang H , Westland C E , et al. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J Virol 2003; 77: 11833-41.", "DOI": "10.1128/JVI.77.21.11833-11841.2003", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB56", "unstructured": "56.\u2002 Bartholomeusz A , Locarnini S , Ayres A , et al. Mechanistic basis for hepatitis B virus resistance to acyclic nucleoside phosphonate analogues, adefovir and tenofovir. Hepatology 2005; 42 (Suppl. 1): 594A."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB57", "unstructured": "57.\u2002 Lai C L , Dienstag J , Schiff E , et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis 2003; 36: 687-96.", "DOI": "10.1086/368083", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB58", "unstructured": "58.\u2002 Leung N. Clinical experience with lamivudine. Semin Liver Dis 2002; 22 (Suppl. 1): 15-21.", "DOI": "10.1055/s-2002-35696", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB59", "unstructured": "59.\u2002 Yeon J E , Yoo W , Hong S P , et al. Resistance to adefovir dipivoxil (ADV) in lamivudine-resistant chronic hepatitis B patients treated with ADV. Gut 2006, in press.", "DOI": "10.1136/gut.2005.077099", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB60", "unstructured": "60.\u2002 Bartholomeusz A , Tehan B G , Chalmers D K. Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations. Antivir Ther 2004; 9: 149-60."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB61", "unstructured": "61.\u2002 Delaney W E IV , Locarnini S , Shaw T. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation. Antivir Chem Chemother 2001; 12: 1-35.", "DOI": "10.1177/095632020101200101", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB62", "unstructured": "62.\u2002 Zollner B , Petersen J , Puchhammer-Stockl E , et al. Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology 2004; 39: 42-50.", "DOI": "10.1002/hep.20016", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB63", "unstructured": "63.\u2002 Angus P , Vaughan R , Xiong S , et al. Resistance to adefovir dipivoxil therapy associated with development of a novel mutation in the HBV polymerase. Gastroenterology 2003; 125: 292-7.", "DOI": "10.1016/S0016-5085(03)00939-9", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB64", "unstructured": "64.\u2002 Bartholomeusz A , Locarnini S , Ayres A , et al. Molecular modelling of hepatitis B virus polymerase and adefovir resistance identifies three clusters of mutations. Hepatology 2004; 40 (Suppl. 1): 246A."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB65", "unstructured": "65.\u2002 Schildgen O , Sirma H , Funk A , et al. Variant of hepatitis B virus with primary resistance to adefovir. N Engl J Med 2006; 354: 1807-12.", "DOI": "10.1056/NEJMoa051214", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB66", "unstructured": "66.\u2002 Chang T T , Lai C L . Hepatitis B virus with primary resistance to adefovir. N Engl J Med 2006; 355: 322-3.", "DOI": "10.1056/NEJMc066267", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB67", "unstructured": "67.\u2002 Warner N , Locarnini S A , Colledge D , et al. Molecular modelling of entecavir resistant mutations in the hepatitis B virus polymerase selected during therapy. Hepatology 2004; 40 (Suppl. 1): 245A."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB68", "unstructured": "68.\u2002 Chin R , Shaw T , Torresi J , et al. In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-d-2,6-diaminopurine dioxolane and 2\u2032-fluoro-5-methyl-beta-l-arabinofuranosyluracil. Antimicrob Agents Chemother 2001; 45: 2495-501.", "DOI": "10.1128/AAC.45.9.2495-2501.2001", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB69", "unstructured": "69.\u2002 Angus P , Locarnini S. Lamivudine-resistant hepatitis B virus and ongoing lamivudine therapy: stop the merry-go-round, it's time to get off!. Antivir Ther 2004; 9: 145-8."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB70", "unstructured": "70.\u2002 Ono-Nita S K , Kato N , Shiratori Y , Carrilho F J , Omata M. Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus. Antimicrob Agents Chemother 2002; 46: 2602-5.", "DOI": "10.1128/AAC.46.8.2602-2605.2002", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB71", "unstructured": "71.\u2002 Levine S , Hernandez D , Yamanaka G , et al. Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro. Antimicrob Agents Chemother 2002; 46: 2525-32.", "DOI": "10.1128/AAC.46.8.2525-2532.2002", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB72", "unstructured": "72.\u2002 Richman D D. The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B. Hepatology 2000; 32: 866-7.", "DOI": "10.1053/jhep.2000.18194", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB73", "unstructured": "73.\u2002 Locarnini S , Birch C. Antiviral chemotherapy for chronic hepatitis B infection: lessons learned from treating HIV infected patients. J Hepatol 1999; 30: 536-50.", "DOI": "10.1016/S0168-8278(99)80118-4", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB74", "unstructured": "74.\u2002 Yang H I , Lu S N , Liaw Y F , et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168-74.", "DOI": "10.1056/NEJMoa013215", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB75", "unstructured": "75.\u2002 Chen C J , Yang H I , Su J , et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.", "DOI": "10.1001/jama.295.1.65", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB76", "unstructured": "76.\u2002 Iloeje U H , Yang H I , Su J , et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006; 130: 678-86.", "DOI": "10.1053/j.gastro.2005.11.016", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB77", "unstructured": "77.\u2002 Marcellin P , Lau G K , Bonino F , et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2004; 351: 1206-17.", "DOI": "10.1056/NEJMoa040431", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB78", "unstructured": "78.\u2002 Lau G K , Piratvisuth T , Luo K X , et al. Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 2005; 352: 2682-95.", "DOI": "10.1056/NEJMoa043470", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB79", "unstructured": "79.\u2002 Shaw T , Locarnini S. Combination chemotherapy for hepatitis B virus: the path forward? Drugs 2000; 60: 517-31."}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB80", "unstructured": "80.\u2002 Shaw T , Locarnini S A. Preclinical aspects of lamivudine and famciclovir against hepatitis B virus. J Viral Hepatol 1999; 6: 89-106.", "DOI": "10.1046/j.1365-2893.1999.00151.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB81", "unstructured": "81.\u2002 Shaw T , Locarnini S A. Hepatic purine and pyrimidine metabolism: implications for antiviral chemotherapy of viral hepatitis. Liver 1995; 15: 169-84.", "DOI": "10.1111/j.1600-0676.1995.tb00667.x", "doi-asserted-by": "crossref"}, {"key": "10.1111/j.1478-3231.2006.01371.x-BIB82", "unstructured": "82.\u2002 Gauthier J , Bourne E J , Lutz M W , et al. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis 1999; 180: 1757-62.", "DOI": "10.1086/315147", "doi-asserted-by": "crossref"}], "container-title": ["Liver International"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1478-3231.2006.01371.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 22]], "date-time": "2019-04-22T07:19:46Z", "timestamp": 1555917586000}, "score": 35.89053, "issued": {"date-parts": [[2006, 12]]}, "references-count": 82, "journal-issue": {"published-print": {"date-parts": [[2006, 12]]}, "issue": "S2"}, "URL": "http://dx.doi.org/10.1111/j.1478-3231.2006.01371.x", "relation": {"cites": []}, "ISSN": ["1478-3223", "1478-3231"], "issn-type": [{"value": "1478-3223", "type": "print"}, {"value": "1478-3231", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T19:26:37Z", "timestamp": 1574191597602}, "reference-count": 14, "publisher": "Wiley", "issue": "S1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3530, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Med. Virol."], "published-print": {"date-parts": [[2006]]}, "DOI": "10.1002/jmv.20608", "type": "journal-article", "created": {"date-parts": [[2006, 4, 18]], "date-time": "2006-04-18T22:50:39Z", "timestamp": 1145400639000}, "page": "S52-S55", "source": "Crossref", "is-referenced-by-count": 62, "title": ["Hepatitis B virus mutations associated with antiviral therapy"], "prefix": "10.1002", "volume": "78", "author": [{"given": "A.", "family": "Bartholomeusz", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Locarnini", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2006]]}, "reference": [{"key": "10.1002/jmv.20608-BIB1", "author": "Angus", "volume": "125", "first-page": "292", "year": "2003", "journal-title": "Gastroenterology", "DOI": "10.1016/S0016-5085(03)00939-9", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB2", "author": "Bartholomeusz", "volume": "9", "first-page": "149", "year": "2004", "journal-title": "Antivir Ther"}, {"key": "10.1002/jmv.20608-BIB3", "author": "Benhamou", "volume": "30", "first-page": "1302", "year": "1999", "journal-title": "Hepatology", "DOI": "10.1002/hep.510300525", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB4", "author": "Besisik", "volume": "38", "first-page": "506", "year": "2003", "journal-title": "J Hepatol", "DOI": "10.1016/S0168-8278(02)00457-9", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB5", "author": "Chen", "volume": "93", "first-page": "1997", "year": "1996", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.93.5.1997", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB6", "author": "Delaney", "volume": "77", "first-page": "11833", "year": "2003", "journal-title": "J Virol", "DOI": "10.1128/JVI.77.21.11833-11841.2003", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB7", "author": "Liaw", "volume": "119", "first-page": "172", "year": "2000", "journal-title": "Gastroenterology", "DOI": "10.1053/gast.2000.8559", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB8", "author": "Locarnini", "volume": "9", "first-page": "679", "year": "2004", "journal-title": "Antivir Ther"}, {"key": "10.1002/jmv.20608-BIB9", "author": "Lok", "volume": "10", "first-page": "46", "year": "1992", "journal-title": "Dig Dis", "DOI": "10.1159/000171343", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB10", "author": "Summers", "volume": "72", "first-page": "4597", "year": "1975", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.72.11.4597", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB11", "author": "Tenney", "volume": "48", "first-page": "3498", "year": "2004", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.48.9.3498-3507.2004", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB12", "author": "Torresi", "volume": "293", "first-page": "305", "year": "2002", "journal-title": "Virology", "DOI": "10.1006/viro.2001.1246", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB13", "author": "Vietheer", "volume": "79", "first-page": "6570", "year": "2005", "journal-title": "J Virol", "DOI": "10.1128/JVI.79.10.6570-6573.2005", "doi-asserted-by": "crossref"}, {"key": "10.1002/jmv.20608-BIB14", "author": "Westland", "volume": "38", "first-page": "96", "year": "2003", "journal-title": "Hepatology", "DOI": "10.1053/jhep.2003.50288", "doi-asserted-by": "crossref"}], "container-title": ["Journal of Medical Virology"], "language": "en", "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.20608", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 8]], "date-time": "2019-01-08T20:25:29Z", "timestamp": 1546979129000}, "score": 35.264244, "issued": {"date-parts": [[2006]]}, "references-count": 14, "journal-issue": {"published-print": {"date-parts": [[2006]]}, "issue": "S1"}, "URL": "http://dx.doi.org/10.1002/jmv.20608", "relation": {"cites": []}, "ISSN": ["0146-6615", "1096-9071"], "issn-type": [{"value": "0146-6615", "type": "print"}, {"value": "1096-9071", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:17:42Z", "timestamp": 1574137062975}, "reference-count": 118, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2002, 12, 1]], "date-time": "2002-12-01T00:00:00Z", "timestamp": 1038700800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Clinical Virology"], "published-print": {"date-parts": [[2002, 12]]}, "DOI": "10.1016/s1386-6532(02)00107-5", "type": "journal-article", "created": {"date-parts": [[2002, 11, 4]], "date-time": "2002-11-04T20:06:14Z", "timestamp": 1036440374000}, "page": "267-283", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Antiviral therapy for hepatitis B virus infections: new targets and technical challenges"], "prefix": "10.1016", "volume": "25", "author": [{"given": "Jordan", "family": "Feld", "sequence": "first", "affiliation": []}, {"given": "Stephen", "family": "Locarnini", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Clinical Virology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1386653202001075?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1386653202001075?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 8]], "date-time": "2019-04-08T01:26:30Z", "timestamp": 1554686790000}, "score": 34.646496, "issued": {"date-parts": [[2002, 12]]}, "references-count": 118, "journal-issue": {"published-print": {"date-parts": [[2002, 12]]}, "issue": "3"}, "alternative-id": ["S1386653202001075"], "URL": "http://dx.doi.org/10.1016/s1386-6532(02)00107-5", "ISSN": ["1386-6532"], "issn-type": [{"value": "1386-6532", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T15:15:18Z", "timestamp": 1575472518925}, "reference-count": 8, "publisher": "American Society for Microbiology", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Virology"], "published-print": {"date-parts": [[2014, 6, 1]]}, "DOI": "10.1128/jvi.00234-14", "type": "journal-article", "created": {"date-parts": [[2014, 5, 6]], "date-time": "2014-05-06T17:08:56Z", "timestamp": 1399396136000}, "page": "6532-6532", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Commonly Found Variations/Mutations in the HBsAg of Hepatitis B Virus in the Context of Effective Immunization Programs: Questionable Clinical and Public Health Significance"], "prefix": "10.1128", "volume": "88", "author": [{"given": "S.", "family": "Locarnini", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Shouval", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[2014, 5, 6]]}, "reference": [{"key": "key20180919084534_B1", "doi-asserted-by": "publisher", "first-page": "12196", "DOI": "10.1128/JVI.02127-13", "article-title": "Change in hepatitis B virus large surface antigen variant prevalence 13 years after implementation of a universal vaccination program in China", "volume": "87", "author": "Bian", "year": "2013", "journal-title": "J. Virol."}, {"key": "key20180919084534_B2", "first-page": "393", "article-title": "Universal hepatitis B vaccination in China boosts breakthrough mutant viruses", "volume": "8", "author": "Bian", "year": "2013", "journal-title": "Microbe"}, {"key": "key20180919084534_B3", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/0140-6736(90)91874-A", "article-title": "Vaccine-induced escape mutant of hepatitis B virus", "volume": "336", "author": "Carman", "year": "1990", "journal-title": "Lancet"}, {"key": "key20180919084534_B4", "doi-asserted-by": "publisher", "first-page": "1483", "DOI": "10.1002/hep.22796", "article-title": "Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model", "volume": "49", "author": "Kamili", "year": "2009", "journal-title": "Hepatology"}, {"key": "key20180919084534_B5", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.1002/hep.510270138", "article-title": "Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation", "volume": "27", "author": "Protzer-Knolle", "year": "1998", "journal-title": "Hepatology"}, {"key": "key20180919084534_B6", "doi-asserted-by": "publisher", "first-page": "2791", "DOI": "10.1016/j.vaccine.2004.01.046", "article-title": "Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries", "volume": "22", "author": "Basuni", "year": "2004", "journal-title": "Vaccine"}, {"key": "key20180919084534_B7", "doi-asserted-by": "publisher", "first-page": "290", "DOI": "10.1053/j.gastro.2012.06.026", "article-title": "Increased prevalence of HBV envelope mutants in Taiwan: an emerging public health risk or a false alarm?", "volume": "143", "author": "Shouval", "year": "2012", "journal-title": "Gastroenterology"}, {"key": "key20180919084534_B8", "doi-asserted-by": "publisher", "first-page": "e00049", "DOI": "10.7554/eLife.00049", "article-title": "Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus", "volume": "1", "author": "Yan", "year": "2012", "journal-title": "eLife"}], "container-title": ["Journal of Virology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/JVI.00234-14", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 21]], "date-time": "2018-09-21T11:20:18Z", "timestamp": 1537528818000}, "score": 34.17291, "issued": {"date-parts": [[2014, 5, 6]]}, "references-count": 8, "journal-issue": {"published-online": {"date-parts": [[2014, 5, 6]]}, "published-print": {"date-parts": [[2014, 6, 1]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1128/jvi.00234-14", "relation": {"cites": []}, "ISSN": ["0022-538X"], "issn-type": [{"value": "0022-538X", "type": "print"}], "subject": ["Immunology", "Insect Science", "Microbiology", "Virology"]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T21:24:52Z", "timestamp": 1576790692958}, "reference-count": 104, "publisher": "Future Medicine Ltd", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Future Virology"], "published-print": {"date-parts": [[2006, 5]]}, "DOI": "10.2217/17460794.1.3.349", "type": "journal-article", "created": {"date-parts": [[2006, 5, 12]], "date-time": "2006-05-12T13:05:55Z", "timestamp": 1147439155000}, "page": "349-360", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The clinical virology of hepatitis B"], "prefix": "10.2217", "volume": "1", "author": [{"given": "Peter", "family": "Revill", "sequence": "first", "affiliation": []}, {"given": "Stephen", "family": "Locarnini", "sequence": "additional", "affiliation": []}], "member": "1057", "reference": [{"key": "ref-1", "DOI": "10.1046/j.1365-2893.2003.00400.x", "doi-asserted-by": "publisher"}, {"key": "ref-2", "DOI": "10.1159/000080872", "doi-asserted-by": "publisher"}, {"key": "ref-3", "unstructured": "GanemD, Schneider R: Hepadnaviridae: The viruses and their replication. In:Fields Virology.Knipe D, Howley PM (Eds). Lippincott-Raven, Philadelphia, PA, USA,2923\u20132970 (2001)."}, {"key": "ref-4", "DOI": "10.1128/JVI.75.15.6874-6883.2001", "doi-asserted-by": "publisher"}, {"key": "ref-5", "DOI": "10.1128/JVI.75.22.10779-10786.2001", "doi-asserted-by": "publisher"}, {"key": "ref-6", "DOI": "10.1016/0042-6822(90)90206-7", "doi-asserted-by": "publisher"}, {"key": "ref-7", "author": "Yang", "volume": "73", "first-page": "9710", "year": "1999", "journal-title": "J. Virol."}, {"key": "ref-8", "DOI": "10.1053/j.gastro.2004.09.016", "doi-asserted-by": "publisher"}, {"key": "ref-9", "DOI": "10.1006/viro.1997.8863", "doi-asserted-by": "publisher"}, {"key": "ref-10", "DOI": "10.1016/S0168-8278(02)00422-1", "doi-asserted-by": "publisher"}, {"key": "ref-11", "DOI": "10.1172/JCI8098", "doi-asserted-by": "publisher"}, {"key": "ref-12", "DOI": "10.1006/viro.2000.0478", "doi-asserted-by": "publisher"}, {"key": "ref-13", "author": "Obert", "volume": "15", "first-page": "2565", "year": "1996", "journal-title": "EMBO J.", "DOI": "10.1002/j.1460-2075.1996.tb00614.x", "doi-asserted-by": "crossref"}, {"key": "ref-14", "DOI": "10.1099/vir.0.80029-0", "doi-asserted-by": "publisher"}, {"key": "ref-15", "author": "Su", "volume": "63", "first-page": "4011", "year": "1989", "journal-title": "J. Virol."}, {"key": "ref-16", "DOI": "10.1073/pnas.86.21.8422", "doi-asserted-by": "publisher"}, {"key": "ref-17", "author": "Terre", "volume": "65", "first-page": "5539", "year": "1991", "journal-title": "J. Virol."}, {"key": "ref-18", "DOI": "10.1002/hep.510240401", "doi-asserted-by": "publisher"}, {"key": "ref-19", "DOI": "10.1053/jhep.2001.22166", "doi-asserted-by": "publisher"}, {"key": "ref-20", "author": "Rosmorduc", "volume": "80", "first-page": "1253", "year": "1999", "journal-title": "J. Gen. Virol.", "DOI": "10.1099/0022-1317-80-5-1253", "doi-asserted-by": "crossref"}, {"key": "ref-21", "DOI": "10.1128/JVI.75.6.2684-2691.2001", "doi-asserted-by": "publisher"}, {"key": "ref-22", "DOI": "10.1016/S0092-8674(00)81666-9", "doi-asserted-by": "publisher"}, {"key": "ref-23", "author": "Zufferey", "volume": "73", "first-page": "2886", "year": "1999", "journal-title": "J. Virol."}, {"key": "ref-24", "author": "Arauz-Ruiz", "volume": "83", "first-page": "2059", "year": "2002", "journal-title": "J. Gen. Virol.", "DOI": "10.1099/0022-1317-83-8-2059", "doi-asserted-by": "crossref"}, {"key": "ref-25", "DOI": "10.1016/S0016-5085(03)00895-3", "doi-asserted-by": "publisher"}, {"key": "ref-26", "DOI": "10.1099/0022-1317-73-12-3141", "doi-asserted-by": "publisher"}, {"key": "ref-27", "DOI": "10.1099/0022-1317-69-10-2575", "doi-asserted-by": "publisher"}, {"key": "ref-28", "author": "Kramvis", "volume": "83", "first-page": "835", "year": "2002", "journal-title": "J. Gen. Virol.", "DOI": "10.1099/0022-1317-83-4-835", "doi-asserted-by": "crossref"}, {"key": "ref-29", "DOI": "10.1099/vir.0.19749-0", "doi-asserted-by": "publisher"}, {"key": "ref-30", "unstructured": "MbayedVA, Barbini L, Lopez JL, Campos RH: Phylogenetic analysis of the hepatitis B virus (HBV) genotype F including Argentine isolates.Arch. Virol.146(9),1803\u20131810 (2001).", "DOI": "10.1007/s007050170066", "doi-asserted-by": "crossref"}, {"key": "ref-31", "DOI": "10.1086/382885", "doi-asserted-by": "publisher"}, {"key": "ref-32", "DOI": "10.1016/S0016-5085(00)70261-7", "doi-asserted-by": "publisher"}, {"key": "ref-33", "DOI": "10.1080/00365520310000500", "doi-asserted-by": "publisher"}, {"key": "ref-34", "DOI": "10.1016/S1386-6346(01)00120-6", "doi-asserted-by": "publisher"}, {"key": "ref-35", "DOI": "10.1007/s535-002-8130-z", "doi-asserted-by": "publisher"}, {"key": "ref-36", "DOI": "10.1046/j.1365-2893.2000.00236.x", "doi-asserted-by": "publisher"}, {"key": "ref-37", "DOI": "10.1053/jhep.2001.27221", "doi-asserted-by": "publisher"}, {"key": "ref-38", "DOI": "10.1002/jmv.10127", "doi-asserted-by": "publisher"}, {"key": "ref-39", "DOI": "10.1046/j.1440-1746.2002.02754.x", "doi-asserted-by": "publisher"}, {"key": "ref-40", "DOI": "10.1016/S0140-6736(05)17701-0", "doi-asserted-by": "publisher"}, {"key": "ref-41", "DOI": "10.1046/j.1440-1746.2002.02605.x", "doi-asserted-by": "publisher"}, {"key": "ref-42", "DOI": "10.1093/jac/dkh533", "doi-asserted-by": "publisher"}, {"key": "ref-43", "DOI": "10.1053/gast.2003.50140", "doi-asserted-by": "publisher"}, {"key": "ref-44", "author": "Bowyer", "volume": "78", "first-page": "1719", "year": "1997", "journal-title": "J. Gen. Virol.", "DOI": "10.1099/0022-1317-78-7-1719", "doi-asserted-by": "crossref"}, {"key": "ref-45", "DOI": "10.1099/vir.0.79811-0", "doi-asserted-by": "publisher"}, {"key": "ref-46", "DOI": "10.1099/vir.0.80972-0", "doi-asserted-by": "publisher"}, {"key": "ref-47", "DOI": "10.1002/jmv.20311", "doi-asserted-by": "publisher"}, {"key": "ref-48", "DOI": "10.1016/j.jcv.2004.10.009", "doi-asserted-by": "publisher"}, {"key": "ref-49", "DOI": "10.1097/00007890-199810150-00012", "doi-asserted-by": "publisher"}, {"key": "ref-50", "DOI": "10.1086/496924", "doi-asserted-by": "publisher"}, {"key": "ref-51", "unstructured": "BowdenS: Laboratory diagnosis of hepatitis B infection. In:Hepatitis B Virus.Lai CL Locarnini SA (Eds). International Medical Press, London,145\u2013159 (2002)."}, {"key": "ref-52", "DOI": "10.1016/0016-5085(87)90613-5", "doi-asserted-by": "publisher"}, {"key": "ref-53", "DOI": "10.7326/0003-4819-135-9-200111060-00006", "doi-asserted-by": "publisher"}, {"key": "ref-54", "DOI": "10.1053/j.gastro.2005.11.016", "doi-asserted-by": "publisher"}, {"key": "ref-55", "DOI": "10.7326/0003-4819-94-6-744", "doi-asserted-by": "publisher"}, {"key": "ref-56", "author": "Realdi", "volume": "79", "first-page": "195", "year": "1980", "journal-title": "Gastroenterology"}, {"key": "ref-57", "DOI": "10.1073/pnas.87.17.6599", "doi-asserted-by": "publisher"}, {"key": "ref-58", "DOI": "10.1073/pnas.91.9.4077", "doi-asserted-by": "publisher"}, {"key": "ref-59", "DOI": "10.1053/he.2000.6709", "doi-asserted-by": "publisher"}, {"key": "ref-60", "author": "Scaglioni", "volume": "71", "first-page": "345", "year": "1997", "journal-title": "J. Virol."}, {"key": "ref-61", "DOI": "10.1159/000086066", "doi-asserted-by": "publisher"}, {"key": "ref-62", "DOI": "10.1128/JCM.43.12.6000-6006.2005", "doi-asserted-by": "publisher"}, {"key": "ref-63", "DOI": "10.1016/j.jhep.2005.08.022", "doi-asserted-by": "publisher"}, {"key": "ref-64", "DOI": "10.1016/0022-2836(87)90418-9", "doi-asserted-by": "publisher"}, {"key": "ref-65", "DOI": "10.1016/j.gastro.2003.07.016", "doi-asserted-by": "publisher"}, {"key": "ref-66", "author": "Yuan", "volume": "72", "first-page": "578", "year": "1998", "journal-title": "J. Virol."}, {"key": "ref-67", "author": "Yuan", "volume": "72", "first-page": "2168", "year": "1998", "journal-title": "J. Virol."}, {"key": "ref-68", "unstructured": "TanakaH, Ueda H, Hamagami Het al.: Mutations in hepatitis B virus core regions correlate with hepatocellular injury in Chinese patients with chronic hepatitis B.World J. Gastroenterol11(30),4693\u20134696 (2005).", "DOI": "10.3748/wjg.v11.i30.4693", "doi-asserted-by": "crossref"}, {"key": "ref-69", "DOI": "10.1016/0270-9139(95)90352-6", "doi-asserted-by": "publisher"}, {"key": "ref-70", "author": "Chuang", "volume": "104", "first-page": "263", "year": "1993", "journal-title": "Gastroenterology", "DOI": "10.1016/0016-5085(93)90861-6", "doi-asserted-by": "crossref"}, {"key": "ref-71", "DOI": "10.1172/JCI116281", "doi-asserted-by": "publisher"}, {"key": "ref-72", "DOI": "10.1172/JCI115581", "doi-asserted-by": "publisher"}, {"key": "ref-73", "DOI": "10.1111/j.1365-2893.2005.00552.x", "doi-asserted-by": "publisher"}, {"key": "ref-74", "DOI": "10.1002/jmv.20016", "doi-asserted-by": "publisher"}, {"key": "ref-75", "DOI": "10.1128/JVI.80.2.643-653.2006", "doi-asserted-by": "publisher"}, {"key": "ref-76", "DOI": "10.1086/368083", "doi-asserted-by": "publisher"}, {"key": "ref-77", "DOI": "10.1016/S0016-5085(03)00939-9", "doi-asserted-by": "publisher"}, {"key": "ref-78", "DOI": "10.1056/NEJMoa042957", "doi-asserted-by": "publisher"}, {"key": "ref-79", "DOI": "10.1128/AAC.48.9.3498-3507.2004", "doi-asserted-by": "publisher"}, {"key": "ref-80", "DOI": "10.1016/S0065-3527(08)60298-5", "doi-asserted-by": "publisher"}, {"key": "ref-81", "DOI": "10.1002/hep.510240304", "doi-asserted-by": "publisher"}, {"key": "ref-82", "DOI": "10.1093/jac/dkf061", "doi-asserted-by": "publisher"}, {"key": "ref-83", "DOI": "10.1053/jhep.2000.19622", "doi-asserted-by": "publisher"}, {"key": "ref-84", "DOI": "10.1128/JVI.78.23.12725-12734.2004", "doi-asserted-by": "publisher"}, {"key": "ref-85", "DOI": "10.1053/j.gastro.2004.03.018", "doi-asserted-by": "publisher"}, {"key": "ref-86", "DOI": "10.1053/j.gastro.2005.03.009", "doi-asserted-by": "publisher"}, {"key": "ref-87", "author": "Kim", "volume": "10", "first-page": "441", "year": "2005", "journal-title": "Antivir. Ther."}, {"key": "ref-88", "DOI": "10.1021/bp0496474", "doi-asserted-by": "publisher"}, {"key": "ref-89", "DOI": "10.1056/NEJMoa043470", "doi-asserted-by": "publisher"}, {"key": "ref-90", "DOI": "10.1016/j.molimm.2004.11.007", "doi-asserted-by": "publisher"}, {"key": "ref-91", "DOI": "10.1128/JVI.76.17.8729-8736.2002", "doi-asserted-by": "publisher"}, {"key": "ref-92", "DOI": "10.1073/pnas.0400525101", "doi-asserted-by": "publisher"}, {"key": "ref-93", "DOI": "10.1126/science.1093616", "doi-asserted-by": "publisher"}, {"key": "ref-94", "DOI": "10.1182/blood-2003-08-2674", "doi-asserted-by": "publisher"}, {"key": "ref-95", "DOI": "10.1172/JCI11918", "doi-asserted-by": "publisher"}, {"key": "ref-96", "DOI": "10.1073/pnas.160027697", "doi-asserted-by": "publisher"}, {"key": "ref-97", "DOI": "10.1084/jem.20021652", "doi-asserted-by": "publisher"}, {"key": "ref-98", "DOI": "10.1084/jem.20041442", "doi-asserted-by": "publisher"}, {"key": "ref-99", "author": "Visvanathan", "volume": "38", "first-page": "138A", "year": "2004", "journal-title": "Hepatology"}, {"key": "ref-100", "DOI": "10.1128/JVI.79.18.12095-12099.2005", "doi-asserted-by": "publisher"}, {"key": "ref-101", "DOI": "10.1126/science.1113329", "doi-asserted-by": "publisher"}, {"key": "ref-102", "DOI": "10.1126/science.1108784", "doi-asserted-by": "publisher"}, {"key": "ref-103", "DOI": "10.1074/jbc.M307089200", "doi-asserted-by": "publisher"}, {"key": "ref-104", "DOI": "10.1016/j.febslet.2005.08.034", "doi-asserted-by": "publisher"}], "container-title": ["Future Virology"], "language": "en", "link": [{"URL": "https://www.futuremedicine.com/doi/pdf/10.2217/17460794.1.3.349", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:20:54Z", "timestamp": 1574245254000}, "score": 32.828003, "issued": {"date-parts": [[2006, 5]]}, "references-count": 104, "journal-issue": {"published-print": {"date-parts": [[2006, 5]]}, "issue": "3"}, "alternative-id": ["10.2217/17460794.1.3.349"], "URL": "http://dx.doi.org/10.2217/17460794.1.3.349", "relation": {"cites": []}, "ISSN": ["1746-0794", "1746-0808"], "issn-type": [{"value": "1746-0794", "type": "print"}, {"value": "1746-0808", "type": "electronic"}], "subject": ["Virology"]}, {"indexed": {"date-parts": [[2019, 11, 29]], "date-time": "2019-11-29T17:07:03Z", "timestamp": 1575047223853}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 8, 1]], "date-time": "1994-08-01T00:00:00Z", "timestamp": 775699200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Virology"], "published-print": {"date-parts": [[1994, 8]]}, "DOI": "10.1006/viro.1994.1457", "type": "journal-article", "created": {"date-parts": [[2002, 9, 19]], "date-time": "2002-09-19T13:00:16Z", "timestamp": 1032440416000}, "page": "81-89", "source": "Crossref", "is-referenced-by-count": 34, "title": ["The Half-Life of Duck Hepatitis B Virus Supercoiled DNA in Congenitally Infected Primary Hepatocyte Cultures"], "prefix": "10.1006", "volume": "203", "author": [{"given": "Gilda M.", "family": "Civitico", "sequence": "first", "affiliation": []}, {"given": "Stephen A.", "family": "Locarnini", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Virology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0042682284714577?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0042682284714577?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 8]], "date-time": "2019-05-08T22:27:09Z", "timestamp": 1557354429000}, "score": 32.10966, "issued": {"date-parts": [[1994, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1994, 8]]}, "issue": "1"}, "alternative-id": ["S0042682284714577"], "URL": "http://dx.doi.org/10.1006/viro.1994.1457", "ISSN": ["0042-6822"], "issn-type": [{"value": "0042-6822", "type": "print"}], "subject": ["Virology"]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T21:51:05Z", "timestamp": 1574113865772}, "reference-count": 122, "publisher": "Wiley", "issue": "2", "license": [{"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2002, 2, 28]], "date-time": "2002-02-28T00:00:00Z", "timestamp": 1014854400000}, "delay-in-days": 1095, "content-version": "vor"}, {"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[1999, 3, 1]], "date-time": "1999-03-01T00:00:00Z", "timestamp": 920246400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Viral Hepatitis"], "published-print": {"date-parts": [[1999, 3]]}, "DOI": "10.1046/j.1365-2893.1999.00151.x", "type": "journal-article", "created": {"date-parts": [[2003, 3, 12]], "date-time": "2003-03-12T09:17:06Z", "timestamp": 1047460626000}, "page": "89-106", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Preclinical aspects of lamivudine and famciclovir against hepatitis B virus"], "prefix": "10.1111", "volume": "6", "author": [{"given": "T.", "family": "Shaw", "sequence": "first", "affiliation": [{"name": "Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia"}]}, {"given": "S. A.", "family": "Locarnini", "sequence": "additional", "affiliation": [{"name": "Victorian Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia"}]}], "member": "311", "published-online": {"date-parts": [[2002, 4, 8]]}, "reference": [{"key": "b1_48", "author": "Lok ASF", "volume": "6", "first-page": "105", "year": "1994", "journal-title": "J Viral Hep"}, {"key": "b2_49", "author": "Shaw T", "volume": "6", "first-page": "169", "year": "1995", "journal-title": "Liver"}, {"key": "b3_50", "DOI": "10.1002/(SICI)1099-1557(199701)6:1<1::AID-PDS247>3.0.CO;2-7", "doi-asserted-by": "publisher"}, {"key": "b4_51", "author": "Nassal M", "volume": "6", "first-page": "217", "year": "1996", "journal-title": "J Viral Hep", "DOI": "10.1111/j.1365-2893.1996.tb00047.x", "doi-asserted-by": "crossref"}, {"key": "b5_52", "author": "Sommadossi J-P", "volume": "6", "first-page": "678", "year": "1994", "journal-title": "Curr Opin Infect Dis", "DOI": "10.1097/00001432-199412000-00009", "doi-asserted-by": "crossref"}, {"key": "b6_53", "author": "Meuth M", "volume": "6", "first-page": "305", "year": "1989", "journal-title": "Exp Cell Res", "DOI": "10.1016/0014-4827(89)90090-6", "doi-asserted-by": "crossref"}, {"key": "b7_54", "author": "Griffith DA", "volume": "6", "first-page": "153", "year": "1996", "journal-title": "Biochim Biophys Acta", "DOI": "10.1016/S0304-4157(96)00008-1", "doi-asserted-by": "crossref"}, {"key": "b8_55", "DOI": "10.1016/0163-7258(95)00015-9", "doi-asserted-by": "publisher"}, {"key": "b9_56", "author": "Felipe A", "volume": "6", "first-page": "997", "year": "1998", "journal-title": "Biochem J", "DOI": "10.1042/bj3300997", "doi-asserted-by": "crossref"}, {"key": "b10_57", "DOI": "10.1073/pnas.94.22.11941", "doi-asserted-by": "publisher"}, {"key": "b11_58", "author": "Johansson M", "volume": "6", "first-page": "8454", "year": "1997", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.272.13.8454", "doi-asserted-by": "crossref"}, {"key": "b12_59", "DOI": "10.1073/pnas.93.14.7258", "doi-asserted-by": "publisher"}, {"key": "b13_60", "DOI": "10.1016/0014-5793(96)00623-0", "doi-asserted-by": "publisher"}, {"key": "b14_61", "author": "Harrison PT", "volume": "6", "first-page": "2583", "year": "1991", "journal-title": "J Gen Virol", "DOI": "10.1099/0022-1317-72-10-2583", "doi-asserted-by": "crossref"}, {"key": "b15_62", "author": "Eriksson S", "volume": "6", "first-page": "586", "year": "1991", "journal-title": "Biochem Biophys Res Commun", "DOI": "10.1016/S0006-291X(05)80224-4", "doi-asserted-by": "crossref"}, {"key": "b16_63", "author": "Verri A", "volume": "6", "first-page": "132", "year": "1997", "journal-title": "Mol Pharmacol", "DOI": "10.1124/mol.51.1.132", "doi-asserted-by": "crossref"}, {"key": "b17_64", "author": "Sjoberg AH", "volume": "6", "first-page": "270", "year": "1998", "journal-title": "Mol Pharmacol", "DOI": "10.1124/mol.53.2.270", "doi-asserted-by": "crossref"}, {"key": "b18_65", "author": "Spadari S", "volume": "6", "first-page": "1231", "year": "1995", "journal-title": "Mol Pharmacol"}, {"key": "b19_66", "author": "Verri A", "volume": "6", "first-page": "317", "year": "1997", "journal-title": "Biochem J", "DOI": "10.1042/bj3280317", "doi-asserted-by": "crossref"}, {"key": "b20_67", "unstructured": "20LL Bennett, PW Allan, and G Arnettet al.Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase.Antimicrob Agents Chemother1998; 10451051."}, {"key": "b21_68", "author": "Brady WA", "volume": "6", "first-page": "16734", "year": "1996", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.271.28.16734", "doi-asserted-by": "crossref"}, {"key": "b22_69", "DOI": "10.1073/pnas.93.12.5720", "doi-asserted-by": "publisher"}, {"key": "b23_70", "author": "Huang SH", "volume": "6", "first-page": "461", "year": "1994", "journal-title": "DNA Cell Biol", "DOI": "10.1089/dna.1994.13.461", "doi-asserted-by": "crossref"}, {"key": "b24_71", "author": "Dopheide TA", "volume": "6", "first-page": "173", "year": "1996", "journal-title": "J Gen Virol", "DOI": "10.1099/0022-1317-77-2-173", "doi-asserted-by": "crossref"}, {"key": "b25_72", "DOI": "10.1074/jbc.273.8.4436", "doi-asserted-by": "publisher"}, {"key": "b26_73", "DOI": "10.1074/jbc.273.10.5662", "doi-asserted-by": "publisher"}, {"key": "b27_74", "author": "Bourdais J", "volume": "6", "first-page": "7887", "year": "1996", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.271.14.7887", "doi-asserted-by": "crossref"}, {"key": "b28_75", "author": "Frederiks WM", "volume": "6", "first-page": "86", "year": "1993", "journal-title": "Histochem J", "DOI": "10.1007/BF00161048", "doi-asserted-by": "crossref"}, {"key": "b29_76", "author": "Smith LH", "volume": "6", "first-page": "764", "year": "1973", "journal-title": "N Engl J Med", "DOI": "10.1056/NEJM197304122881505", "doi-asserted-by": "crossref"}, {"key": "b30_77", "author": "Giorgelli F", "volume": "6", "first-page": "6", "year": "1997", "journal-title": "Biochim Biophys Acta"}, {"key": "b31_78", "DOI": "10.1016/0378-1119(84)90205-1", "doi-asserted-by": "publisher"}, {"key": "b32_79", "author": "Laliberte J", "volume": "6", "first-page": "5401", "year": "1994", "journal-title": "Cancer Res"}, {"key": "b33_80", "author": "Ito S", "volume": "6", "first-page": "113", "year": "1990", "journal-title": "Clin Biochem", "DOI": "10.1016/0009-9120(90)80021-A", "doi-asserted-by": "crossref"}, {"key": "b34_81", "author": "Misumi Y", "volume": "6", "first-page": "2178", "year": "1990", "journal-title": "J Biol Chem"}, {"key": "b35_82", "DOI": "10.1006/abbi.1994.1282", "doi-asserted-by": "publisher"}, {"key": "b36_83", "author": "Keller PM", "volume": "6", "first-page": "8664", "year": "1985", "journal-title": "J Biol Chem"}, {"key": "b37_84", "author": "Ganem D", "volume": "6", "first-page": "85", "year": "1994", "journal-title": "Infect Agents Dis"}, {"key": "b38_85", "author": "Zoulim F", "volume": "6", "first-page": "6", "year": "1994", "journal-title": "J Virol"}, {"key": "b39_86", "author": "Focher F", "volume": "6", "first-page": "2840", "year": "1995", "journal-title": "Nucl Acids Res", "DOI": "10.1093/nar/23.15.2840", "doi-asserted-by": "crossref"}, {"key": "b40_87", "DOI": "10.1016/0166-3542(96)00938-2", "doi-asserted-by": "publisher"}, {"key": "b41_88", "author": "Boyd MR", "volume": "6", "first-page": "4", "year": "1993", "journal-title": "Antiviral Chem Chemother"}, {"key": "b42_89", "author": "Vere Hodge RA", "volume": "6", "first-page": "1765", "year": "1989", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.33.10.1765", "doi-asserted-by": "crossref"}, {"key": "b43_90", "author": "Vere Hodge RA", "volume": "6", "first-page": "67", "year": "1993", "journal-title": "Antiviral Chem Chemother"}, {"key": "b44_91", "author": "Perry CM", "volume": "6", "first-page": "396", "year": "1995", "journal-title": "Drugs", "DOI": "10.2165/00003495-199550020-00011", "doi-asserted-by": "crossref"}, {"key": "b45_92", "DOI": "10.1016/S0140-6736(89)91839-4", "doi-asserted-by": "publisher"}, {"key": "b46_93", "author": "Wang Y", "volume": "6", "first-page": "107", "year": "1991", "journal-title": "Antiviral Chem Chemother", "DOI": "10.1177/095632029100200206", "doi-asserted-by": "crossref"}, {"key": "b47_94", "author": "Shaw T", "volume": "6", "first-page": "719", "year": "1994", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.38.4.719", "doi-asserted-by": "crossref"}, {"key": "b48_95", "author": "Lin E", "volume": "6", "first-page": "413", "year": "1996", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.40.2.413", "doi-asserted-by": "crossref"}, {"key": "b49_96", "unstructured": "49E Lin, C Luscombe, YY Wang, D Colledge, and S Locarnini . Long term therapy with penciclovir controls chronic duck hepatitis B virus infectionin vivo. Antimicrob Agents Chemother1998; 42: 21322137."}, {"key": "b50_97", "unstructured": "50KN Tsiquaye, MJ Slomka, and M Maung . Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infectedin ovo. J Med Virol1994; 42: 306310."}, {"key": "b51_98", "author": "Tsiquaye KN", "volume": "6", "first-page": "153", "year": "1994", "journal-title": "Antiviral Chem Chemother"}, {"key": "b52_99", "author": "Korba BE", "volume": "6", "first-page": "1282", "year": "1996", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.40.5.1282", "doi-asserted-by": "crossref"}, {"key": "b53_100", "author": "Main J", "volume": "6", "first-page": "211", "year": "1996", "journal-title": "J Viral Hep", "DOI": "10.1111/j.1365-2893.1996.tb00098.x", "doi-asserted-by": "crossref"}, {"key": "b54_101", "author": "Kruger M", "volume": "6", "first-page": "253", "year": "1996", "journal-title": "Liver Transpl Surg", "DOI": "10.1002/lt.500020402", "doi-asserted-by": "crossref"}, {"key": "b55_102", "author": "Singh N", "volume": "6", "first-page": "1415", "year": "1997", "journal-title": "Transplantation", "DOI": "10.1097/00007890-199705270-00008", "doi-asserted-by": "crossref"}, {"key": "b56_103", "author": "Filer CW", "volume": "6", "first-page": "477", "year": "1995", "journal-title": "Xenobiotica", "DOI": "10.3109/00498259509061867", "doi-asserted-by": "crossref"}, {"key": "b57_104", "author": "Gill KS", "volume": "6", "first-page": "1", "year": "1996", "journal-title": "Clin Pharmacokinet", "DOI": "10.2165/00003088-199631010-00001", "doi-asserted-by": "crossref"}, {"key": "b58_105", "author": "Fowles SE", "volume": "6", "first-page": "355", "year": "1994", "journal-title": "Eur J Clin Pharmacol"}, {"key": "b59_106", "author": "Clarke SE", "volume": "6", "first-page": "251", "year": "1995", "journal-title": "Drug Metab Dispos"}, {"key": "b60_107", "author": "Rashidi MR", "volume": "6", "first-page": "805", "year": "1997", "journal-title": "Drug Metab Dispos"}, {"key": "b61_108", "author": "Shaw T", "volume": "6", "first-page": "996", "year": "1996", "journal-title": "Hepatology", "DOI": "10.1002/hep.510240504", "doi-asserted-by": "crossref"}, {"key": "b62_109", "DOI": "10.1016/0006-2952(95)00052-2", "doi-asserted-by": "publisher"}, {"key": "b63_110", "author": "Smee DF", "volume": "6", "first-page": "75", "year": "1985", "journal-title": "Mol Cell Biochem"}, {"key": "b64_111", "DOI": "10.1016/S0166-3542(97)00034-X", "doi-asserted-by": "publisher"}, {"key": "b65_112", "author": "Dannaoui E", "volume": "6", "first-page": "38", "year": "1997", "journal-title": "Antiviral Chem Chemother", "DOI": "10.1177/095632029700800104", "doi-asserted-by": "crossref"}, {"key": "b66_113", "author": "Ilsley DD", "volume": "6", "first-page": "2504", "year": "1995", "journal-title": "Biochemistry", "DOI": "10.1021/bi00008a014", "doi-asserted-by": "crossref"}, {"key": "b67_114", "unstructured": "67Famvir product information . SmithKline Beecham (International) Pty., Ltd., 1996."}, {"key": "b68_115", "DOI": "10.1016/0166-3542(96)00961-8", "doi-asserted-by": "publisher"}, {"key": "b69_116", "author": "Haynes P", "volume": "6", "first-page": "65", "year": "1996", "journal-title": "Mutat Res", "DOI": "10.1016/S0165-1218(96)90049-X", "doi-asserted-by": "crossref"}, {"key": "b70_117", "author": "Greenberg ML", "volume": "6", "first-page": "517", "year": "1990", "journal-title": "Ann NY Acad Sci", "DOI": "10.1111/j.1749-6632.1990.tb17880.x", "doi-asserted-by": "crossref"}, {"key": "b71_118", "author": "Coates JA", "volume": "6", "first-page": "733", "year": "1992", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.36.4.733", "doi-asserted-by": "crossref"}, {"key": "b72_119", "author": "Hart GJ", "volume": "6", "first-page": "1688", "year": "1992", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.36.8.1688", "doi-asserted-by": "crossref"}, {"key": "b73_120", "author": "Pluda JM", "volume": "6", "first-page": "1438", "year": "1995", "journal-title": "J Infect Dis", "DOI": "10.1093/infdis/171.6.1438", "doi-asserted-by": "crossref"}, {"key": "b74_121", "DOI": "10.1006/abio.1993.1058", "doi-asserted-by": "publisher"}, {"key": "b75_122", "DOI": "10.1016/0141-0229(93)90005-M", "doi-asserted-by": "publisher"}, {"key": "b76_123", "author": "Perry CM", "volume": "6", "first-page": "657", "year": "1997", "journal-title": "Drugs", "DOI": "10.2165/00003495-199753040-00008", "doi-asserted-by": "crossref"}, {"key": "b77_124", "author": "Doong SL", "volume": "6", "first-page": "8495", "year": "1991", "journal-title": "Proc Natl Acad Sci USA", "DOI": "10.1073/pnas.88.19.8495", "doi-asserted-by": "crossref"}, {"key": "b78_125", "author": "Chang C-N", "volume": "6", "first-page": "13938", "year": "1992", "journal-title": "J Biol Chem"}, {"key": "b79_126", "unstructured": "79DLJ Tyrell, K Fisher, and J Cameron . 2',3'-dideoxy-3'-thiacytidine (Lamivudine) treatment of chimpanzees chronically infected with hepatitis B virus (HBV) resulted in a rapid suppression of HBV DNA in sera (abstr 228).Program and abstracts of the 18th International Symposium on Viral Hepatitis and Liver Diseases.Tokyo: Viral Hepatitis Research Foundation of Japan, 1993; p.156."}, {"key": "b80_127", "DOI": "10.1016/S0140-6736(95)90388-7", "doi-asserted-by": "publisher"}, {"key": "b81_128", "DOI": "10.1056/NEJM199512213332501", "doi-asserted-by": "publisher"}, {"key": "b82_129", "author": "Honkoop P", "volume": "6", "first-page": "103", "year": "1997", "journal-title": "Liver"}, {"key": "b83_130", "author": "Nevens F", "volume": "6", "first-page": "1258", "year": "1997", "journal-title": "Gastroenterology", "DOI": "10.1053/gast.1997.v113.pm9322520", "doi-asserted-by": "crossref"}, {"key": "b84_131", "author": "Bain VG", "volume": "6", "first-page": "1456", "year": "1996", "journal-title": "Transplantation", "DOI": "10.1097/00007890-199611270-00013", "doi-asserted-by": "crossref"}, {"key": "b85_132", "author": "Al Faraidy K", "volume": "6", "first-page": "926", "year": "1997", "journal-title": "Transplantation", "DOI": "10.1097/00007890-199709270-00024", "doi-asserted-by": "crossref"}, {"key": "b86_133", "author": "Morris DM", "volume": "6", "first-page": "255", "year": "1994", "journal-title": "J Pharm Biomed Anal", "DOI": "10.1016/0731-7085(94)90037-X", "doi-asserted-by": "crossref"}, {"key": "b87_134", "DOI": "10.1016/S0021-9673(97)00311-7", "doi-asserted-by": "publisher"}, {"key": "b88_135", "author": "Blaney SM", "volume": "6", "first-page": "2779", "year": "1995", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.39.12.2779", "doi-asserted-by": "crossref"}, {"key": "b89_136", "author": "Rajagopalan P", "volume": "6", "first-page": "642", "year": "1996", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.40.3.642", "doi-asserted-by": "crossref"}, {"key": "b90_137", "author": "Hussey EK", "volume": "6", "first-page": "975", "year": "1994", "journal-title": "J Clin Pharmacol", "DOI": "10.1002/j.1552-4604.1994.tb01968.x", "doi-asserted-by": "crossref"}, {"key": "b91_138", "author": "Yuen GJ", "volume": "6", "first-page": "1174", "year": "1995", "journal-title": "J Clin Pharmacol", "DOI": "10.1002/j.1552-4604.1995.tb04043.x", "doi-asserted-by": "crossref"}, {"key": "b92_139", "author": "Plumb RS", "volume": "6", "first-page": "457", "year": "1996", "journal-title": "J Chromatogr B", "DOI": "10.1016/S0378-4347(96)00247-2", "doi-asserted-by": "crossref"}, {"key": "b93_140", "author": "Heald AE", "volume": "6", "first-page": "1514", "year": "1996", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.40.6.1514", "doi-asserted-by": "crossref"}, {"key": "b94_141", "author": "Chang CN", "volume": "6", "first-page": "22414", "year": "1992", "journal-title": "J Biol Chem"}, {"key": "b95_142", "author": "Rahn JJ", "volume": "6", "first-page": "918", "year": "1997", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.41.5.918", "doi-asserted-by": "crossref"}, {"key": "b96_143", "DOI": "10.1016/0006-2952(92)90162-C", "doi-asserted-by": "publisher"}, {"key": "b97_144", "DOI": "10.1016/0006-2952(95)96620-A", "doi-asserted-by": "publisher"}, {"key": "b98_145", "DOI": "10.1016/S0006-2952(97)00189-5", "doi-asserted-by": "publisher"}, {"key": "b99_146", "DOI": "10.1016/0006-2952(93)90058-5", "doi-asserted-by": "publisher"}, {"key": "b100_147", "author": "Severini A", "volume": "6", "first-page": "1430", "year": "1995", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.39.7.1430", "doi-asserted-by": "crossref"}, {"key": "b101_148", "author": "Fischer KP", "volume": "6", "first-page": "1957", "year": "1996", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.40.8.1957", "doi-asserted-by": "crossref"}, {"key": "b102_149", "author": "Colledge D", "volume": "6", "first-page": "216", "year": "1997", "journal-title": "Hepatology"}, {"key": "b103_150", "author": "Moraleda G", "volume": "6", "first-page": "9392", "year": "1997", "journal-title": "J Virol"}, {"key": "b104_151", "unstructured": "104Epivir (lamivudine) product information . Glaxo Wellcome Inc. Research Triangle Park, NC, USA, 1996."}, {"key": "b105_152", "author": "Cui L", "volume": "6", "first-page": "1577", "year": "1996", "journal-title": "Biochem Pharmacol", "DOI": "10.1016/S0006-2952(96)00562-X", "doi-asserted-by": "crossref"}, {"key": "b106_153", "author": "Honkoop P", "volume": "6", "first-page": "211", "year": "1997", "journal-title": "Hepatology", "DOI": "10.1002/hep.510260128", "doi-asserted-by": "crossref"}, {"key": "b107_154", "author": "Back NKT", "volume": "6", "first-page": "4040", "year": "1996", "journal-title": "EMBO J", "DOI": "10.1002/j.1460-2075.1996.tb00777.x", "doi-asserted-by": "crossref"}, {"key": "b108_155", "DOI": "10.1016/S0168-8278(97)80345-5", "doi-asserted-by": "publisher"}, {"key": "b109_156", "volume": "6", "first-page": "83", "year": "1997", "journal-title": "J Mol Evol"}, {"key": "b110_157", "author": "Ling R", "volume": "6", "first-page": "711", "year": "1996", "journal-title": "Hepatology", "DOI": "10.1002/hep.510240339", "doi-asserted-by": "crossref"}, {"key": "b111_158", "DOI": "10.1016/S0168-8278(97)80476-X", "doi-asserted-by": "publisher"}, {"key": "b112_159", "DOI": "10.1016/S0140-6736(96)02266-0", "doi-asserted-by": "publisher"}, {"key": "b113_160", "author": "Tipples GA", "volume": "6", "first-page": "714", "year": "1996", "journal-title": "Hepatology"}, {"key": "b114_161", "DOI": "10.1016/S0168-8278(97)80125-0", "doi-asserted-by": "publisher"}, {"key": "b115_162", "author": "Bartholomeusz A", "volume": "6", "first-page": "322", "year": "1998", "journal-title": "Intervirology"}, {"key": "b116_163", "author": "Melegari M", "volume": "6", "first-page": "628", "year": "1998", "journal-title": "Hepatology", "DOI": "10.1002/hep.510270243", "doi-asserted-by": "crossref"}, {"key": "b117_164", "author": "Fontana RJ", "volume": "6", "first-page": "234", "year": "1997", "journal-title": "Hepatology", "DOI": "10.1002/hep.510260133", "doi-asserted-by": "crossref"}, {"key": "b118_165", "DOI": "10.1016/0166-3542(95)00915-9", "doi-asserted-by": "publisher"}, {"key": "b119_166", "author": "Tillmann HL", "volume": "6", "first-page": "429", "year": "1997", "journal-title": "Hepatology"}, {"key": "b120_167", "author": "Fagan EA", "volume": "6", "first-page": "504", "year": "1997", "journal-title": "Hepatology"}, {"key": "b121_168", "DOI": "10.1016/S0140-6736(95)91829-9", "doi-asserted-by": "publisher"}, {"key": "b122_169", "author": "Trepo C", "volume": "6", "first-page": "188", "year": "1996", "journal-title": "Hepatology"}], "container-title": ["Journal of Viral Hepatitis"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2893.1999.00151.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2893.1999.00151.x", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2893.1999.00151.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 5]], "date-time": "2019-04-05T17:48:11Z", "timestamp": 1554486491000}, "score": 31.659845, "issued": {"date-parts": [[1999, 3]]}, "references-count": 122, "journal-issue": {"published-online": {"date-parts": [[2002, 4, 8]]}, "published-print": {"date-parts": [[1999, 3]]}, "issue": "2"}, "alternative-id": ["10.1046/j.1365-2893.1999.00151.x"], "URL": "http://dx.doi.org/10.1046/j.1365-2893.1999.00151.x", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1352-0504", "1365-2893"], "issn-type": [{"value": "1352-0504", "type": "print"}, {"value": "1365-2893", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T07:50:42Z", "timestamp": 1575273042857}, "reference-count": 56, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2013, 10, 1]], "date-time": "2013-10-01T00:00:00Z", "timestamp": 1380585600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Virology"], "published-print": {"date-parts": [[2013, 10]]}, "DOI": "10.1016/j.coviro.2013.08.006", "type": "journal-article", "created": {"date-parts": [[2013, 9, 7]], "date-time": "2013-09-07T23:47:07Z", "timestamp": 1378597627000}, "page": "495-500", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Hepatitis B antivirals and resistance"], "prefix": "10.1016", "volume": "3", "author": [{"given": "Uma", "family": "Devi", "sequence": "first", "affiliation": []}, {"given": "Stephen", "family": "Locarnini", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Current Opinion in Virology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1879625713001429?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1879625713001429?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 13]], "date-time": "2018-10-13T08:53:42Z", "timestamp": 1539420822000}, "score": 31.5388, "issued": {"date-parts": [[2013, 10]]}, "references-count": 56, "journal-issue": {"published-print": {"date-parts": [[2013, 10]]}, "issue": "5"}, "alternative-id": ["S1879625713001429"], "URL": "http://dx.doi.org/10.1016/j.coviro.2013.08.006", "ISSN": ["1879-6257"], "issn-type": [{"value": "1879-6257", "type": "print"}], "subject": ["Virology"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T02:18:15Z", "timestamp": 1575425895724}, "reference-count": 44, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 596, "content-version": "tdm"}], "funder": [{"name": "Australian Centre for HIV and Hepatitis Virology Research", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Med. Virol."], "published-print": {"date-parts": [[2014, 4]]}, "DOI": "10.1002/jmv.23888", "type": "journal-article", "created": {"date-parts": [[2014, 1, 13]], "date-time": "2014-01-13T09:18:43Z", "timestamp": 1389604723000}, "page": "695-706", "source": "Crossref", "is-referenced-by-count": 17, "title": ["Molecular virology of hepatitis B virus, sub-genotype C4 in northern Australian Indigenous populations"], "prefix": "10.1002", "volume": "86", "author": [{"given": "M.", "family": "Littlejohn", "sequence": "first", "affiliation": [{"name": "Victorian Infectious Diseases Reference Laboratory; Melbourne VIC Australia"}]}, {"given": "J.", "family": "Davies", "sequence": "additional", "affiliation": [{"name": "Menzies School of Health Research and Charles Darwin University; Darwin Northern Territory Australia"}, {"name": "Department of Infectious Diseases; Royal Darwin Hospital; Darwin Northern Territory Australia"}]}, {"given": "L.", "family": "Yuen", "sequence": "additional", "affiliation": [{"name": "Victorian Infectious Diseases Reference Laboratory; Melbourne VIC Australia"}]}, {"given": "R.", "family": "Edwards", "sequence": "additional", "affiliation": [{"name": "Victorian Infectious Diseases Reference Laboratory; Melbourne VIC Australia"}]}, {"given": "T.", "family": "Sozzi", "sequence": "additional", "affiliation": [{"name": "Victorian Infectious Diseases Reference Laboratory; Melbourne VIC Australia"}]}, {"given": "K.", "family": "Jackson", "sequence": "additional", "affiliation": [{"name": "Victorian Infectious Diseases Reference Laboratory; Melbourne VIC Australia"}]}, {"given": "B.", "family": "Cowie", "sequence": "additional", "affiliation": [{"name": "Victorian Infectious Diseases Reference Laboratory; Melbourne VIC Australia"}, {"name": "Victorian Infectious Diseases Service; Royal Melbourne Hospital; Melbourne VIC Australia"}]}, {"given": "S.", "family": "Tong", "sequence": "additional", "affiliation": [{"name": "Menzies School of Health Research and Charles Darwin University; Darwin Northern Territory Australia"}, {"name": "Department of Infectious Diseases; Royal Darwin Hospital; Darwin Northern Territory Australia"}]}, {"given": "J.", "family": "Davis", "sequence": "additional", "affiliation": [{"name": "Menzies School of Health Research and Charles Darwin University; Darwin Northern Territory Australia"}, {"name": "Department of Infectious Diseases; Royal Darwin Hospital; Darwin Northern Territory Australia"}]}, {"given": "S.", "family": "Locarnini", "sequence": "additional", "affiliation": [{"name": "Victorian Infectious Diseases Reference Laboratory; Melbourne VIC Australia"}]}], "member": "311", "published-online": {"date-parts": [[2014, 1, 13]]}, "reference": [{"key": "10.1002/jmv.23888-BIB0001|jmv23888-cit-0001", "doi-asserted-by": "crossref", "first-page": "1126", "DOI": "10.1002/jmv.21844", "article-title": "Molecular and clinical characteristics of hepatitis B virus in Korea", "volume": "82", "author": "Ahn", "year": "2010", "journal-title": "J Med Virol"}, {"key": "10.1002/jmv.23888-BIB0002|jmv23888-cit-0002", "first-page": "297", "article-title": "Further studies on a \u201cnew\u201d human isoprecipitin system (Australia antigen)", "volume": "27", "author": "Alter", "year": "1966", "journal-title": "Blood"}, {"key": "10.1002/jmv.23888-BIB0003|jmv23888-cit-0003", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1001/jama.1965.03080070025007", "article-title": "A \u201cnew\u201d antigen in leukemia sera", "volume": "191", "author": "Blumberg", "year": "1965", "journal-title": "JAMA"}, {"key": "10.1002/jmv.23888-BIB0004|jmv23888-cit-0004", "doi-asserted-by": "crossref", "first-page": "628", "DOI": "10.1111/j.1440-1746.2011.06695.x", "article-title": "Natural history of chronic hepatitis B REVEALed", "volume": "26", "author": "Chen", "year": "2011", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/jmv.23888-BIB0005|jmv23888-cit-0005", "doi-asserted-by": "crossref", "first-page": "1153", "DOI": "10.1053/j.gastro.2006.01.011", "article-title": "High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases", "volume": "130", "author": "Chen", "year": "2006", "journal-title": "Gastroenterology"}, {"key": "10.1002/jmv.23888-BIB0006|jmv23888-cit-0006", "doi-asserted-by": "crossref", "first-page": "1905", "DOI": "10.1111/j.1349-7006.2010.01612.x", "article-title": "Nucleotide changes related to hepatocellular carcinoma in the enhancer 1/x-promoter of hepatitis B virus subgenotype C2 in cirrhotic patients", "volume": "101", "author": "Cho", "year": "2010", "journal-title": "Cancer Sci"}, {"key": "10.1002/jmv.23888-BIB0007|jmv23888-cit-0007", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1016/S1470-2045(08)70150-5", "article-title": "Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia", "volume": "9", "author": "Cunningham", "year": "2008", "journal-title": "Lancet Oncol"}, {"key": "10.1002/jmv.23888-BIB0008|jmv23888-cit-0008", "doi-asserted-by": "crossref", "first-page": "1234", "DOI": "10.1111/jgh.12177", "article-title": "The molecular epidemiology of hepatitis B in the Indigenous people of northern Australia", "volume": "28", "author": "Davies", "year": "2013", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/jmv.23888-BIB0009|jmv23888-cit-0009", "first-page": "435", "article-title": "Incomplete protection against hepatitis B among remote Aboriginal adolescents despite full vaccination in infancy", "volume": "34", "author": "Dent", "year": "2010", "journal-title": "Commun Dis Intell Q Rep"}, {"key": "10.1002/jmv.23888-BIB0010|jmv23888-cit-0010", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1016/j.jhep.2007.11.011", "article-title": "Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors", "volume": "48", "author": "Fattovich", "year": "2008", "journal-title": "J Hepatol"}, {"key": "10.1002/jmv.23888-BIB0011|jmv23888-cit-0011", "first-page": "5437", "article-title": "A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients", "volume": "69", "author": "Gunther", "year": "1995", "journal-title": "J Virol"}, {"key": "10.1002/jmv.23888-BIB0012|jmv23888-cit-0012", "doi-asserted-by": "crossref", "first-page": "518", "DOI": "10.1111/j.1445-5994.1987.tb00113.x", "article-title": "Occurrence and distribution of hepatitis B infection in the aboriginal population of Western Australia", "volume": "17", "author": "Holman", "year": "1987", "journal-title": "Aust N Z J Med"}, {"key": "10.1002/jmv.23888-BIB0013|jmv23888-cit-0013", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/j.jhep.2004.03.025", "article-title": "Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region", "volume": "41", "author": "Jazayeri", "year": "2004", "journal-title": "J Hepatol"}, {"key": "10.1002/jmv.23888-BIB0014|jmv23888-cit-0014", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1002/jmv.1890130207", "article-title": "Hepatitis B surface antigen (HBsAg) subtype-specific antibodies in persons vaccinated against hepatitis B", "volume": "13", "author": "Jilg", "year": "1984", "journal-title": "J Med Virol"}, {"key": "10.1002/jmv.23888-BIB0015|jmv23888-cit-0015", "doi-asserted-by": "crossref", "first-page": "772", "DOI": "10.1093/molbev/mst010", "article-title": "MAFFT multiple sequence alignment software version 7: Improvements in performance and usability", "volume": "30", "author": "Katoh", "year": "2013", "journal-title": "Mol Biol Evol"}, {"key": "10.1002/jmv.23888-BIB0016|jmv23888-cit-0016", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.1016/j.virusres.2007.02.021", "article-title": "Hepatitis B virus genetic variability and evolution", "volume": "127", "author": "Kay", "year": "2007", "journal-title": "Virus Res"}, {"key": "10.1002/jmv.23888-BIB0017|jmv23888-cit-0017", "doi-asserted-by": "crossref", "first-page": "1002", "DOI": "10.1002/jmv.21501", "article-title": "Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma", "volume": "81", "author": "Kim", "year": "2009", "journal-title": "J Med Virol"}, {"key": "10.1002/jmv.23888-BIB0018|jmv23888-cit-0018", "doi-asserted-by": "crossref", "first-page": "S9", "DOI": "10.1111/j.1872-034X.2007.00098.x", "article-title": "Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes", "volume": "37", "author": "Kramvis", "year": "2007", "journal-title": "Hepatol Res"}, {"key": "10.1002/jmv.23888-BIB0019|jmv23888-cit-0019", "doi-asserted-by": "crossref", "first-page": "2409", "DOI": "10.1016/j.vaccine.2004.10.045", "article-title": "Hepatitis B virus genotypes", "volume": "23", "author": "Kramvis", "year": "2005", "journal-title": "Vaccine"}, {"key": "10.1002/jmv.23888-BIB0020|jmv23888-cit-0020", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1002/jmv.21049", "article-title": "Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus", "volume": "80", "author": "Kramvis", "year": "2008", "journal-title": "J Med Virol"}, {"key": "10.1002/jmv.23888-BIB0021|jmv23888-cit-0021", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1111/j.1440-1746.2010.06541.x", "article-title": "The clinical implications of hepatitis B virus genotype: Recent advances", "volume": "26", "author": "Lin", "year": "2011", "journal-title": "J Gastroenterol Hepatol"}, {"key": "10.1002/jmv.23888-BIB0022|jmv23888-cit-0022", "first-page": "152", "article-title": "Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination", "volume": "73", "author": "Lole", "year": "1999", "journal-title": "J Virol"}, {"key": "10.1002/jmv.23888-BIB0023|jmv23888-cit-0023", "doi-asserted-by": "crossref", "first-page": "2095", "DOI": "10.1016/S0140-6736(12)61728-0", "article-title": "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010", "volume": "380", "author": "Lozano", "year": "2012", "journal-title": "Lancet"}, {"key": "10.1002/jmv.23888-BIB0024|jmv23888-cit-0024", "doi-asserted-by": "crossref", "first-page": "492", "DOI": "10.5694/mja12.11481", "article-title": "Liver cancer is the fastest increasing cause of cancer death in Australians", "volume": "197", "author": "MacLachlan", "year": "2012", "journal-title": "Med J Aust"}, {"key": "10.1002/jmv.23888-BIB0025|jmv23888-cit-0025", "doi-asserted-by": "crossref", "first-page": "416", "DOI": "10.1111/1753-6405.12049", "article-title": "The burden of chronic hepatitis B virus infection in Australia, 2011", "volume": "37", "author": "MacLachlan", "year": "2013", "journal-title": "Aust N Z J Public Health"}, {"key": "10.1002/jmv.23888-BIB0026|jmv23888-cit-0026", "first-page": "126", "year": "2008", "volume-title": "B positive-All you wanted to know about hepatitis B: A guide for primary care providers: Australasian Society for HIV Medicine"}, {"key": "10.1002/jmv.23888-BIB0027|jmv23888-cit-0027", "doi-asserted-by": "crossref", "first-page": "289", "DOI": "10.1159/000080872", "article-title": "Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes", "volume": "47", "author": "Norder", "year": "2004", "journal-title": "Intervirology"}, {"key": "10.1002/jmv.23888-BIB0028|jmv23888-cit-0028", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1016/j.jas.2003.11.005", "article-title": "Dating the colonization of Sahul (Pleistocene Australia-New Guinea): A review of recent research", "volume": "31", "author": "O'Connell", "year": "2004", "journal-title": "J Archaeol Sci"}, {"key": "10.1002/jmv.23888-BIB0029|jmv23888-cit-0029", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1016/j.jhep.2010.02.035", "article-title": "Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review", "volume": "53", "author": "Papatheodoridis", "year": "2010", "journal-title": "J Hepatol"}, {"key": "10.1002/jmv.23888-BIB0030|jmv23888-cit-0030", "doi-asserted-by": "crossref", "first-page": "908", "DOI": "10.1002/hep.26079", "article-title": "Dating the origin and dispersal of hepatitis B virus infection in humans and primates", "volume": "57", "author": "Paraskevis", "year": "2013", "journal-title": "Hepatology"}, {"key": "10.1002/jmv.23888-BIB0031|jmv23888-cit-0031", "doi-asserted-by": "crossref", "first-page": "466", "DOI": "10.1053/jhep.2002.30698", "article-title": "Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients", "volume": "35", "author": "Preikschat", "year": "2002", "journal-title": "Hepatology"}, {"key": "10.1002/jmv.23888-BIB0032|jmv23888-cit-0032", "doi-asserted-by": "crossref", "first-page": "106", "DOI": "10.1080/00223347608572294", "article-title": "Origins of Pacific Island Laborers in Queensland, 1863-1904-Research note", "volume": "11", "author": "Price", "year": "1976", "journal-title": "J Pac Hist"}, {"key": "10.1002/jmv.23888-BIB0033|jmv23888-cit-0033", "doi-asserted-by": "crossref", "first-page": "94", "DOI": "10.1126/science.1211177", "article-title": "An Aboriginal Australian genome reveals separate human dispersals into Asia", "volume": "334", "author": "Rasmussen", "year": "2011", "journal-title": "Science"}, {"key": "10.1002/jmv.23888-BIB0034|jmv23888-cit-0034", "doi-asserted-by": "crossref", "first-page": "1701", "DOI": "10.1097/QAD.0b013e32826fb305", "article-title": "Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals", "volume": "21", "author": "Revill", "year": "2007", "journal-title": "AIDS"}, {"key": "10.1002/jmv.23888-BIB0035|jmv23888-cit-0035", "doi-asserted-by": "crossref", "first-page": "153", "DOI": "10.1038/345153a0", "article-title": "Thermoluminescence dating of a 50,000-year-old human occupation site in Northern Australia", "volume": "345", "author": "Roberts", "year": "1990", "journal-title": "Nature"}, {"key": "10.1002/jmv.23888-BIB0036|jmv23888-cit-0036", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1186/1756-0500-5-50", "article-title": "SSE: A nucleotide and amino acid sequence analysis platform", "volume": "5", "author": "Simmonds", "year": "2012", "journal-title": "BMC Res Notes"}, {"key": "10.1002/jmv.23888-BIB0037|jmv23888-cit-0037", "doi-asserted-by": "crossref", "first-page": "15467", "DOI": "10.1128/JVI.79.24.15467-15476.2005", "article-title": "Recombination in the genesis and evolution of hepatitis B virus genotypes", "volume": "79", "author": "Simmonds", "year": "2005", "journal-title": "J Virol"}, {"key": "10.1002/jmv.23888-BIB0038|jmv23888-cit-0038", "doi-asserted-by": "crossref", "first-page": "883", "DOI": "10.1099/0022-1317-82-4-883", "article-title": "A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: Complete genome sequence and phylogenetic relatedness", "volume": "82", "author": "Sugauchi", "year": "2001", "journal-title": "J Gen Virol"}, {"key": "10.1002/jmv.23888-BIB0039|jmv23888-cit-0039", "doi-asserted-by": "crossref", "first-page": "2731", "DOI": "10.1093/molbev/msr121", "article-title": "MEG A5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods", "volume": "28", "author": "Tamura", "year": "2011", "journal-title": "Mol Biol Evol"}, {"key": "10.1002/jmv.23888-BIB0040|jmv23888-cit-0040", "doi-asserted-by": "crossref", "first-page": "10538", "DOI": "10.1128/JVI.00462-09", "article-title": "A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J", "volume": "83", "author": "Tatematsu", "year": "2009", "journal-title": "J Virol"}, {"key": "10.1002/jmv.23888-BIB0041|jmv23888-cit-0041", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1111/j.1753-6405.2008.00228.x", "article-title": "Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in Australia", "volume": "32", "author": "Wood", "year": "2008", "journal-title": "Aust N Z J Public Health"}, {"key": "10.1002/jmv.23888-BIB0042|jmv23888-cit-0042", "doi-asserted-by": "crossref", "first-page": "1134", "DOI": "10.1093/jnci/djn243", "article-title": "Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma", "volume": "100", "author": "Yang", "year": "2008", "journal-title": "J Natl Cancer Inst"}, {"key": "10.1002/jmv.23888-BIB0043|jmv23888-cit-0043", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1038/ajg.2010.399", "article-title": "Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma", "volume": "106", "author": "Yin", "year": "2011", "journal-title": "Am J Gastroenterol"}, {"key": "10.1002/jmv.23888-BIB0044|jmv23888-cit-0044", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1016/j.antiviral.2006.11.014", "article-title": "SeqHepB: A sequence analysis program and relational database system for chronic hepatitis B", "volume": "75", "author": "Yuen", "year": "2007", "journal-title": "Antiviral Res"}], "container-title": ["Journal of Medical Virology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjmv.23888", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.23888", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T18:55:44Z", "timestamp": 1533495344000}, "score": 31.523682, "subtitle": ["HBV Molecular Virology in Indigenous Australians"], "issued": {"date-parts": [[2014, 1, 13]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[2014, 4]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/jmv.23888", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0146-6615"], "issn-type": [{"value": "0146-6615", "type": "print"}], "subject": ["Virology", "Infectious Diseases"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T14:33:35Z", "timestamp": 1575470015850}, "reference-count": 0, "publisher": "American Society of Microbiology", "isbn-type": [{"value": "9781555814250", "type": "print"}, {"value": "9781555815981", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1128/9781555815981.ch31", "type": "book-chapter", "created": {"date-parts": [[2014, 4, 30]], "date-time": "2014-04-30T09:24:12Z", "timestamp": 1398849852000}, "page": "673-707", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Hepatitis B Virus"], "prefix": "10.1128", "author": [{"given": "Alexander J. V.", "family": "Thompson", "sequence": "first", "affiliation": []}, {"given": "Stephen A.", "family": "Locarnini", "sequence": "additional", "affiliation": []}, {"given": "Sally J.", "family": "Bell", "sequence": "additional", "affiliation": []}], "member": "235", "container-title": ["Clinical Virology, Third Edition"], "deposited": {"date-parts": [[2015, 9, 25]], "date-time": "2015-09-25T23:06:03Z", "timestamp": 1443222363000}, "score": 30.587345, "issued": {"date-parts": [[null]]}, "ISBN": ["9781555814250", "9781555815981"], "references-count": 0, "URL": "http://dx.doi.org/10.1128/9781555815981.ch31"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T10:03:40Z", "timestamp": 1574330620953}, "publisher-location": "Totowa, NJ", "reference-count": 47, "publisher": "Humana Press", "isbn-type": [{"value": "9781588292025", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/978-1-59259-963-9_53", "type": "book-chapter", "created": {"date-parts": [[2007, 11, 17]], "date-time": "2007-11-17T07:11:40Z", "timestamp": 1195283500000}, "page": "554-566", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Molecular Diagnostics in Hepatitis B"], "prefix": "10.1007", "author": [{"given": "Scott", "family": "Bowden", "sequence": "first", "affiliation": []}, {"given": "Stephen", "family": "Locarnini", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "53_CR1", "first-page": "18", "volume": "38", "author": "A. A. Can", "year": "2003", "unstructured": "Alberti A. Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B? Hepatology 2003;38:18\u201320.", "journal-title": "Hepatology"}, {"key": "53_CR2", "doi-asserted-by": "crossref", "first-page": "3413", "DOI": "10.1002/j.1460-2075.1992.tb05420.x", "volume": "11", "author": "R. Bartenschlager", "year": "1992", "unstructured": "Bartenschlager R, Schaller H. Hepadnaviral assembly is initiated by poly merase binding to the encapsidation signal in the viral RNA genome. EMBO J 1992;11:3413\u20133420.", "journal-title": "EMBO J"}, {"key": "53_CR3", "doi-asserted-by": "publisher", "first-page": "1129", "DOI": "10.1016/S0140-6736(81)90585-7", "volume": "2", "author": "R. Beasley", "year": "1981", "unstructured": "Beasley R, Lin C, Hwang L, Chien C. Hepatocellular carcinoma and hep titis B virus. Lancet 1981;2:1129\u20131133.", "journal-title": "Lancet"}, {"key": "53_CR4", "first-page": "3319", "volume": "64", "author": "F. Birnbaum", "year": "1990", "unstructured": "Birnbaum F, Nassal M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol 1990;64:3319\u20133330.", "journal-title": "J Virol"}, {"key": "53_CR5", "doi-asserted-by": "publisher", "first-page": "194", "DOI": "10.1053/jhep.2001.25172", "volume": "34", "author": "C. Brechot", "year": "2001", "unstructured": "Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely \u201coccult\u201d? Hepatology 2001;34:194\u2013203.", "journal-title": "Hepatology"}, {"key": "53_CR6", "doi-asserted-by": "publisher", "first-page": "588", "DOI": "10.1016/S0140-6736(89)90713-7", "volume": "2", "author": "W.F. Carman", "year": "1989", "unstructured": "Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;2:588\u2013591.", "journal-title": "Lancet"}, {"key": "53_CR7", "doi-asserted-by": "publisher", "first-page": "325", "DOI": "10.1016/0140-6736(90)91874-A", "volume": "336", "author": "W.F. Carman", "year": "1990", "unstructured": "Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325\u2013329.", "journal-title": "Lancet"}, {"key": "53_CR8", "doi-asserted-by": "publisher", "first-page": "364", "DOI": "10.1038/337364a0", "volume": "337", "author": "L.J. Chang", "year": "1989", "unstructured": "Chang LJ, Pryciak P, Ganem D, Varmus HE. Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting. Nature 1989;337:364\u2013368.", "journal-title": "Nature"}, {"key": "53_CR9", "doi-asserted-by": "publisher", "first-page": "943", "DOI": "10.1016/0092-8674(94)90142-2", "volume": "77", "author": "R. Crowther", "year": "1994", "unstructured": "Crowther R, Kiselev N, Bottcher B, et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomi croscopy. Cell 1994;77:943\u2013950.", "journal-title": "Cell"}, {"key": "53_CR10", "doi-asserted-by": "publisher", "first-page": "4771", "DOI": "10.1128/JVI.75.10.4771-4779.2001", "volume": "75", "author": "K. Das", "year": "2001", "unstructured": "Das K, Xiong X, Yang H, et al. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J Virol 2001; 75:4771\u20134779.", "journal-title": "J Virol"}, {"key": "53_CR11", "doi-asserted-by": "publisher", "first-page": "294", "DOI": "10.1136/gut.32.3.294", "volume": "32", "author": "G. Fattovich", "year": "1991", "unstructured": "Fattovich G, Brollo L, Giustina G, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991;32:294\u2013298.", "journal-title": "Gut"}, {"key": "53_CR12", "author": "D. Ganem", "first-page": "2923", "year": "2001", "unstructured": "Ganem D, Schneider R. Hepadnaviridae: The Viruses and Their Replication. In: Knipe DM, Howley PM, eds. Fields Virology, vol. 2, Philadelphia: Lippincott-Raven, 2001; pp. 2923\u20132970.", "volume-title": "Fields Virology"}, {"key": "53_CR13", "doi-asserted-by": "publisher", "first-page": "1757", "DOI": "10.1086/315147", "volume": "180", "author": "J. Gauthier", "year": "1999", "unstructured": "Gauthier J, Bourne EJ, Lutz MW, et al. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine. J Infect Dis 1999; 180:1757\u20131762.", "journal-title": "J Infect Dis"}, {"key": "53_CR14", "author": "Z. Goodman", "first-page": "131", "year": "2002", "unstructured": "Goodman Z. Histopathology of hepatitis B virus infection. In: Lai CLS, ed. Human Virus Guides, vol. 1, London: International Medical Press, 2002:131\u2013143.", "volume-title": "Human Virus Guides"}, {"key": "53_CR15", "doi-asserted-by": "publisher", "first-page": "825", "DOI": "10.1126/science.284.5415.825", "volume": "284", "author": "L.G. Guidotti", "year": "1999", "unstructured": "Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999;284:825\u2013829.", "journal-title": "Science"}, {"key": "53_CR16", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1016/S0065-3527(08)60298-5", "volume": "52", "author": "S. Gunther", "year": "1999", "unstructured": "Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999;52:25\u2013137.", "journal-title": "Adv Virus Res"}, {"key": "53_CR17", "doi-asserted-by": "publisher", "first-page": "656", "DOI": "10.1002/hep.1840030505", "volume": "3", "author": "S.J. Hadziyannis", "year": "1983", "unstructured": "Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg vs. anti-HBe positive carriers of hepatitis B virus. Hepatology 1983;3:656\u2013662.", "journal-title": "Hepatology"}, {"key": "53_CR18", "first-page": "2638", "volume": "63", "author": "O. Hino", "year": "1989", "unstructured": "Hino O, Ohtake K, Rogler CE. Features of two hepatitis B virus (HBV) DNA integrations suggest mechanisms of HBV integration. J Virol 1989;63:2638\u20132643.", "journal-title": "J Virol"}, {"key": "53_CR19", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1016/S1473-3099(01)00172-4", "volume": "2", "author": "M. Jung", "year": "2002", "unstructured": "Jung M, Pape G. Immunology of hepatitis B infection. Lancet Infect Dis 2002;2:43\u201350.", "journal-title": "Lancet Infect Dis"}, {"key": "53_CR20", "author": "M. Kann", "first-page": "77", "year": "1998", "unstructured": "Kann M, Gerlich W. Hepadnaviridae: structure and molecular virology. In: Zuckerman A, Thomas H, eds. Viral Hepatitis. London: Churchill Livingstone, 1998:77\u2013105.", "volume-title": "Viral Hepatitis"}, {"issue": "Suppl. 1", "key": "53_CR21", "doi-asserted-by": "publisher", "first-page": "29", "DOI": "10.1159/000048273", "volume": "62", "author": "K. Koike", "year": "2002", "unstructured": "Koike K, Tsutsumi T, Fujie H, Shintani Y, Kyoji M. Molecular mechanism of viral hepatocarcinogenesis. Oncology 2002;62(Suppl. 1):29\u201337.", "journal-title": "Oncology"}, {"key": "53_CR22", "doi-asserted-by": "publisher", "first-page": "4077", "DOI": "10.1073/pnas.91.9.4077", "volume": "91", "author": "A.S. Lok", "year": "1994", "unstructured": "Lok AS, Akarca U, Greene S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci USA 1994;91:4077\u20134081.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "53_CR23", "doi-asserted-by": "publisher", "first-page": "1828", "DOI": "10.1053/gast.2001.24839", "volume": "120", "author": "A.S. Lok", "year": "2001", "unstructured": "Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 2001;120:1828\u20131853.", "journal-title": "Gastroenterology"}, {"key": "53_CR24", "first-page": "3617", "volume": "141", "author": "D.R. Milich", "year": "1988", "unstructured": "Milich DR, McLachlan A, Stahl S, et al. Comparative immunogenicity of hepatitis B virus core and E antigens. J Immunol 1988;141:3617\u20133624.", "journal-title": "J Immunol"}, {"key": "53_CR25", "doi-asserted-by": "crossref", "first-page": "1248", "DOI": "10.1016/0016-5085(90)90811-E", "volume": "99", "author": "N.V. Naoumov", "year": "1990", "unstructured": "Naoumov NV, Portmann BC, Tedder RS, et al. Detection of hepatitis B virus antigens in liver tissue. Gastroenterology 1990;99:1248\u20131253.", "journal-title": "Gastroenterology"}, {"key": "53_CR26", "first-page": "3350", "volume": "69", "author": "J.E. Newbold", "year": "1995", "unstructured": "Newbold JE, Xin H, Tencza M, et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minochromosomes. J Virol 1995;69:3350\u20133357.", "journal-title": "J Virol"}, {"key": "53_CR27", "doi-asserted-by": "publisher", "first-page": "4398", "DOI": "10.1073/pnas.93.9.4398", "volume": "93", "author": "M.A. Nowak", "year": "1996", "unstructured": "Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996;93:4398\u20134402.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "53_CR28", "doi-asserted-by": "publisher", "first-page": "866867", "DOI": "10.1053/jhep.2000.18194", "volume": "32", "author": "D.D. Richman", "year": "2000", "unstructured": "Richman DD. The impact of drug resistance on the effectiveness of chemotherapy for chronic hepatitis B. Hepatology 2000;32:866,867.", "journal-title": "Hepatology"}, {"key": "53_CR29", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1002/jmv.1890360207", "volume": "36", "author": "M.T. Rossner", "year": "1992", "unstructured": "Rossner MT. Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator. J Med Virol 1992;36:101\u2013117.", "journal-title": "J Med Virol"}, {"key": "53_CR30", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1046/j.1423-0410.2001.00003.x", "volume": "80", "author": "J. Saldanha", "year": "2001", "unstructured": "Saldanha J, Gerlich W, Lelie N, Dawson P, Heermann K, Heath A. An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques. Vox Sang 2001;80:63\u201371.", "journal-title": "Vox Sang"}, {"key": "53_CR31", "first-page": "21", "volume": "168", "author": "H. Schaller", "year": "1991", "unstructured": "Schaller H, Fischer M. Transcriptional control of hepadnavirus gene expression. CurrTop Microbiol Immunol 1991;168:21\u201339.", "journal-title": "CurrTop Microbiol Immunol"}, {"key": "53_CR32", "author": "H.J. Schlicht", "first-page": "171", "year": "1991", "unstructured": "Schlicht HJ, Bartenschlager R, Schaller H. Biosynthesis and enzymatic functions of the hepadnaviral reverse transcriptase. In: McLachlan A, ed. Molecular Biology of the Hepatitis B Viruses. Boca Raton, FL: CRC Press, 1991:171\u2013180.", "volume-title": "Molecular Biology of the Hepatitis B Viruses"}, {"key": "53_CR33", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1128/MMBR.64.1.51-68.2000", "volume": "64", "author": "C. Seeger", "year": "2000", "unstructured": "Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000;64:51\u201368.", "journal-title": "Microbiol Mol Biol Rev"}, {"key": "53_CR34", "author": "Y. Shaul", "first-page": "193", "year": "1991", "unstructured": "Shaul Y. Regulation of hepadnavirus transcription. In: McLachlan A, ed. Molecular Biology of the Hepatitis B Virus. Boca Raton, FL: CRC Press, 1991:193\u2013211.", "volume-title": "Molecular Biology of the Hepatitis B Virus"}, {"key": "53_CR35", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1053/jhep.2001.22166", "volume": "33", "author": "L.J. Stuyver", "year": "2001", "unstructured": "Stuyver LJ, Locarnini SA, Lok A, et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001;33:751\u2013757.", "journal-title": "Hepatology"}, {"key": "53_CR36", "doi-asserted-by": "publisher", "first-page": "403", "DOI": "10.1016/0092-8674(82)90157-X", "volume": "29", "author": "J. Summers", "year": "1982", "unstructured": "Summers J, Mason WS. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982;29:403\u2013415.", "journal-title": "Cell"}, {"key": "53_CR37", "doi-asserted-by": "publisher", "first-page": "638", "DOI": "10.1073/pnas.0307422100", "volume": "101", "author": "J. Summers", "year": "2004", "unstructured": "Summers J, Mason WS. Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy. Proc Natl Acad Sci USA 2004;101:638\u2013640.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "53_CR38", "first-page": "2819", "volume": "64", "author": "J. Summers", "year": "1990", "unstructured": "Summers J, Smith PM, Horwich AL. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 1990;64:2819\u20132824.", "journal-title": "J Virol"}, {"key": "53_CR39", "doi-asserted-by": "publisher", "first-page": "11652", "DOI": "10.1073/pnas.1635109100", "volume": "100", "author": "J. Summers", "year": "2003", "unstructured": "Summers J, Jilbert AR, Yang W, et al. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci USA 2003;100:11,652\u201311,659.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "53_CR40", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1016/0092-8674(86)90602-1", "volume": "47", "author": "J.S. Tuttleman", "year": "1986", "unstructured": "Tuttleman JS, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986;47:451\u2013460.", "journal-title": "Cell"}, {"key": "53_CR41", "first-page": "5", "volume": "3", "author": "W.A. Wallace", "year": "1997", "unstructured": "Wallace WA, Carman WF. Surface variation of HBV: scientific and medical relevance. Viral Hepat Rev 1997;3:5\u201316.", "journal-title": "Viral Hepat Rev"}, {"key": "53_CR42", "first-page": "6507", "volume": "67", "author": "G.H. Wang", "year": "1993", "unstructured": "Wang GH, Seeger C. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 1993;67:6507\u20136512.", "journal-title": "J Virol"}, {"key": "53_CR43", "doi-asserted-by": "publisher", "first-page": "1750", "DOI": "10.1053/j.gastro.2004.03.018", "volume": "126", "author": "B. Werle", "year": "2004", "unstructured": "Werle B, Bowden D, Locarnini S, et al. Persistence of viral cccDNA during the natural history of chronic hepatitis B and slow decline with adefovir dipivoxil therapy. Gastroenterology 2004;126:1750\u20131758.", "journal-title": "Gastroenterology"}, {"key": "53_CR44", "first-page": "904", "volume": "61", "author": "H. Will", "year": "1987", "unstructured": "Will H, Reiser W, Weimer T, et al. Replication strategy of human hepatitis B virus. J Virol 1987;61:904\u2013911.", "journal-title": "J Virol"}, {"key": "53_CR45", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1016/0042-6822(90)90206-7", "volume": "175", "author": "T.T. Wu", "year": "1990", "unstructured": "Wu TT, Coates L, Aldrich CE, Summers J, Mason WS. In hepatocytes nfected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 1990;175:255\u2013261.", "journal-title": "Virology"}, {"key": "53_CR46", "doi-asserted-by": "publisher", "first-page": "771", "DOI": "10.1016/S1097-2765(01)80009-5", "volume": "3", "author": "S.A. Wynne", "year": "1999", "unstructured": "Wynne SA, Crowther RA, Leslie AG. The crystal structure of the human hepatitis B virus capsid. Mol Cell 1999;3:771\u2013780.", "journal-title": "Mol Cell"}, {"key": "53_CR47", "first-page": "2026", "volume": "68", "author": "F. Zoulim", "year": "1994", "unstructured": "Zoulim F, Saputelli J, Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 1994;68:2026\u20132030.", "journal-title": "J Virol"}], "container-title": ["Principles of Molecular Medicine"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-59259-963-9_53", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 25]], "date-time": "2019-02-25T16:56:12Z", "timestamp": 1551113772000}, "score": 30.068336, "issued": {"date-parts": [[null]]}, "ISBN": ["9781588292025"], "references-count": 47, "URL": "http://dx.doi.org/10.1007/978-1-59259-963-9_53", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T04:31:15Z", "timestamp": 1574397075749}, "publisher-location": "New York, NY", "reference-count": 327, "publisher": "Springer New York", "isbn-type": [{"value": "9781461283942", "type": "print"}, {"value": "9781461239000", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1988]]}, "DOI": "10.1007/978-1-4612-3900-0_39", "type": "book-chapter", "created": {"date-parts": [[2011, 9, 12]], "date-time": "2011-09-12T17:13:06Z", "timestamp": 1315847586000}, "page": "750-796", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Hepadnaviridae: Hepatitis B Virus and the Delta Virus"], "prefix": "10.1007", "author": [{"given": "S. A.", "family": "Locarnini", "sequence": "first", "affiliation": []}, {"given": "I. D.", "family": "Gust", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "39_CR1", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1056/NEJM197802232980807", "volume": "298", "author": "T Aikawa", "year": "1978", "unstructured": "Aikawa, T., H. Sairenjii, and S. Furuta. 1978. Seroconversion from hepatitis Be antigen to anti-HBe in acute hepatitis B virus infection. N. Engl. J. Med. 298: 439\u2013441.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR2", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1136/gut.20.3.190", "volume": "20", "author": "A Alberti", "year": "1979", "unstructured": "Alberti, A., S. Diana, A. L. W. F. Eddleston, and R. Williams. 1979. Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B. Gut 20: 190\u2013195.", "journal-title": "Gut"}, {"key": "39_CR3", "first-page": "297", "volume": "34", "author": "C Albin", "year": "1980", "unstructured": "Albin, C., and W. S. Robinson. 1980. Protein kinase activity in hepatitis B virus. J. Virol. 34: 297\u2013302.", "journal-title": "J. Virol"}, {"key": "39_CR4", "author": "ZR Alessandro", "first-page": "127", "year": "1983", "unstructured": "Alessandro, Z. R., T. Elisabetta, F. Pierino, and E. Magliano. 1983. Vertical transmission of the HBV-associated delta agent, p. 127\u2013132. InG. Verne, F. Bonino, and M. Rizzetto, (ed.), Viral hepatitis and delta infection. R. Allan, New York.", "volume-title": "Viral hepatitis and delta infection"}, {"key": "39_CR5", "author": "J Alexander", "year": "1978", "unstructured": "Alexander, J., G. Macnab, and R. Saunders. 1978. Studies on in vitroproduction of HBsAg by a human hepatoma cell line, p. 103\u2013120. InM. Pollard (ed.), Perspectives in virology, vol. 10. Raven Press, New York.", "volume-title": "In Perspectives in virology"}, {"key": "39_CR6", "doi-asserted-by": "crossref", "first-page": "1225", "DOI": "10.1016/S0140-6736(71)90543-5", "volume": "2", "author": "JD Almeida", "year": "1971", "unstructured": "Almeida, J. D., D. Rubenstein, and E. J. Scott. 1971. New antigen-antibody system in Australia antigen positive hepatitis. Lancet 2: 1225\u20131227.", "journal-title": "Lancet"}, {"key": "39_CR7", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1056/NEJM197610212951701", "volume": "295", "author": "HJ Alter", "year": "1976", "unstructured": "Alter, H. J., J. B. Seeff, P. M. Kaplan, V. J. McAuliffe, E. C. Wright, J. L. Gerin, R. H. Purcell, P. V. Holland, and H. J. Zimmerman. 1976. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N. Engl. J. Med. 295: 909\u2013913.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR8", "author": "MJ Alter", "year": "1984", "unstructured": "Alter, M. J., M. S. Favero, and J. E. Maynard. 1984. Haemodialysis-associated hepatitis in the United States (abstract), p. 636. InG. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle (ed.), Viral hepatitis and liver disease. Grune and Stratton, Orlando.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "39_CR9", "doi-asserted-by": "crossref", "first-page": "604", "DOI": "10.1093/infdis/151.4.604", "volume": "151", "author": "WLM Alward", "year": "1985", "unstructured": "Alward, W. L. M., B. J. McMahon, D. B. Hall, W. L. Heyward, D. R. Francis, and T. R. Bender. 1985. The long term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J. Infect. Dis. 151: 604\u2013609.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR10", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.1016/S0140-6736(87)92090-3", "volume": "1", "author": "M Aragona", "year": "1987", "unstructured": "Aragona, M., S. Macagno, F. Caredda, O. Crivelli, C. Lavarini, E. Marcan, P. Farci, R. H. Purcell, and M. Rizzetto. 1987. Serological response to the hepatitis delta virus in hepatitis D. Lancet 1: 478\u2013480.", "journal-title": "Lancet"}, {"key": "39_CR11", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1016/S0140-6736(85)92497-3", "volume": "2", "author": "S Arico", "year": "1985", "unstructured": "Arico, S., M. Aragona, M. Rizzetto, F. Caredda, A. Zanetti, G. Marinucci, S. Diana, P. Farci, M. Arnone, N. Caporaso, A. Ascione, P. Dentico, G. Pustore, G. Raimondo, and A. Craxi. 1985. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers. Lancet 2: 356\u2013358.", "journal-title": "Lancet"}, {"key": "39_CR12", "first-page": "842", "volume": "109", "author": "WH Bancroft", "year": "1972", "unstructured": "Bancroft, W. H., F. K. Mundon, and P. K. Russell. 1972. Detection of additional antigenic determinants of hepatitis B antigen. J. Immunol. 109: 842\u2013848.", "journal-title": "J. Immunol"}, {"key": "39_CR13", "doi-asserted-by": "crossref", "first-page": "189", "DOI": "10.1097/00000441-197507000-00026", "volume": "270", "author": "LF Barker", "year": "1975", "unstructured": "Barker, L. F., J. E. Maynard, R. H. Purcell, J. H. Hoofnagle, K. R. Berquist, and W. T. London. 1975. Viral hepatitis, type B, in experimental animals. Am. J. Med. Sci. 270: 189\u2013195.", "journal-title": "Am. J. Med. Sci"}, {"key": "39_CR14", "doi-asserted-by": "crossref", "first-page": "27", "DOI": "10.1097/00000441-197201000-00005", "volume": "263", "author": "LF Barker", "year": "1971", "unstructured": "Barker, L. F., and R. Murray. 1971. Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis-associated antigen. Am. J. Med. Sci. 263: 27\u201333.", "journal-title": "Am. J. Med. Sci"}, {"key": "39_CR15", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.1016/S0163-4453(84)93835-0", "volume": "8", "author": "AH Basalamah", "year": "1984", "unstructured": "Basalamah, A. H., F. Serebour, and E. Kazim. 1984. Materno-foetal transmission of hepatitis B in Saudi Arabia. J. Infect. 8: 200\u2013204.", "journal-title": "J. Infect"}, {"key": "39_CR16", "doi-asserted-by": "crossref", "first-page": "1057", "DOI": "10.1038/2181057a0", "volume": "218", "author": "ME Bayer", "year": "1968", "unstructured": "Bayer, M. E., B. S. Blumberg, and B. Werner. 1968. Particles associated with Australia antigen in the sera of patients with leukaemia, Down\u2019s syndrome and hepatitis. Nature (London) 218: 1057\u20131059.", "journal-title": "Nature (London)"}, {"key": "39_CR17", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.3109/00313027609094420", "volume": "8", "author": "RW Beal", "year": "1976", "unstructured": "Beal, R. W. 1976. Hepatitis B antigen screening in South Australia and Northern Territory blood donors. Pathology 8: 21\u201327.", "journal-title": "Pathology"}, {"key": "39_CR18", "author": "RP Beasley", "year": "1978", "unstructured": "Beasley, R. P., and C. E. Stevens. 1978. Vertical transmission of HBV and interruption with globulin, p. 333\u2013345. InG. N. Vyas, S. N. Cohen, and R. Schmid (ed.), Viral hepatitis. The Franklin Institute Press, Philadelphia.", "volume-title": "Viral hepatitis"}, {"key": "39_CR19", "doi-asserted-by": "crossref", "first-page": "702", "DOI": "10.1093/infdis/154.4.702", "volume": "154", "author": "KF Bergmann", "year": "1986", "unstructured": "Bergmann, K. F., and J. L. Gerin. 1986. Antigens of hepatitis delta virus in the liver and serum of humans and animals. J. Infect. Dis. 154: 702\u2013706.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR20", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1002/jmv.1890090109", "volume": "9", "author": "M Berninger", "year": "1982", "unstructured": "Berninger, M., M. Hammer, B. Hoyer, and J. L. Gerin. 1982. An assay for the detection of the DNA genome of hepatitis B virus in serum. J. Med. Virol. 9: 57\u201368.", "journal-title": "J. Med. Virol"}, {"key": "39_CR21", "first-page": "333", "volume": "1", "author": "L Bianchi", "year": "1971", "unstructured": "Bianchi, L., J. DeGroote, V. J. Desmet, P. Gedigk, G. Korb, H. Popper, H. Poulsen, P. J. Schever, M. Schmid, H. Thaler, and W. Wepler. 1971. Morphological criteria in viral hepatitis. Lancet 1: 333\u2013337.", "journal-title": "Lancet"}, {"key": "39_CR22", "author": "L Bianchi", "year": "1983", "unstructured": "Bianchi, L., and F. G. Gudat. 1983. Histo and immunopathology of viral hepatitis, p. 335\u2013382. InF. Deinhardt and G. Deinhardt (ed.) Viral hepatitis: laboratory and clinical science. Marcel Dekker, Basel.", "volume-title": "Viral hepatitis: laboratory and clinical science"}, {"key": "39_CR23", "doi-asserted-by": "crossref", "first-page": "771", "DOI": "10.1016/S0140-6736(84)90703-7", "volume": "2", "author": "HE Blum", "year": "1984", "unstructured": "Blum, H. E., A. T. Haase, and G. N. Vyas. 1984. Molecular pathogenesis of HBV infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet 2: 771\u2013775.", "journal-title": "Lancet"}, {"key": "39_CR24", "doi-asserted-by": "crossref", "first-page": "6685", "DOI": "10.1073/pnas.80.21.6685", "volume": "80", "author": "HE Blum", "year": "1983", "unstructured": "Blum, H. E., L. Stowring, and A. Figus. 1983. Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium and vascular elements by in situhybridization. Proc. Natl. Acad. Sci. USA. 80: 6685\u20136688.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR25", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1001/jama.1965.03080070025007", "volume": "191", "author": "BS Blumberg", "year": "1965", "unstructured": "Blumberg, B. S., H. J. Alter, and A. Visnich. 1965. A \u201cnew\u201d antigen in leukaemia sera. J. Am. Med. Assoc. 191: 541\u2013546.", "journal-title": "J. Am. Med. Assoc"}, {"key": "39_CR26", "doi-asserted-by": "crossref", "first-page": "924", "DOI": "10.7326/0003-4819-66-5-924", "volume": "66", "author": "BS Blumberg", "year": "1967", "unstructured": "Blumberg, B. S., B. J. S. Gerstley, D. A. Hungerford, W. T. London, and A. J. Sutnick. 1967. A serum antigen (Australia antigen) in Downs syndrome, leukaemia and hepatitis. Ann. Intern. Med. 66: 924\u2013931.", "journal-title": "Ann. Intern. Med"}, {"key": "39_CR27", "first-page": "535", "volume": "18", "author": "WW Bond", "year": "1983", "unstructured": "Bond, W. W., M. S. Favero, J. J. Petersen, and J. W. Ebert. 1983. Inactivation of hepatitis B virus by intermediate-to-high level disinfectant chemicals. J. Clin. Microbiol. 18: 535\u2013538.", "journal-title": "J. Clin. Microbiol"}, {"key": "39_CR28", "doi-asserted-by": "crossref", "first-page": "550", "DOI": "10.1016/S0140-6736(81)92877-4", "volume": "1", "author": "WW Bond", "year": "1981", "unstructured": "Bond, W. W., M. S. Favero, J. J. Petersen, C. R. Gravelle, J. W. Ebert, and J. E. Maynard. 1981. Survival of hepatitis B virus after drying and storage for one week. Lancet 1: 550\u2013551.", "journal-title": "Lancet"}, {"key": "39_CR29", "first-page": "235", "volume": "14", "author": "WW Bond", "year": "1977", "unstructured": "Bond, W. W., N. J. Petersen, and M. S. Favero. 1977. Viral hepatitis B: aspects of environmental control. Health Lab. Sci. 14: 235\u2013252.", "journal-title": "Sci"}, {"key": "39_CR30", "first-page": "945", "volume": "58", "author": "F Bonino", "year": "1986", "unstructured": "Bonino, F., K. H. Heerman, M. Rizzetto, and W. H. Gerlich. 1986. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J. Virol. 58: 945\u2013950.", "journal-title": "J. Virol"}, {"key": "39_CR31", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1002/hep.1840010207", "volume": "1", "author": "F Bonino", "year": "1981", "unstructured": "Bonino, F., B. Hoyer, E. J. Ford, J. W. K. Shih, R. H. Purcell, and J. L. Gerin. 1981. The delta agent: HBsAg particles with delta antigen and RNA in the serum of an HBV carrier. Hepatology 1: 127\u2013131.", "journal-title": "Hepatology"}, {"key": "39_CR32", "doi-asserted-by": "crossref", "first-page": "386", "DOI": "10.1002/hep.1840010503", "volume": "1", "author": "F Bonino", "year": "1981", "unstructured": "Bonino, F., B. Hoyer, J. Nelson, R. Engle, G. Verme, and J. L. Gerin. 1981. Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology 1: 386\u2013391.", "journal-title": "Hepatology"}, {"key": "39_CR33", "first-page": "1000", "volume": "43", "author": "F Bonino", "year": "1984", "unstructured": "Bonino, F., B. Hoyer, J. W. K. Shih, M. Rizzetto, R. H. Purcell, and J. L. Gerin. 1984. Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect. Immun. 43: 1000\u20131005.", "journal-title": "Immun"}, {"key": "39_CR34", "doi-asserted-by": "crossref", "first-page": "270", "DOI": "10.1056/NEJM198501313120503", "volume": "312", "author": "C Brechot", "year": "1985", "unstructured": "Brechot, C., P. Degos, C. Lugassy, V. Thiers, S. Zafrani, D. Franco, H. Bismuth, C. Trepo, J-P. Benhamou, J. Wands, K. Isselbacher, P. Tiollais, and P. Berthelot. 1985. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N. Engl. J. Med. 312: 270\u2013276.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR35", "doi-asserted-by": "crossref", "first-page": "765", "DOI": "10.1016/S0140-6736(81)90182-3", "volume": "2", "author": "C Brechot", "year": "1981", "unstructured": "Brechot, C., M. Hadchouel, J. Scotto, F. Degos, P. Charnay, C. Trepo, and P. Tiollais. 1981. Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet 2: 765\u2013768.", "journal-title": "Lancet"}, {"key": "39_CR36", "author": "C Brechot", "year": "1984", "unstructured": "Brechot, C., C. Lugassy, A. Dejean, P. Pontisso, V. Thiers, P. Bertholet, and P. Tiollais. 1984. Hepatitis B virus DNA in infected human tissues, p. 395\u2013410. InG. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, (ed.), Viral hepatitis and liver disease. Grune and Stratton, New York.", "volume-title": "Viral hepatitis and liver disease"}, {"issue": "(Suppl.)", "key": "39_CR37", "first-page": "27", "volume": "2", "author": "C Brechot", "year": "1982", "unstructured": "Brechot, C., C. Pourcel, M. Hadchouel, A. Dejean, A. Louise, J. Scotto, and P. Tiollais. 1982. State of hepatitis B virus DNA in liver diseases. Hepatology 2 (Suppl.): 27\u201334.", "journal-title": "Hepatology"}, {"key": "39_CR38", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1016/0042-6822(83)90460-9", "volume": "126", "author": "DJ Brigati", "year": "1983", "unstructured": "Brigati, D. J., D. Myerson, J. J. Leary, B. Spalholz, S. Z. Travis, C. K. Y. Fong, G. D. Hsiung, and D. C. Ward. 1983. Detection of viral genomes in cultured cells and paraffin-embedded tissue sections using biotin-labelled hybridization probes. Virology 126: 32\u201350.", "journal-title": "Virology"}, {"key": "39_CR39", "doi-asserted-by": "crossref", "first-page": "717", "DOI": "10.1016/0092-8674(85)90220-X", "volume": "40", "author": "M Buescher", "year": "1985", "unstructured": "Buescher, M., W. Reiser, H. Will, and H. Schaller. 1985. Characterization of transcripts and the potential RNA pregenome of duck hepatitis B virus: implication for replication by reverse transcription. Cell 40: 717\u2013724.", "journal-title": "Cell"}, {"issue": "(Suppl.)", "key": "39_CR40", "first-page": "85", "volume": "2", "author": "CJ Burrell", "year": "1982", "unstructured": "Burrell, C. J., E. J. Gowans, A. R. Jilbert, J. R. Lake, and B. P. Marmion. 1982. Hepatitis B virus DNA detection by in situcytohybridization: implications for viral replication strategy and pathogenesis of chronic hepatitis. Hepatology 2 (Suppl.): 85\u201391.", "journal-title": "Hepatology"}, {"key": "39_CR41", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1002/hep.1840040104", "volume": "4", "author": "CJ Burrell", "year": "1984", "unstructured": "Burrell, C. J., E. J. Gowans, R. Rowland, P. Hall, A. R. Jilbert, and B. P. Marmion. 1984. Correlation between liver histology and markers of hepatitis B virus replication in infected patients. Hepatology 4: 20\u201324.", "journal-title": "Hepatology"}, {"key": "39_CR42", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1038/279043a0", "volume": "279", "author": "CJ Burrell", "year": "1979", "unstructured": "Burrell, C. J., P. MacKay, P. J. Greenaway, P. H. Hofschneider, and K. Murray. 1979. Expression in Escherichia coliof hepatitis B virus DNA sequences cloned in plasmid pBR 322. Nature (London) 279: 43\u201347.", "journal-title": "Nature (London)"}, {"key": "39_CR43", "doi-asserted-by": "crossref", "first-page": "81", "DOI": "10.1002/jmv.1890180110", "volume": "18", "author": "M Buti", "year": "1986", "unstructured": "Buti, M., R. Esteban, R. Jardi, J-I. Esteban, and J. Guardia. 1986. Serological diagnosis of acute delta hepatitis. J. Med. Virol. 18: 81\u201385.", "journal-title": "J. Med. Virol"}, {"key": "39_CR44", "doi-asserted-by": "crossref", "first-page": "336", "DOI": "10.1038/305336a0", "volume": "305", "author": "R Cattaneo", "year": "1983", "unstructured": "Cattaneo, R., H. Will, N. Hernandez, and H. Schaller. 1983. Signals regulating hepatitis B surface antigen transcription. Nature (London) 305: 336\u2013338.", "journal-title": "Nature (London)"}, {"key": "39_CR45", "doi-asserted-by": "crossref", "first-page": "2191", "DOI": "10.1002/j.1460-2075.1984.tb02113.x", "volume": "3", "author": "R Cattaneo", "year": "1984", "unstructured": "Cattaneo, R., H. Will, and H. Schaller. 1984. Hepatitis B virus transcription in infected liver. EMBO J. 3: 2191\u20132196.", "journal-title": "EMBO J"}, {"key": "39_CR46", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1016/0042-6822(81)90364-0", "volume": "111", "author": "PR Chakraborty", "year": "1981a", "unstructured": "Chakraborty, P. R., N. Ruiz-Opazo, and D. A. Shafritz. 1981a. Transcription of human HBV core antigen gene sequences in an in vitroHeLa cellular extract. Virology 111: 647\u2013652.", "journal-title": "Virology"}, {"key": "39_CR47", "first-page": "532", "volume": "286", "author": "PR Chakraborty", "year": "1981b", "unstructured": "Chakraborty, P. R., N. Ruiz-Opazo, D. Shouval, and D. A. Shafritz. 1981b. Identification of integrated hepatitis B virus DNA and expression of viral DNA in an HBsAg producing human hepatocellular carcinoma cell line. Nature (London) 286: 532\u2013533.", "journal-title": "Nature (London)"}, {"key": "39_CR48", "doi-asserted-by": "crossref", "first-page": "142", "DOI": "10.1002/hep.1840030202", "volume": "3", "author": "KH Chau", "year": "1983", "unstructured": "Chau, K. H., M. P. Hargie, R. H. Decker, I. K. Mushawar, and L. R. Overby. 1983. Serodiagnosis of recent hepatitis B infection by IgM anti-HBc. Hepatology 3: 142\u2013149.", "journal-title": "Hepatology"}, {"key": "39_CR49", "doi-asserted-by": "crossref", "first-page": "502", "DOI": "10.1002/hep.1840040324", "volume": "4", "author": "DS Chen", "year": "1984", "unstructured": "Chen, D. S., M. Y. Lai, and J. L. Sung. 1984. Delta agent infection in patients with chronic liver diseases and hepatocellular carcinoma\u2014an infrequent finding in Taiwan. Hepatology 4: 502\u2013503.", "journal-title": "Hepatology"}, {"key": "39_CR50", "doi-asserted-by": "crossref", "first-page": "8774", "DOI": "10.1073/pnas.83.22.8774", "volume": "83", "author": "PJ Chen", "year": "1986", "unstructured": "Chen, P. J., G. Kaplana, J. Goldberg, W. Mason, B. Werner, J. L. Gerin, and J. Taylor. 1986. Structure and replication of the genome of the hepatitis delta virus. Proc. Natl. Acad. Sci. USA 83: 8774\u20138778.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR51", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1016/S0163-4453(81)90865-3", "volume": "3", "author": "KC Chin", "year": "1981", "unstructured": "Chin, K. C., A. K. R. Chaudhuri, and E. A. C. Follett. 1981. Materno-foetal transmission of HBsAg by asymptomatic carrier mothers in Glasgow. J. Infect. 3: 246\u2013252.", "journal-title": "J. Infect"}, {"key": "39_CR52", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1002/hep.1840050315", "volume": "5", "author": "CM Chu", "year": "1985", "unstructured": "Chu, C-M., P. Karayiannis, M. J. F. Fowler, J. Monjardino, Y-F. Liaw, and H. C. Thomas. 1985. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 5: 431\u2013434.", "journal-title": "Hepatology"}, {"key": "39_CR53", "first-page": "1", "volume": "42", "author": "AM Courouce", "year": "1975", "unstructured": "Courouce, A. M., P. V. Holland, J. Y. Muller, and J. P. Soulier. 1975. HBsAg antigen subtypes: Proceedings of the International Workshop on HBs antigen subtypes. Bibl. Haematologica 42: 1\u2013158.", "journal-title": "Haematologica"}, {"key": "39_CR54", "first-page": "173", "volume": "14", "author": "O Crivelli", "year": "1981", "unstructured": "Crivelli, O., M. Rizzetto, C. Lavarini, A. Smedile, and J. L. Gerin. 1981. Enzyme-linked immunosorbent assay for detection of antibody to the hepatitis B surface antigen- associated delta antigen. J. Clin. Microbiol. 14: 173\u2013177.", "journal-title": "J. Clin. Microbiol"}, {"key": "39_CR55", "author": "O Crivelli", "first-page": "121", "year": "1983", "unstructured": "Crivelli, O., J. W. K. Shih, and M. Rizzetto. 1983. Methods for detection of the delta antigen and antibody in liver and serum, p. 121\u2013126. InG. Verne, F. Bonino, and M. Rizzetto (ed.), Viral hepatitis and delta infection. Alan R. Liss, New York.", "volume-title": "Viral hepatitis and delta infection"}, {"key": "39_CR56", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.1016/S0140-6736(70)90926-8", "volume": "1", "author": "DS Dane", "year": "1970", "unstructured": "Dane, D. S., C. H. Cameron, and M. Briggs. 1970. Viruslike particles in serum of patients with Australia antigen associated hepatitis. Lancet 1: 695\u2013698.", "journal-title": "Lancet"}, {"key": "39_CR57", "doi-asserted-by": "crossref", "first-page": "762", "DOI": "10.7326/0003-4819-102-6-762", "volume": "102", "author": "GL Davis", "year": "1985", "unstructured": "Davis, G. L., and J. H. Hoofnagle. 1985. Reactivation of chronic type B hepatitis presenting as acute viral hepatitis. Ann. Intern. Med. 102: 762\u2013765.", "journal-title": "Ann. Intern. Med"}, {"key": "39_CR58", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1016/0016-5085(84)90406-2", "volume": "86", "author": "GL Davis", "year": "1984", "unstructured": "Davis, G. L., J. H. Hoofnagle, and J. F. Waggoner. 1984. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 86: 230\u2013235.", "journal-title": "Gastroenterology"}, {"key": "39_CR59", "first-page": "661", "volume": "60", "author": "F Deinhardt", "year": "1982", "unstructured": "Deinhardt, F., and I. D. Gust. 1982. Viral hepatitis. Bull. W.H.O. 60: 661\u2013691.", "journal-title": "Viral hepatitis. Bull. W.H.O."}, {"key": "39_CR60", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1002/jmv.1890170302", "volume": "17", "author": "F Deinhardt", "year": "1985", "unstructured": "Deinhardt, F., and A. J. Zuckerman. 1985. Immunization against hepatitis B: report of a WHO meeting on viral hepatitis in Europe. J. Med. Virol. 17: 209\u2013217.", "journal-title": "J. Med. Virol"}, {"key": "39_CR61", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1099/0022-1317-65-3-651", "volume": "65", "author": "A Dejean", "year": "1984", "unstructured": "Dejean, A., C. Lugassy, and E. S. Zafrani. 1984. Detection of hepatitis B virus DNA in pancreas, kidney and skin of two human carriers of the virus. J. Gen. Virol. 65: 651\u2013655.", "journal-title": "J. Gen. Virol"}, {"key": "39_CR62", "doi-asserted-by": "crossref", "first-page": "5350", "DOI": "10.1073/pnas.81.17.5350", "volume": "81", "author": "A Dejean", "year": "1985", "unstructured": "Dejean, A., P. Sonigo, S. Wain-Hobson, and P. Tiollais. 1985. Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat. Proc. Natl. Acad. Sci. USA 81: 5350\u20135354.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR63", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1001/jama.1978.03280300042018", "volume": "239", "author": "AE Denes", "year": "1978", "unstructured": "Denes, A. E., J. L. Smith, and J. E. Maynard. 1978. Hepatitis B virus infection in physicians. Results of a nationwide seroepidemiologic survey. J. Am. Med. Assoc. 239: 210\u2013212.", "journal-title": "J. Am. Med. Assoc"}, {"key": "39_CR64", "doi-asserted-by": "crossref", "first-page": "873", "DOI": "10.1126/science.3704630", "volume": "232", "author": "KJ Denniston", "year": "1986", "unstructured": "Denniston, K. J., B. H. Hoyer, A. Smedile, F. V. Wells, J. Nelson, and J. L. Gerin. 1986. Cloned fragments of the hepatitis delta virus RNA genome: sequence and diagnostic applications. Science 232: 873\u2013875.", "journal-title": "Science"}, {"key": "39_CR65", "first-page": "797", "volume": "23", "author": "PS Diegutis", "year": "1986", "unstructured": "Diegutis, P. S., E. Keirnan, L. Burnett, B. N. Nightingale, and Y. Cossart. 1986. False-positive results with hepatitis B virus DNA dot-hybridization in hepatitis B surface antigen-negative specimens. J. Clin. Microbiol. 23: 797\u2013799.", "journal-title": "J. Clin. Microbiol"}, {"key": "39_CR66", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1055/s-2008-1063929", "volume": "1", "author": "JL Dienstag", "year": "1981", "unstructured": "Dienstag, J. L. 1981. Hepatitis B as an immune complex disease. Semin. Liver Dis. 1: 45\u201349.", "journal-title": "Liver Dis"}, {"key": "39_CR67", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/0016-5085(83)90336-0", "volume": "85", "author": "JL Dienstag", "year": "1983a", "unstructured": "Dienstag, J. L. 1983a. Non-A, non-B hepatitis. I. Recognition, epidemiology and clinical features. Gastroenterology 85: 439\u2013462.", "journal-title": "Gastroenterology"}, {"key": "39_CR68", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.1016/0016-5085(83)90036-7", "volume": "85", "author": "JL Dienstag", "year": "1983b", "unstructured": "Dienstag, J. L. 1983b. Non-A, non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention. Gastroenterology, 85: 743\u2013768.", "journal-title": "Gastroenterology"}, {"key": "39_CR69", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/0166-0934(84)90070-3", "volume": "8", "author": "M Dimitrakakis", "year": "1984", "unstructured": "Dimitrakakis, M., A. G. Coulepis, R. C. Pringle, and I. D. Gust. 1984. Detection of delta infection using reagents obtained from the serum of patients infected with HBV. J. Virol. Methods 8: 331\u2013334.", "journal-title": "J. Virol. Methods"}, {"key": "39_CR70", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1002/jmv.1890200403", "volume": "20", "author": "M Dimitrakakis", "year": "1986a", "unstructured": "Dimitrakakis, M., S. Crowe, and I. D. Gust. 1986a. Prevalence of delta infection in the Western Pacific region. J. Med. Virol. 20: 305\u2013311.", "journal-title": "J. Med. Virol"}, {"key": "39_CR71", "first-page": "197", "volume": "2", "author": "M Dimitrakakis", "year": "1984", "unstructured": "Dimitrakakis, M., and I. D. Gust. 1984. Delta infection in Pacific islanders. Med. J. Aust. 2: 197.", "journal-title": "J. Aust"}, {"key": "39_CR72", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1002/jmv.1890200403", "volume": "20", "author": "M Dimitrakakis", "year": "1986b", "unstructured": "Dimitrakakis, M., M. J. Waters, A. Wootton, and I. D. Gust. 1986b. Detection of IgM antibodies to delta antigen after coinfection and superinfection with the delta virus. J. Med. Virol. 20: 305\u2013311.", "journal-title": "J. Med. Virol"}, {"key": "39_CR73", "doi-asserted-by": "crossref", "first-page": "6250", "DOI": "10.1073/pnas.83.17.6250", "volume": "83", "author": "G Dimter-Gottlieb", "year": "1986", "unstructured": "Dimter-Gottlieb, G. 1986. Viroids and virusoids are related to group I introns. Proc. Natl. Acad. Sci. USA 83: 6250.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR74", "unstructured": "Dreesman, G. R. 1984. Molecular immunology of hepatitis antigens, p. 583\u2013586. In G. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle. Viral hepatitis and liver disease. Grune and Stratton, New York."}, {"key": "39_CR75", "unstructured": "Dudley, F. J., P. J. Schever, and S. Sherlock. 1972. Natural history of hepatitis B-associated antigen-positive chronic liver disease. Lancet ii: 1388\u20131391.", "DOI": "10.1016/S0140-6736(72)92963-7", "doi-asserted-by": "crossref"}, {"key": "39_CR76", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1002/jmv.1890040104", "volume": "4", "author": "W Duermeyer", "year": "1979", "unstructured": "Duermeyer, W., F. Wielaard, and J. van der Veen. 1979. A new principle for the detection of specific IgM antibodies applied in an ELISA for hepatitis A. J. Med. Virol. 4: 25\u201332.", "journal-title": "J. Med. Virol"}, {"key": "39_CR77", "author": "ALWF Eddleston", "year": "1979", "unstructured": "Eddleston, A. L. W. F., and R. Williams. 1979. HL-A system and liver disease, p. 285\u2013299. InH. Popper and F. Schaffner (ed.), Progress in liver diseases, vol. 6. Grune and Stratton, New York.", "volume-title": "Progress in liver diseases"}, {"key": "39_CR78", "doi-asserted-by": "crossref", "first-page": "3526", "DOI": "10.1073/pnas.81.11.3526", "volume": "81", "author": "E Elfassi", "year": "1984", "unstructured": "Elfassi, E., J.-L. Romet-Lemoune, M. Essex, M. Frances-McLane, and W. A. Haseltine. 1984. Evidence of extra chromosomal forms of HBV DNA in a bone marrow culture obtained from a patient recently infected with HBV. Proc. Natl. Acad. Sci. USA 81: 3526\u20133528.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR79", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1016/0166-0934(85)90136-3", "volume": "12", "author": "EA Fagan", "year": "1985", "unstructured": "Fagan, E. A., P. Guarner, S. D. K. Perera, R. Trowbridge, N. Rolando, F. Davison, and R. Williams. 1985. Quantitation of hepatitis B virus DNA (HBV DNA) in serum using the sport hybridization technique and scintillation counting. J. Virol. Methods 12: 251\u2013262.", "journal-title": "J. Virol. Methods"}, {"key": "39_CR80", "doi-asserted-by": "crossref", "first-page": "1443", "DOI": "10.1001/jama.1986.03370110065022", "volume": "255", "author": "P Farci", "year": "1986", "unstructured": "Farci, P., J. L. Gerin, M. Aragona, I. Lindsey, O. Crivelli, A. Balestrieri, A. Smedile, H. C. Thomas, and M. Rizzetto. 1986. Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus. J. Am. Med. Assoc. 255: 1443\u20131446.", "journal-title": "J. Am. Med. Assoc"}, {"key": "39_CR81", "author": "SM Feinstone", "year": "1979", "unstructured": "Feinstone, S. M., L. F. Barker, and R. H. Purcell. 1979. Hepatitis A and B, p. 879\u2013925. InE. H. Lennette and N. J. Schmidt (ed.), Diagnostic procedures for viral, rickettsial and chlamydial infections, 5th ed. American Public Health Association, Washington, D.C.", "volume-title": "Diagnostic procedures for viral, rickettsial and chlamydial infections, 5th ed. American Public Health Association"}, {"key": "39_CR82", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1056/NEJM198407193110311", "volume": "311", "author": "SM Feinstone", "year": "1984", "unstructured": "Feinstone, S. M., and J. H. Hoofnagle. 1984. Non-A, maybe-B hepatitis. N. Engl. J. Med. 311: 185\u2013189.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR83", "first-page": "447", "volume": "39", "author": "MA Feitelson", "year": "1981", "unstructured": "Feitelson, M. A., P. L. Marion, and W. S. Robinson. 1981. Antigenic and structural relationships of the surface antigens of hepatitis B virus, ground squirrel hepatitis virus, and woodchuck hepatitis virus. J. Virol. 39: 447\u2013454.", "journal-title": "J. Virol"}, {"key": "39_CR84", "first-page": "687", "volume": "43", "author": "MA Feitelson", "year": "1982a", "unstructured": "Feitelson, M. A., P. L. Marion, and W. S. Robinson. 1982a. Core particles of HBV and GSHV. I. Relationship between HBcAg and GSHcAg associated polypeptides by SDS-PAGE and tryptic peptide mapping. J. Virol. 43: 687\u2013696.", "journal-title": "J. Virol"}, {"key": "39_CR85", "first-page": "741", "volume": "43", "author": "MA Feitelson", "year": "1982b", "unstructured": "Feitelson, M. A., P. L. Marion, and W. S. Robinson. 1982b. Core particles on HBV and GSHV. II. Characterization of the protein kinase reaction associated with ground-squirrel hepatitis and hepatitis B virus. J. Virol. 43: 741\u2013748.", "journal-title": "J. Virol"}, {"key": "39_CR86", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1016/S0035-9203(37)90055-5", "volume": "31", "author": "GM Findlay", "year": "1937", "unstructured": "Findlay, G. M., and F. O. MacCallum. 1937. Note on acute hepatitis and yellow fever immunization. Trans. R. Soc. Trop. Med. Hyg. 31: 297.", "journal-title": "Trans. R. Soc. Trop. Med. Hyg"}, {"key": "39_CR87", "first-page": "544", "volume": "16", "author": "A Flaum", "year": "1926", "unstructured": "Flaum, A., H. Malmros, and E. Persson. 1926. Eine nosocomial Ikterus-Epidemie. Beta. Med. Scand. Suppl. 16: 544.", "journal-title": "Beta. Med. Scand. Suppl"}, {"key": "39_CR88", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1002/jmv.1890130110", "volume": "13", "author": "MJF Fowler", "year": "1984", "unstructured": "Fowler, M. J. F., J. Monjardino, K. N. Tsiquaye, A. J. Zuckerman, and H. C. Thomas. 1984. The mechanism of replication of hepatitis B virus: evidence of asymmetric replication of the two DNA strands. J. Med. Virol. 13: 83\u201391.", "journal-title": "J. Med. Virol"}, {"key": "39_CR89", "first-page": "125", "volume": "115", "author": "D Frommel", "year": "1984", "unstructured": "Frommel, D., D. Crevat, L. Vitvitsky, C. Pichoud, O. Hanitz, M. Chevalier, J.-A. Grimaud, J. Lindberg, and C. G. Tolpo. 1984. Immunopathologic aspects of wood-chuck hepatitis. Am. J. Pathol. 115: 125\u2013134.", "journal-title": "Am. J. Pathol"}, {"key": "39_CR90", "author": "GG Frosner", "year": "1984", "unstructured": "Frosner, G. G., and E. Franco. 1984. New developments of open questions in the serology of hepatitis A and B, p. 487\u2013496. InG. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle (ed.), Viral hepatitis and liver disease. Grune and Stratton, New York.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "39_CR91", "doi-asserted-by": "crossref", "first-page": "4601", "DOI": "10.1093/nar/11.13.4601", "volume": "11", "author": "A Fujiyama", "year": "1983", "unstructured": "Fujiyama, A., A. Miyanohara, C. Nozaki, T. Yoneyama, N. Ohtomo, and K. Matsubara. 1983. Cloning and structural analysis of hepatitis B virus DNAs, subtype adr. Nucleic Acids Res. 11: 4601\u20134610.", "journal-title": "Nucleic Acids Res"}, {"key": "39_CR92", "first-page": "51", "volume": "41", "author": "F Galibert", "year": "1982", "unstructured": "Galibert, F., T. N. Chen, and E. Mandart. 1982. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: comparison with the hepatitis B virus sequence. J. Virol. 41: 51\u201365.", "journal-title": "J. Virol"}, {"key": "39_CR93", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1038/281646a0", "volume": "281", "author": "F Galibert", "year": "1979", "unstructured": "Galibert, F., E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay. 1979. Nucleotide sequence of hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (London) 281: 646\u2013650.", "journal-title": "Nature (London)"}, {"key": "39_CR94", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1038/302021a0", "volume": "302", "author": "DA Galloway", "year": "1983", "unstructured": "Galloway, D. A., and J. K. McDougall. 1983. The oncogenic potential of herpes simplex viruses: evidence for a \u201chit and run\u201d mechanism. Nature (London) 302: 21\u201324.", "journal-title": "Nature (London)"}, {"key": "39_CR95", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1172/JCI101939", "volume": "27", "author": "SJ Gellis", "year": "1948", "unstructured": "Gellis, S. J., J. R. Neefe, J. Stokes, Jr., L. E. Strong, C. E. Jane way, and G. Scatchard. 1948. Chemical, clinical and immunological studies on the products of human plasma fractionation. XXXVI. Inactivation of the virus of homologous serum hepatitis in solution of normal serum albumin by means of heat. J. Clin. Invest. 27: 239\u2013244.", "journal-title": "J. Clin. Invest"}, {"key": "39_CR96", "first-page": "489", "volume": "75", "author": "MA Gerber", "year": "1974", "unstructured": "Gerber, M. A., S. Hadziyannis, C. Vissoulis, F. Schaffner, F. Paronetto, and H. Popper. 1974. Electron microscopy and immunoelectron microscopy of cytoplasmic hepatitis B antigen in hepatocytes. Am. J. Pathol. 75: 489\u2013502.", "journal-title": "Am. J. Pathol"}, {"key": "39_CR97", "first-page": "572", "volume": "52", "author": "MA Gerber", "year": "1985", "unstructured": "Gerber, M. A., and S. N. Thung. 1985. Biology of disease: molecular and cellular pathology of hepatitis B. Lab. Invest. 52: 572\u2013590.", "journal-title": "Invest"}, {"key": "39_CR98", "author": "MA Gerber", "year": "1983", "unstructured": "Gerber, M. A., S. N. Thung, and H. Popper. 1983. Viral hepatitis and hepatocellular carcinoma, p. 317\u2013334. InF. Deinhardt and J. Deinhardt (ed.), Viral hepatitis: laboratory and clinical sciences. Marcel Dekker, Inc., Basel.", "volume-title": "Viral hepatitis: laboratory and clinical sciences. Marcel Dekker"}, {"key": "39_CR99", "author": "JL Gerin", "year": "1978", "unstructured": "Gerin, J. L., and J. W. K. Shih. 1978. Structure of HBsAg and HBcAg, p. 147\u2013158. InG. N. Vyas, S. N. Cohen, and R. Schmid (ed.), Viral hepatitis. The Franklin Institute Press, Philadelphia.", "volume-title": "Viral hepatitis"}, {"key": "39_CR100", "first-page": "787", "volume": "36", "author": "WH Gerlich", "year": "1980", "unstructured": "Gerlich, W. H., M. A. Feitelson, P. L. Marion, and W. S. Robinson. 1980. Structural relationships between the surface antigens of ground squirrel hepatitis virus and human hepatitis B virus. J. Virol. 36: 787\u2013795.", "journal-title": "J. Virol"}, {"key": "39_CR101", "doi-asserted-by": "crossref", "first-page": "801", "DOI": "10.1016/0092-8674(80)90443-2", "volume": "31", "author": "WH Gerlich", "year": "1980", "unstructured": "Gerlich, W. H., and W. J. Robinson. 1980. Hepatitis B virus contains protein attached to the 5\u2019 terminus of its complete DNA strand. Cell 31: 801\u2013809.", "journal-title": "Cell"}, {"key": "39_CR102", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1056/NEJM196907172810302", "volume": "281", "author": "JP Giles", "year": "1969", "unstructured": "Giles, J. P., H. E. McCollum, L. W. Berndtson, and S. Krugman. 1969. Viral hepatitis Australia: SH antigen and Willowbrook MS2 strain. N. Engl. J. Med. 281: 119\u2013122.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR103", "doi-asserted-by": "crossref", "first-page": "335", "DOI": "10.1002/jmv.1890150403", "volume": "15", "author": "B Gilja", "year": "1985", "unstructured": "Gilja, B., E. Kasambalides, R. S. Bressler, S. N. Thung, and M. A. Gerber. 1985. Secretion of polyalbumin receptors in vitro. J. Med. Virol. 15: 335\u2013341.", "journal-title": "J. Med. Virol"}, {"key": "39_CR104", "first-page": "1417", "volume": "86", "author": "S Govindarajan", "year": "1984", "unstructured": "Govindarajan, S., K. P. Chin, A. G. Redeker, and R. L. Peters. 1984. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 86: 1417\u20131420.", "journal-title": "Gastroenterology"}, {"key": "39_CR105", "first-page": "439", "volume": "145", "author": "EJ Gowans", "year": "1986", "unstructured": "Gowans, E. J. 1986. Relationship between HBeAg and HBV DNA in patients with acute and persistent hepatitis B infection. Med. J. Aust. 145: 439\u2013441.", "journal-title": "J. Aust"}, {"key": "39_CR106", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1002/jmv.1890080106", "volume": "8", "author": "EJ Gowans", "year": "1981", "unstructured": "Gowans, E. J., C. J. Burrell, A. R. Jilbert, and B. P. Marmion. 1981. Detection of hepatitis B virus DNA sequences in infected hepatocytes by in situhybridization. J. Med. Virol. 8: 67\u201378.", "journal-title": "J. Med. Virol"}, {"key": "39_CR107", "doi-asserted-by": "crossref", "first-page": "1194", "DOI": "10.1016/S0016-5085(19)31906-7", "volume": "73", "author": "F Gudat", "year": "1977", "unstructured": "Gudat, F., and L. Bianchi. 1977. Evidence for phasic sequences in HbcAg formation and cell membrane-directed flow of core particles in chronic hepatitis B. Gastroenterology 73: 1194\u20131197.", "journal-title": "Gastroenterology"}, {"key": "39_CR108", "first-page": "1", "volume": "32", "author": "F Gudat", "year": "1975", "unstructured": "Gudat, F., L. Bianchi, W. Sonnabend, G. Thiel, W. Aenishaenslin, and G. A. Stalder. 1975. Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab. Invest. 32: 1\u20139.", "journal-title": "Invest"}, {"key": "39_CR109", "author": "ID Gust", "year": "1984", "unstructured": "Gust, I. D. 1984. The epidemiology of viral hepatitis, p. 415\u2013421. InG. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, (ed.), Viral hepatitis and liver disease. Grune and Stratton, Orlando.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "39_CR110", "doi-asserted-by": "crossref", "first-page": "14", "DOI": "10.1159/000149651", "volume": "25", "author": "ID Gust", "year": "1986", "unstructured": "Gust, I. D., C. J. Burrell, A. G. Coulepis, W. S. Robinson, and A. J. Zuckerman. 1986. Toxonomic classification of human hepatitis B virus. Intervirology 25: 14\u201329.", "journal-title": "Intervirology"}, {"key": "39_CR111", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.7326/0003-4819-100-3-339", "volume": "100", "author": "SC Hadler", "year": "1984", "unstructured": "Hadler, S. C., M. DeMonzon, A. Ponzetto, E. Anzola, D. Rivero, A. Mondolfi, A. Bracho, D. Francis, M. Gerber, S. Thung, J. L. Gerin, J. Maynard, H. Popper, and R. Purcell. 1984. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann. Int. Med. 100: 339\u2013344.", "journal-title": "Ann. Int. Med"}, {"key": "39_CR112", "doi-asserted-by": "crossref", "first-page": "656", "DOI": "10.1002/hep.1840030505", "volume": "3", "author": "SJ Hadziyannis", "year": "1983", "unstructured": "Hadziyannis, S. J., H. M. Lieberman, G. G. Karvountzis, and D. A. Shafritz. 1983. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg versus anti-HBe positive carriers of hepatitis B virus. Hepatology 3: 656\u2013662.", "journal-title": "Hepatology"}, {"key": "39_CR113", "doi-asserted-by": "crossref", "first-page": "544", "DOI": "10.1002/hep.1840050404", "volume": "5", "author": "SJ Hadziyannis", "year": "1985", "unstructured": "Hadziyannis, S. J., M. Sherman, H. M. Lieberman, and D. A. Shafritz. 1985. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers. Hepatology 5: 544\u2013547.", "journal-title": "Hepatology"}, {"key": "39_CR114", "doi-asserted-by": "crossref", "first-page": "318", "DOI": "10.1093/infdis/136.Supplement_2.S318", "volume": "136", "author": "SP Halbert", "year": "1977", "unstructured": "Halbert, S. P., and M. Anken. 1977. Detection of hepatitis B surface antigen (HBsAg) with use of alkaline phosphatase-labelled antibody to HBsAg. J. Infect. Dis. 136: 318\u2013323.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR115", "first-page": "213", "volume": "1", "author": "MS Halpern", "year": "1984", "unstructured": "Halpern, M. S., J. Egan, W. S. Mason, and J. M. England. 1984. Viral antigen in endocrine cells of the pancreatic islets and adrenal cortex of Pekin ducks infected with DHBV. Virus. Res. 1: 213\u2013224.", "journal-title": "Res"}, {"key": "39_CR116", "doi-asserted-by": "crossref", "first-page": "4865", "DOI": "10.1073/pnas.80.15.4865", "volume": "80", "author": "MS Halpern", "year": "1983", "unstructured": "Halpern, M. S., J. M. England, and D. T. Deery. 1983. Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. Proc. Natl. Acad. Sci. USA 80: 4865\u20134869.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR117", "doi-asserted-by": "crossref", "first-page": "472", "DOI": "10.1093/infdis/146.4.472", "volume": "146", "author": "BG Hansson", "year": "1982", "unstructured": "Hansson, B. G., T. Moestrup, A. Widell, and E. Nordenfelt. 1982. Infection with delta agent in Sweden: introduction of a new hepatitis agent. J. Infect. Dis. 146: 472\u2013478.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR118", "first-page": "125", "volume": "26", "author": "BG Hansson", "year": "1979", "unstructured": "Hansson, B. G., and R. H. Purcell. 1979. Sites that bind polymerized albumin on hepatitis B surface antigen particles: detection by radioimmunoassay. Infect. Immun. 26: 125\u2013130.", "journal-title": "Immun"}, {"key": "39_CR119", "author": "WP Havens Jr", "year": "1968", "unstructured": "Havens, W. P. Jr. 1968. Viral hepatitis, chap. 13. InR. S. Anderson, (ed.) Internal medicine in World War II, vol. 3. Office of the Surgeon General, Department of the Army, Washington, D.C.", "volume-title": "Internal medicine in World War II"}, {"key": "39_CR120", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1038/290475a0", "volume": "290", "author": "WS Hayward", "year": "1981", "unstructured": "Hayward, W. S., B. G. Neel, and S. M. Astrin. 1981. Activation of a cellular onegene by promoter insertion in ALV-induced lymphoid leukosis. Nature (London) 290: 475\u2013480.", "journal-title": "Nature (London)"}, {"key": "39_CR121", "first-page": "396", "volume": "52", "author": "KH Heermann", "year": "1984", "unstructured": "Heermann, K. H., U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, and W. H. Gerlich. 1984. Large surface proteins of HBV containing the pre-S sequence. J. Virol. 52: 396\u2013402.", "journal-title": "J. Virol"}, {"key": "39_CR122", "doi-asserted-by": "crossref", "first-page": "761", "DOI": "10.3181/00379727-143-37408", "volume": "143", "author": "AA Hirata", "year": "1973", "unstructured": "Hirata, A. A., A. J. Emerick, and W. F. Boley. 1973. Hepatitis B virus antigen detection by reverse passive haemagglutination. Proc. Soc. Exp. Biol. Med. 143: 761\u2013766.", "journal-title": "Proc. Soc. Exp. Biol. Med"}, {"key": "39_CR123", "first-page": "239", "volume": "31", "author": "P Hohenberger", "year": "1984", "unstructured": "Hohenberger, P. 1984. Detection of HBsAg in the pancreas in cases on pancreatic carcinoma. Hepatogastroenterology 31: 239\u2013241.", "journal-title": "Hepatogastroenterology"}, {"key": "39_CR124", "author": "FB Hollinger", "first-page": "1981", "year": "1981", "unstructured": "Hollinger, F. B., E. Adam, D. Heiberg, and J. L. Melnick. 1981. Response to hepatitis B vaccine in a young adult population, p. 451\u2013466. InW. Szmuness, H. J. Alter, and J. E. Maynard, (ed.) Viral hepatitis, 1981 International Symposium. The Franklin Institute Press, Philadelphia.", "volume-title": "Viral hepatitis"}, {"key": "39_CR125", "author": "FB Hollinger", "year": "1980", "unstructured": "Hollinger, F. B., and Dienstag, J. L. 1980. Hepatitis viruses, p. 899\u2013921. InE. H. Lennette, A. Balows, W. J. Hausler, and J. P. Truant, (ed.) Manual of clinical microbiology, 3rd ed. American Society for Microbiology, Washington, D.C.", "volume-title": "Manual of clinical microbiology, 3rd ed. American Society for Microbiology"}, {"key": "39_CR126", "author": "FB Hollinger", "year": "1985", "unstructured": "Hollinger, F. B., and J. L. Dienstag. 1985. Hepatitis viruses, p. 813\u2013835. InE. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy, (ed.) Manual of clinical microbiology. 4th ed. American Society for Microbiology, Washington, D.C.", "volume-title": "E. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy, (ed.) Manual of clinical microbiology"}, {"key": "39_CR127", "author": "FB Hollinger", "year": "1985", "unstructured": "Hollinger, F. B., and J. L. Melnick. 1985. Prevention and control of hepatitis B infection, p. 165\u2013203. InF. B. Hollinger, J. L. Melnick, and W. S. Robinson (ed.), Viral hepatitis. Raven Press, New York.", "volume-title": "Viral hepatitis"}, {"key": "39_CR128", "first-page": "1099", "volume": "107", "author": "FB Hollinger", "year": "1971", "unstructured": "Hollinger, F. B., V. Vorndam, and G. R. Dreesman. 1971. Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive haemagglutination methods. J. Immunol. 107: 1099\u20131111.", "journal-title": "J. Immunol"}, {"key": "39_CR129", "author": "JH Hoofnagle", "first-page": "97", "year": "1984", "unstructured": "Hoofnagle, J. H., and H. J. Alter. 1984. Chronic viral hepatitis, p. 97\u2013113. InG. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, (ed.), Viral hepatitis and liver disease. Grune and Stratton, Orlando, Florida.", "volume-title": "Viral hepatitis and liver disease. Grune and Stratton"}, {"key": "39_CR130", "doi-asserted-by": "crossref", "first-page": "869", "DOI": "10.1016/S0140-6736(73)92004-7", "volume": "2", "author": "JH Hoofnagle", "year": "1973", "unstructured": "Hoofnagle, J. H., R. J. Gerety, and L. F. Barker. 1973. Antibody to hepatitis B virus core in man. Lancet 2: 869\u2013873.", "journal-title": "Lancet"}, {"key": "39_CR131", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1055/s-2008-1040787", "volume": "6", "author": "JH Hoofnagle", "year": "1986", "unstructured": "Hoofnagle, J. H., and D. F. Schafer. 1986. Serologic markers of hepatitis B virus infection. Semin. Liver Dis. 6: 1\u201310.", "journal-title": "Liver Dis"}, {"key": "39_CR132", "author": "JH Hoofnagle", "year": "1978", "unstructured": "Hoofnagle, J. H., L. B. Seeff, Z. B. Bales, R. J. Gerety, and E. Tabor. 1978. Serological responses in hepatitis B, p. 219\u2013242. InG. N. Vyas, S. N. Cohen, and R. Schmid, (ed.), Viral hepatitis. Franklin Institute Press, Philadelphia.", "volume-title": "Viral hepatitis"}, {"key": "39_CR133", "doi-asserted-by": "crossref", "first-page": "734", "DOI": "10.1093/ajcp/75.5.734", "volume": "75", "author": "SM Hsu", "year": "1981a", "unstructured": "Hsu, S. M., L. Raine, and H. Fanger. 1981a. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol. 75: 734\u2013738.", "journal-title": "Am. J. Clin. Pathol"}, {"key": "39_CR134", "doi-asserted-by": "crossref", "first-page": "577", "DOI": "10.1177/29.4.6166661", "volume": "29", "author": "SM Hsu", "year": "1981b", "unstructured": "Hsu, S. M., L. Raine, and H. Fanger. 1981b. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577\u2013580.", "journal-title": "J. Histochem. Cytochem"}, {"key": "39_CR135", "first-page": "383", "volume": "35", "author": "S Huang", "year": "1976", "unstructured": "Huang, S., H. Minassian, and J. D. More. 1976. Application of immunofluorescent staining on paraffin sections improved by trypsin digestion. Lab. Invest. 35: 383\u2013390.", "journal-title": "Invest"}, {"key": "39_CR136", "first-page": "1", "volume": "40", "author": "SN Huang", "year": "1979", "unstructured": "Huang, S. N., and A. R. Neurath. 1979. Immunohistologic demonstration of hepatitis B viral antigens in liver with reference to its significance in liver injury. Lab. Invest. 40: 1\u201317.", "journal-title": "Invest"}, {"key": "39_CR137", "first-page": "69", "volume": "128", "author": "M Imai", "year": "1982", "unstructured": "Imai, M., M. Nomura, T. Gotanda, T. Sano, K. Tachibana, H. Miyamoto, K. Takahashi, G. Toyama, Y. Miyakawa, and M. Mayumi. 1982. Demonstration of two distinct antigenic determinants on HBeAg by monoclonal antibodies. J. Immunol. 128: 69\u201372.", "journal-title": "J. Immunol"}, {"key": "39_CR138", "doi-asserted-by": "crossref", "first-page": "242", "DOI": "10.1016/0016-5085(79)90328-7", "volume": "76", "author": "M Imai", "year": "1979", "unstructured": "Imai, M., Y. Yanase, T. Nojiri, Y. Miyakawa, and M. Mayumi. 1979. A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles occurring with HBeAg. Gastroenterology 76: 242\u2013247.", "journal-title": "Gastroenterology"}, {"key": "39_CR139", "doi-asserted-by": "crossref", "first-page": "188", "DOI": "10.1002/hep.1840050205", "volume": "5", "author": "IM Jacobson", "year": "1985", "unstructured": "Jacobson, I. M., J. L. Dienstag, B. G. Werner, D. B. Brettler, P. H. Levine, and I. K. Musahawar. 1985. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology 5: 188\u2013191.", "journal-title": "Hepatology"}, {"key": "39_CR140", "doi-asserted-by": "crossref", "first-page": "560", "DOI": "10.3181/00379727-140-36503", "volume": "140", "author": "A Jambazian", "year": "1972", "unstructured": "Jambazian, A., and J. C. Halper. 1972. Rheophoresis: a sensitive immuno-diffusion method for detection of hepatitis associated antigen. Proc. Soc. Exp. Biol. Med. 140: 560\u2013564.", "journal-title": "Proc. Soc. Exp. Biol. Med"}, {"key": "39_CR141", "first-page": "615", "volume": "39", "author": "T Juji", "year": "1969", "unstructured": "Juji, T., and T. Yokochi. 1969. Haemagglutination technique with erythrocytes coated with specific antibody for detection of Australia antigen. Jpn. J. Exp. Med. 39: 615\u2013619.", "journal-title": "Jpn. J. Exp. Med"}, {"key": "39_CR142", "doi-asserted-by": "crossref", "first-page": "7522", "DOI": "10.1073/pnas.79.23.7522", "volume": "79", "author": "W Kam", "year": "1982", "unstructured": "Kam, W., L. Rail, E. Smuckler, R. Schmid, and W. Rutter. 1982. Hepatitis B viral DNA in liver and serum of asymptomatic carriers. Proc. Natl. Acad. Sci. USA 79: 7522\u20137526.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR143", "doi-asserted-by": "crossref", "first-page": "392", "DOI": "10.1002/hep.1840010504", "volume": "1", "author": "T Kamimura", "year": "1981", "unstructured": "Kamimura, T., A. Yoshikawa, F. Ichida, and H. Sasaki. 1981. Electron microscopic studies of Dane particles in hepatocytes with special reference to intracellular development of Dane particles and their relation to HBeAg. Hepatology 1: 392\u2013397.", "journal-title": "Hepatology"}, {"key": "39_CR144", "first-page": "995", "volume": "12", "author": "PN Kaplan", "year": "1973", "unstructured": "Kaplan, P. N., R. L. Greenman, J. L. Gerin, R. H. Purcell, and W. L. Robinson. 1973. DNA polymerase associated with human hepatitis B antigen. J. Virol. 12: 995\u20131005.", "journal-title": "J. Virol"}, {"key": "39_CR145", "doi-asserted-by": "crossref", "first-page": "1853", "DOI": "10.1136/bmj.290.6485.1853", "volume": "290", "author": "P Karayiannis", "year": "1985", "unstructured": "Karayiannis, P., D. Novick, A. S. Lok, M. J. F. Fowler, J. Monjardino, and H. C. Thomas. 1985. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis Be antigen. Br. Med. J. 290: 1853\u20131854.", "journal-title": "Br. Med. J"}, {"key": "39_CR146", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1002/j.1460-2075.1985.tb03774.x", "volume": "4", "author": "A Kay", "year": "1985", "unstructured": "Kay, A., E. Mandert, C. Trepo, and G. Galibert. 1985. The HBV HBx gene expressed in E. coliis recognized by sera from hepatitis patients. EMBO J. 4: 1287\u20131292.", "journal-title": "EMBO J"}, {"key": "39_CR147", "doi-asserted-by": "crossref", "first-page": "558", "DOI": "10.1038/323558a0", "volume": "323", "author": "A Kos", "year": "1986", "unstructured": "Kos, A., R. Dijkeura, A. C. Arnberg, P. H. Van der Meide, and H. Schellekeus. 1986. The hepatitis delta (8) virus possesses a circular RNA. Nature (London) 323: 558\u2013560.", "journal-title": "Nature (London)"}, {"key": "39_CR148", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1016/0092-8674(83)90152-6", "volume": "34", "author": "R Koshy", "year": "1983", "unstructured": "Koshy, R., S. Koch, A. Freytag von Loringhoven, R. Kahmann, K. Murray, and P. H. Hofschneider. 1983. Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap. Cell 34: 215\u2013223.", "journal-title": "Cell"}, {"key": "39_CR149", "first-page": "10", "volume": "5", "author": "K Krogsgaard", "year": "1985", "unstructured": "Krogsgaard, K., P. Kryger, J. Aldershuile, P. Andersson, C. Brechot, and The Copenhagen Hepatitis Acuta Programme. 1985. Hepatitis B virus DNA in serum from patients with acute hepatitis B. Hepatology 5: 10\u201313.", "journal-title": "Hepatitis B virus DNA in serum from patients with acute hepatitis B. Hepatology"}, {"issue": "(suppl.)", "key": "39_CR150", "first-page": "9", "volume": "38", "author": "S Krugman", "year": "1983", "unstructured": "Krugman, S. 1983. The development of a vaccine against hepatitis B. Scand. J. Infect. Dis. 38 (suppl.): 9\u201312.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR151", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1056/NEJM197304122881503", "volume": "288", "author": "S Krugman", "year": "1973", "unstructured": "Krugman, S., and J. P. Giles. 1973. Viral hepatitis, type B (MS2 strain): further observations of natural history and prevention. N. Engl. J. Med. 288: 755\u2013760.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR152", "doi-asserted-by": "crossref", "first-page": "365", "DOI": "10.1001/jama.1967.03120180053006", "volume": "200", "author": "S Krugman", "year": "1967", "unstructured": "Krugman, S., J. P. Giles, and J. Hammond. 1967. Infectious hepatitis: evidence for two distinctive clinical, epidemiological and immunological types of infection. J. Am. Med. Assoc. 200: 365\u2013369.", "journal-title": "J. Am. Med. Assoc"}, {"key": "39_CR153", "doi-asserted-by": "crossref", "first-page": "432", "DOI": "10.1093/infdis/122.5.432", "volume": "122", "author": "S Krugman", "year": "1970", "unstructured": "Krugman, S., J. P. Giles, and J. Hammond. 1970. Hepatitis virus: effect of heat infectivity and antigenicity of MS-1 and MS-2 strains. J. Infect. Dis. 122: 432\u2013436.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR154", "doi-asserted-by": "crossref", "first-page": "41", "DOI": "10.1001/jama.1971.03190010023005", "volume": "217", "author": "S Krugman", "year": "1971", "unstructured": "Krugman, S., J. P. Giles, and J. Hammond. 1971. Viral hepatitis, type B (MS2 strain): studies in active immunization. J. Am. Med. Assoc. 217: 41\u201345.", "journal-title": "J. Am. Med. Assoc"}, {"key": "39_CR155", "doi-asserted-by": "crossref", "first-page": "1331", "DOI": "10.1056/NEJM197406132902401", "volume": "290", "author": "S Krugman", "year": "1974", "unstructured": "Krugman, S., J. H. Hoofnagle, R. J. Gerety, P. M. Kaplan, and J. L. Gerin. 1974. Viral hepatitis, type B: DNA polymerase activity and antibody to hepatitis B core antigen. N. Engl. J. Med. 290: 1331\u20131335.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR156", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1056/NEJM197901183000301", "volume": "300", "author": "S Krugman", "year": "1979", "unstructured": "Krugman, S., L. R. Overby, I. K. Mushahwar, C. Ling, G. G. Frosner, and F. Deinhardt. 1979. Viral hepatitis, type B: studies on natural history and prevention reexamined. N. Engl. Med. J. 300: 101\u2013106.", "journal-title": "N. Engl. Med. J"}, {"key": "39_CR157", "first-page": "50", "volume": "2", "author": "P Kryger", "year": "1982a", "unstructured": "Kryger, P., J. Aldershuile, L. R. Mathieson, J. O. Nielsen, and The Copenhagen Hepatitis Acuta Programme. 1982a. Acute type B hepatitis among HBsAg negative patients detected by anti-HBc IgM. Hepatology 2: 50\u201353.", "journal-title": "Acute type B hepatitis among HBsAg negative patients detected by anti-HBc IgM"}, {"key": "39_CR158", "first-page": "233", "volume": "1", "author": "P Kryger", "year": "1981", "unstructured": "Kryger, P., L. R. Mathieson, J. Aldershuile, J. O. Nielsen, and The Copenhagen Hepatitis Acuta Programme. 1981. Presence and meaning of anti-HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers. Hepatology 1: 233\u2013237.", "journal-title": "Presence and meaning of anti-HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers"}, {"key": "39_CR159", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1093/infdis/145.1.23", "volume": "145", "author": "P Kryger", "year": "1982b", "unstructured": "Kryger, P., N. S. Pederson, L. Mathieson, and J. O. Nielsen. 1982b. Increased risk of infection with hepatitis A and B viruses in men with a history of syphilis. J. Infect. Dis. 145: 23\u201326.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR160", "doi-asserted-by": "crossref", "first-page": "6633", "DOI": "10.1073/pnas.78.11.6633", "volume": "78", "author": "PR Langer", "year": "1981", "unstructured": "Langer, P. R., A. A. Waldrop, and D. C. Ward. 1981. Enzymatic synthesis of biotin-labelled polynucleotides: novel nucleic acid affinity probe. Proc. Natl. Acad. Sci. USA 78: 6633\u20136637.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR161", "doi-asserted-by": "crossref", "first-page": "597", "DOI": "10.1136/bmj.4.5787.597", "volume": "4", "author": "JM Leach", "year": "1971", "unstructured": "Leach, J. M., and B. J. Ruck. 1971. Detection of hepatitis associated antigen by the latex agglutination test. Br. Med. J. 4: 597\u2013598.", "journal-title": "Br. Med. J"}, {"key": "39_CR162", "doi-asserted-by": "crossref", "first-page": "671", "DOI": "10.1093/infdis/123.6.671", "volume": "123", "author": "GL LeBouvier", "year": "1971", "unstructured": "LeBouvier, G. L. 1971. The heterogenicity of Australia antigen. J. Infect. Dis. 123: 671\u2013675.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR163", "doi-asserted-by": "crossref", "first-page": "803", "DOI": "10.1093/infdis/143.6.803", "volume": "143", "author": "SM Lemon", "year": "1981", "unstructured": "Lemon, S. M., N. L. Gates, T. E. Simms, and W. H. Bancroft. 1981. IgM antibody to hepatitis B core antigen as a diagnostic parameter of acute infection with hepatitis B virus. J. Infect. Dis. 143: 803\u2013809.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR164", "doi-asserted-by": "crossref", "first-page": "3403", "DOI": "10.1073/pnas.78.6.3403", "volume": "78", "author": "RA Lerner", "year": "1981", "unstructured": "Lerner, R. A., N. Green, H. Alexander, F. T. Liu, J. G. Sutcliffe, and T. M. Shinnick. 1981. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc. Natl. Acad. Sci. USA 78: 3403\u20133407.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR165", "doi-asserted-by": "crossref", "first-page": "164", "DOI": "10.7326/0003-4819-53-1-164", "volume": "53", "author": "RA Levine", "year": "1960", "unstructured": "Levine, R. A., and M. A. Payne. 1960. Homologous serum hepatitis in youthful heroin users. Ann. Intern. Med. 53: 164\u2013178.", "journal-title": "Ann. Intern. Med"}, {"key": "39_CR166", "first-page": "439", "volume": "3", "author": "GA Levy", "year": "1981", "unstructured": "Levy, G. A., and F. V. Chisari. 1981. The immuno pathogenesis of chronic HBV induced liver disease. Semin. Immunopathol. 3: 439\u2013459.", "journal-title": "Immunopathol"}, {"key": "39_CR167", "doi-asserted-by": "crossref", "first-page": "423", "DOI": "10.1126/science.3764420", "volume": "234", "author": "R Lewin", "year": "1986", "unstructured": "Lewin, R. 1986. New class of animal virus found in virulent form of human hepatitis. Science 234: 423\u2013424.", "journal-title": "Science"}, {"key": "39_CR168", "first-page": "216", "volume": "84", "author": "YF Liaw", "year": "1983", "unstructured": "Liaw, Y.-F., C.-M. Chu, I.-J. Su, M.-J. Huang, D.-Y. Lin, and C.-S. Chang-Chien. 1983. Clinical and histological events preceding hepatitis Be antigen seroconversion in chronic type B hepatitis. Gastroenterology 84: 216\u2013219.", "journal-title": "Gastroenterology"}, {"key": "39_CR169", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.1002/hep.1840030302", "volume": "3", "author": "HM Lieberman", "year": "1983", "unstructured": "Lieberman, H. M., D. R. Labrecque, M. C. Kew, S. J. Hadziyannis, and D. A. Shafritz. 1983. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers. Hepatology 3: 285\u2013291.", "journal-title": "Hepatology"}, {"key": "39_CR170", "first-page": "229", "volume": "57", "author": "JM Lieu", "year": "1986", "unstructured": "Lieu, J.-M., C. E. Aldrich, and W. S. Mason. 1986. Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J. Virol. 57: 229\u2013236.", "journal-title": "J. Virol"}, {"key": "39_CR171", "doi-asserted-by": "crossref", "first-page": "61", "DOI": "10.1002/jmv.1890120107", "volume": "12", "author": "HJ Lin", "year": "1983", "unstructured": "Lin, H.-J., J. P.-W. Kwan, P.-C. Wu, and W. Chak. 1983. Phosphonoformic acid-inhibitable nucleotide incorporation as a measure of hepatitis B viral DNA polymerase activity. J. Med. Virol. 12: 61\u201370.", "journal-title": "J. Med. Virol"}, {"key": "39_CR172", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.1002/hep.1840010605", "volume": "1", "author": "KL Lindsay", "year": "1981", "unstructured": "Lindsay, K. L., A. G. Redeker, and M. Ashcavai. 1981. Delayed HBsAg clearance in chronic hepatitis B viral infection. Hepatology 1: 586\u2013589.", "journal-title": "Hepatology"}, {"key": "39_CR173", "first-page": "459", "volume": "9", "author": "SA Locarnani", "year": "1979", "unstructured": "Locarnani, S. A., A. G. Coulepis, A. M. Stratton, J. Kaldor, and I. D. Gust. 1979. Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A-specific immunoglobulin M. J. Clin. Microbiol. 9: 459\u2013465.", "journal-title": "J. Clin. Microbiol"}, {"key": "39_CR174", "first-page": "277", "volume": "8", "author": "SA Locarnini", "year": "1978", "unstructured": "Locarnini, S. A., S. M. Garland, N. I. Lehmann, R. C. Pringle, and I. D. Gust. 1978. Solid-phase enzyme-linked immunosorbent assay for detection of hepatitis A virus. J. Clin. Microbiol. 8: 277\u2013282.", "journal-title": "J. Clin. Microbiol"}, {"key": "39_CR175", "first-page": "20", "volume": "22", "author": "A Lurmann", "year": "1885", "unstructured": "Lurmann, A. 1885. II. Eine Icterusepidemic. Berl. Klin. Wchnschr. 22: 20.", "journal-title": "Wchnschr"}, {"key": "39_CR176", "doi-asserted-by": "crossref", "first-page": "105", "DOI": "10.1093/oxfordjournals.bmb.a070906", "volume": "28", "author": "FO MacCallum", "year": "1972", "unstructured": "MacCallum, F. O. 1972. Early studies on viral hepatitis. Br. Med. Bull. 28: 105\u2013108.", "journal-title": "Br. Med. Bull"}, {"key": "39_CR177", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1002/jmv.1890080404", "volume": "8", "author": "P Mackay", "year": "1981", "unstructured": "Mackay, P., J. Lees, and K. Murray. 1981. The conversion of hepatitis B core antigen synthesized in E. coliinto e antigen. J. Med. Virol. 8: 237\u2013243.", "journal-title": "J. Med. Virol"}, {"key": "39_CR178", "first-page": "209", "volume": "20", "author": "LO Magnius", "year": "1975", "unstructured": "Magnius, L. O. 1975. Characterization of new antigen-antibody system associated with hepatitis B. Clin. Exp. Immunol. 20: 209\u2013216.", "journal-title": "Immunol"}, {"key": "39_CR179", "first-page": "782", "volume": "49", "author": "E Mandart", "year": "1984", "unstructured": "Mandart, E., A. Kay, and F. Galibert. 1984. Nucleotide sequence of a cloned duck hepatitis B virus genome: comparison with woodchuck and human hepatitis B virus sequences. J. Virol. 49: 782\u2013792.", "journal-title": "J. Virol"}, {"key": "39_CR180", "first-page": "534", "volume": "48", "author": "PL Marion", "year": "1983a", "unstructured": "Marion, P. L., S. S. Knight, M. A. Feitelson, L. S. Oshiro, and W. S. Robinson. 1983a. Major polypeptide of duck hepatitis B surface antigen particles. J. Virol. 48: 534\u2013541.", "journal-title": "J. Virol"}, {"key": "39_CR181", "doi-asserted-by": "crossref", "first-page": "898", "DOI": "10.1073/pnas.81.3.898", "volume": "81", "author": "PL Marion", "year": "1984", "unstructured": "Marion, P. L., S. S. Knight, B.-K. Ho, Y.-Y. Guo, W. S. Robinson, and H. Popper. 1984. Liver disease associated with DHBV infection of domestic ducks. Proc. Natl. Acad. Sci. USA 81: 898\u2013902.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR182", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1002/hep.1840030408", "volume": "3", "author": "PL Marion", "year": "1983b", "unstructured": "Marion, P. L., S. S. Knight, F. H. Salazar, H. Popper, and W. S. Robinson. 1983b. Ground squirrel hepatitis virus infection. Hepatology 3: 519\u2013527.", "journal-title": "Hepatology"}, {"key": "39_CR183", "doi-asserted-by": "crossref", "first-page": "2941", "DOI": "10.1073/pnas.77.5.2941", "volume": "77", "author": "PL Marion", "year": "1980", "unstructured": "Marion, P. L., L. Oshiro, D. C. Regnery, G. H. Scullard, and W. S. Robinson. 1980. A virus in Beechey ground squirrels that is related to hepatitis B virus of humans. Proc. Natl. Acad. Sci. USA 77: 2941\u2013294.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR184", "first-page": "99", "volume": "105", "author": "PL Marion", "year": "1983", "unstructured": "Marion, P. L., and W. Robinson. 1983. Hepadnaviruses. Hepatitis B and related viruses. Curr. Top. Microbiol. Immunol. 105: 99\u2013121.", "journal-title": "Curr. Top. Microbiol. Immunol"}, {"key": "39_CR185", "doi-asserted-by": "crossref", "first-page": "3997", "DOI": "10.1073/pnas.79.13.3997", "volume": "79", "author": "WS Mason", "year": "1982", "unstructured": "Mason, W. S., C. Aldrich, and J. Summers. 1982. Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus-strand DNA. Proc. Natl. Acad. Sci. USA 79: 3997\u20134001.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR186", "author": "WS Mason", "year": "1984", "unstructured": "Mason, W. S., J. Newbold, G. Seal, C. E. Aldrich, L. Coates, J. M. England, J. Summers, and M. S. Halpern. 1984. Expression of duck hepatitis B virus in congenitally and experimentally infected Pekin ducks, p. 443\u2013450. In G. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, (ed.), Viral hepatitis and liver disease. Grune and Stratton, New York.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "39_CR187", "first-page": "829", "volume": "36", "author": "WS Mason", "year": "1980", "unstructured": "Mason, W. S., G. Seal, and J. Summers. 1980. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J. Virol. 36: 829\u2013836.", "journal-title": "J. Virol"}, {"key": "39_CR188", "doi-asserted-by": "crossref", "first-page": "1195", "DOI": "10.1126/science.2408336", "volume": "228", "author": "DR Milich", "year": "1985", "unstructured": "Milich, D. R., G. B. Thornton, A. R. Neurath, S. B. Kent, M.-L. Michel, P. Tiollais, and F. U. Chisari. 1985. Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228: 1195\u20131199.", "journal-title": "Science"}, {"key": "39_CR189", "doi-asserted-by": "crossref", "first-page": "2531", "DOI": "10.1073/pnas.83.8.2531", "volume": "83", "author": "RH Miller", "year": "1986", "unstructured": "Miller, R. H., and W. S. Robinson. 1986. Common evolutionary origin of hepatitis B virus and retroviruses. Proc. Natl. Acad. Sci. USA 83: 2531\u20132535.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR190", "first-page": "529", "volume": "98", "author": "A Milne", "year": "1985", "unstructured": "Milne, A., G. K. Allwood, C. D. Moyes, N. E. Pearce, and C. R. Lucas. 1985. The prevalence of hepatitis B infections in a multiracial New Zealand community. N. Z. Med. J. 98: 529\u2013531.", "journal-title": "N. Z. Med. J"}, {"key": "39_CR191", "first-page": "1589", "volume": "124", "author": "CA Mims", "year": "1974", "unstructured": "Mims, C. A. 1974. Factors in the mechanism of persistence of viral infections. Progr. Med. Virol. 18:1\u201315. Misharo, S., M. Imai, K. Takahashi, A. Machida, T. Gotanda, Y. Miyakawa, and M. Mayumi. 1980. A 49,000-dalton polypeptide bearing all the antigenic determinant and full immunogenicity of 22nm hepatitis B surface antigen particles. J. Immunol. 124: 1589\u20131593.", "journal-title": "Progr. Med. Virol. 18:1\u201315. Misharo, S., M. Imai, K. Takahashi, A. Machida, T. Gotanda, Y. Miyakawa, and M. Mayumi. 1980. A 49,000-dalton polypeptide bearing all the antigenic determinant and full immunogenicity of 22nm hepatitis B surface antigen particl"}, {"key": "39_CR192", "doi-asserted-by": "crossref", "first-page": "208", "DOI": "10.1073/pnas.82.1.208", "volume": "82", "author": "H Mizusawa", "year": "1985", "unstructured": "Mizusawa, H., M. Taira, K. Yaginuma, M. Kobayashi, E. Yoshida, and K. Koike. 1985. Inversely repeating integrated HBV DNA and cellular flanking sequences in the human hepatoma-derived cell line husp. Proc. Natl. Acad. Sci. USA 82: 208\u2013212.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR193", "first-page": "181", "volume": "51", "author": "KL Molnar-Kimber", "year": "1984", "unstructured": "Molnar-Kimber, K. L., J. Summers, and W. S. Mason. 1984. Mapping of the cohesive overlap of DHBV DNA and of the site of the initiation of reverse transcription. J. Virol. 51: 181\u2013191.", "journal-title": "J. Virol"}, {"key": "39_CR194", "first-page": "165", "volume": "45", "author": "K Molnar-Kimber", "year": "1983", "unstructured": "Molnar-Kimber, K., J. Summers, J. M. Taylor, and W. S. Mason. 1983. Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus. J. Virol. 45: 165\u2013172.", "journal-title": "J. Virol"}, {"key": "39_CR195", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1055/s-2008-1040645", "volume": "4", "author": "M Mondelli", "year": "1984", "unstructured": "Mondelli, M., and A. L. W. F. Eddleston. 1984. Mechanism of liver cell injury in acute and chronic hepatitis B. Semin. Liver Dis. 4:47\u201351.", "journal-title": "B. Semin. Liver Dis."}, {"key": "39_CR196", "doi-asserted-by": "crossref", "first-page": "235", "DOI": "10.1016/0166-0934(85)90134-X", "volume": "12", "author": "G Morace", "year": "1985", "unstructured": "Morace, G., K. Von Der Helm, and F. Deinhardt. 1985. Detection of hepatitis B virus DNA in serum by a rapid filtration-hybridization assay. J. Virol. Methods 12: 235\u2013242.", "journal-title": "J. Virol. Methods"}, {"key": "39_CR197", "first-page": "729", "volume": "293", "author": "AM Moriarty", "year": "1985", "unstructured": "Moriarty, A. M., H. Alexander, R. A. Lerner, and S. B. Thornton. 1985. Antibodies to peptides detect new hepatitis B antigen: serological correlation with hepatocellular carcinoma. Science 227:429\u2013432. Mosley, J. W., V. M. Edwards, and G. Casey. 1975. Hepatitis B virus infection in dentist. N. Engl. J. Med. 293: 729\u2013734.", "journal-title": "J. W., V. M. Edwards, and G. Casey. 1975. Hepatitis B virus infection in dentist. N. Engl. J. Med"}, {"key": "39_CR198", "first-page": "63", "volume": "4", "author": "R Murray", "year": "1953", "unstructured": "Murray, R., and W. D. DieFenbach. 1953. Effect of heat on the agent of homologous serum hepatitis. Proc. Soc. Exp. Biol. Med. 84:230\u2013231. Naumov, N. V., M. Mondelli, G. J. M. Alexander, R. S. Tedder, A. L. W. F. Eddleston, and R. Williams. 1984. Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection. Hepatology 4: 63\u201368.", "journal-title": "Proc. Soc. Exp. Biol. Med. 84:230\u2013231. Naumov, N. V., M. Mondelli, G. J. M. Alexander, R. S. Tedder, A. L. W. F. Eddleston, and R. Williams. 1984. Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphoc"}, {"key": "39_CR199", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1002/jmv.1890150407", "volume": "15", "author": "F Negro", "year": "1985", "unstructured": "Negro, F., M. Berninger, E. Chiaberge, P. Gugliotta, G. Bussolati, G. C. Actis, M. Rizzetto, and F. Bonino. 1985. Detection of HBV-DNA by in situhybridization using a biotin-labelled probe. J. Med. Virol. 15: 373\u2013382.", "journal-title": "J. Med. Virol"}, {"key": "39_CR200", "doi-asserted-by": "crossref", "first-page": "154", "DOI": "10.1038/315154a0", "volume": "31", "author": "AR Neurath", "year": "1985", "unstructured": "Neurath, A. R., S. B. H. Kent, N. Strick, P. Taylor, and C. E. Stevens. 1985. Hepatitis B virus contains pre-S gene encoded domains. Nature (London) 31: 154\u2013156.", "journal-title": "Nature (London)"}, {"key": "39_CR201", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1159/000149024", "volume": "11", "author": "AR Neurath", "year": "1979", "unstructured": "Neurath, A. R., and N. Strick. 1979. Radioimmunoassay for albumin-binding sites associated with HBsAg: correlation of results with the presence of e-antigen in serum. Intervirology 11: 128\u2013132.", "journal-title": "Intervirology"}, {"key": "39_CR202", "first-page": "1157", "volume": "285", "author": "JO Nielsen", "year": "1981", "unstructured": "Nielsen, J. O., O. Dietrichson, and P. Elling. 1981. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. New Engl. J. Med. 285: 1157\u20131160.", "journal-title": "J. Med"}, {"key": "39_CR203", "first-page": "293", "volume": "52", "author": "K Nishioka", "year": "1975", "unstructured": "Nishioka, K., A. G. Levin, and M. J. Simons. 1975. Hepatitis B antigen, antigen subytpes, and hepatitis B antibody in normal subjects and patients with liver disease. Bull. W.H.O. 52: 293\u2013300.", "journal-title": "Bull. W.H.O."}, {"key": "39_CR204", "doi-asserted-by": "crossref", "first-page": "1245", "DOI": "10.1093/infdis/152.6.1245", "volume": "152", "author": "MJ Nowicki", "year": "1985", "unstructured": "Nowicki, M. J., M. J. Tong, and R. E. Bohman. 1985. Alterations in the immune response of non responders to the hepatitis B vaccine. J. Infect. Dis. 152: 1245\u20131248.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR205", "doi-asserted-by": "crossref", "first-page": "1703", "DOI": "10.1073/pnas.80.6.1703", "volume": "80", "author": "AP O\u2019Connell", "year": "1983", "unstructured": "O\u2019Connell, A. P., M. K. Urban, and W. T. London. 1983. Naturally occurring infection of Pekin duck embryos by duck hepatitis B virus. Proc. Natl. Acad. Sci. USA 80: 1703\u20131706.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR206", "doi-asserted-by": "crossref", "first-page": "385", "DOI": "10.1016/0092-8674(82)90155-6", "volume": "29", "author": "CW Ogston", "year": "1982", "unstructured": "Ogston, C. W., G. J. Jonak, C. E. Rogler, S. M. Astrin, and J. Summers. 1982. Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell 29: 385\u2013394.", "journal-title": "Cell"}, {"key": "39_CR207", "doi-asserted-by": "crossref", "first-page": "374", "DOI": "10.1111/j.1423-0410.1968.tb04078.x", "volume": "15", "author": "K Okochi", "year": "1968", "unstructured": "Okochi, K., and S. Murakami. 1968. Observations on Australia antigen in Japanese. Vox Sang. 15: 374\u2013379.", "journal-title": "Vox Sang"}, {"key": "39_CR208", "doi-asserted-by": "crossref", "first-page": "1003", "DOI": "10.1016/0016-5085(78)90066-5", "volume": "75", "author": "M Omata", "year": "1978", "unstructured": "Omata, M., A. Afroukedis, C. T. Liew, M. Ashcavai, and R. L. Peters. 1978. Comparison of serum hepatitis B surface antigen (HBsAg) and serum anti-core with tissue HBsAg and hepatitis B core antigen (HBeAg). Gastroenterology 75: 1003\u20131009.", "journal-title": "Gastroenterology"}, {"key": "39_CR209", "doi-asserted-by": "crossref", "first-page": "260", "DOI": "10.1016/0016-5085(83)90309-8", "volume": "85", "author": "M. Omata", "year": "1983", "unstructured": "Omata, M., K. Uchiumi, Y. Ho, O. Yokosuka, J. Mori, K. Terao, Y. Wei-Fa, A. V. O\u2019Connell, W. T. London, and K. Okuda. 1983. Duck hepatitis B virus and liver diseases. Gastroenterology 85:260\u2013267.", "journal-title": "Gastroenterology"}, {"key": "39_CR210", "doi-asserted-by": "crossref", "first-page": "1747", "DOI": "10.1093/nar/11.6.1747", "volume": "11", "author": "Y Ono", "year": "1983", "unstructured": "Ono, Y., H. Onada, R. Sasanda, K. Igarashi, Y. Sugino, and K. Nishioka. 1983. The complete nucleotide sequence of the cloned hepatitis B virus DNA: subtypes adrand adw. Nucleus Acids Res. 11: 1747\u20131757.", "journal-title": "Nucleus Acids Res"}, {"key": "39_CR211", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1038/282575a0", "volume": "282", "author": "M Pasek", "year": "1979", "unstructured": "Pasek, M., T. Goto, W. Gilbert, B. Zink, H. Schaller, P. MacKay, G. Leadbetter, and K. Murray. 1979. Hepatitis B virus genes and their expression in E. coli. Nature (London) 282: 575\u2013579.", "journal-title": "Nature (London)"}, {"key": "39_CR212", "first-page": "220", "volume": "84", "author": "P Pontisso", "year": "1983", "unstructured": "Pontisso, P., A. Alberti, F. Bortolotti, and G. Realdi. 1983. Virus-associated receptors of polymerized human serum albumin in acute and chronic hepatitis B virus infection. Gastroenterology 84: 220\u2013226.", "journal-title": "Gastroenterology"}, {"key": "39_CR213", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1002/jmv.1890170207", "volume": "17", "author": "P Pontisso", "year": "1985", "unstructured": "Pontisso, P., L. Chemello, G. Fattovich, A. Alberti, G. Realdi, and C. Brechot. 1985. Relationship between HBeAg in serum and liver and HBV replication in patients with HBsAg-positive chronic liver disease. J. Med. Virol. 17: 145\u2013152.", "journal-title": "J. Med. Virol"}, {"key": "39_CR214", "doi-asserted-by": "crossref", "first-page": "1563", "DOI": "10.1136/bmj.288.6430.1563", "volume": "228", "author": "P Pontisso", "year": "1984", "unstructured": "Pontisso, P., M. C. Poon, P. Tiollais, and C. Brechot. 1984. Detection of hepatitis B virus DNA in mononuclear blood cells. Br. Med. J. 228: 1563\u20131566.", "journal-title": "Br. Med. J"}, {"key": "39_CR215", "unstructured": "Ponzetto, A., B. J. Cohen, E. M. Vandervelde, and P. P. Mortimer. 1983. Delta antigen in Britain. Lancet irl 141\u20131142.", "DOI": "10.1016/S0140-6736(83)90655-4", "doi-asserted-by": "crossref"}, {"key": "39_CR216", "doi-asserted-by": "crossref", "first-page": "2208", "DOI": "10.1073/pnas.81.7.2208", "volume": "81", "author": "A Ponzetto", "year": "1984a", "unstructured": "Ponzetto, A., P. J. Cote, H. Popper, B. H. Hoyer, W. T. London, E. C. Ford, F. Bonino, R. H. Purcell, and J. L. Gerin. 1984a. Transmission of the hepatitis B virus-associated S agent to the eastern woodchuck. Proc. Natl. Acad. Sci. USA 81: 2208\u20132212.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR217", "doi-asserted-by": "crossref", "first-page": "1111", "DOI": "10.1002/hep.1840040603", "volume": "4", "author": "Ponzetto, A., L. B. Seeff, Z. Buskell-Bales, and the Veterans Administration Hepatitis Co-operative Study Group", "year": "1984b", "unstructured": "Ponzetto, A., L. B. Seeff, Z. Buskell-Bales, and the Veterans Administration Hepatitis Co-operative Study Group. 1984b. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus. Hepatology 4: 1111\u20131115.", "journal-title": "Hepatology"}, {"key": "39_CR218", "first-page": "91", "volume": "387", "author": "H Popper", "year": "1980", "unstructured": "Popper, H., J. L. Dienstag, S. M. Feinstone, H. J. Alter, and R. H. Purcell. 1980. The pathology of viral hepatitis in chimpanzees. Virchows Arch. [Pathol. Anat.] 387: 91\u2013106.", "journal-title": "Anat.]"}, {"key": "39_CR219", "first-page": "1", "volume": "2", "author": "H Popper", "year": "1982", "unstructured": "Popper, H., M. A. Gerber, and S. N. Thung. 1982. The relation of hepatocellular carcinoma to infection with hepatitis B and related viruses in man and animals. Hepatology Suppl 2: 1\u20139.", "journal-title": "Hepatology Suppl"}, {"key": "39_CR220", "doi-asserted-by": "crossref", "first-page": "91", "DOI": "10.1002/hep.1840010202", "volume": "1", "author": "H Popper", "year": "1981", "unstructured": "Popper, H., J. W. K. Shih, J. L. Gerin, D. C. Wong, B. H. Hoyer, W. T. London, D. L. Sly, and R. H. Purcell. 1981. Woodchuck hepatitis and hepatocellular carcinoma: correlation of histologic with virologic observations. Hepatology 1: 91\u201398.", "journal-title": "Hepatology"}, {"key": "39_CR221", "first-page": "100", "volume": "42", "author": "H Popper", "year": "1983", "unstructured": "Popper, H., S. N. Thung, M. A. Gerber, S. C. Hadler, M. Le Monzon, A. Ponzetto, E. Anzola, D. Rivera, A. Mondolfi, A. Bracho, D. P. Francis, J. L. Gerin, J. E. Maynard, and R. H. Purcell. 1983. Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology 3:906\u2013912. Pourcel, C., A. Louise, M. Gervais, N. Chenciner, M-F. Dubois, and P. Tiollais. 1982. Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA. J. Virol. 42: 100\u2013105.", "journal-title": "C., A. Louise, M. Gervais, N. Chenciner, M-F. Dubois, and P. Tiollais. 1982. Transcription of the hepatitis B surface antigen gene in mouse cells transformed with cloned viral DNA. J. Virol"}, {"key": "39_CR222", "doi-asserted-by": "crossref", "first-page": "814", "DOI": "10.1073/pnas.60.3.814", "volume": "60", "author": "AM Prince", "year": "1968", "unstructured": "Prince, A. M. 1968. An antigen detected in the blood during the incubation period of serum hepatitis. Proc. Natl. Acad. Sci. USA 60: 814\u2013821.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR223", "doi-asserted-by": "crossref", "first-page": "92", "DOI": "10.1093/clinids/5.1.92", "volume": "5", "author": "A. M. Prince", "year": "1983", "unstructured": "Prince, A. M., W. Stephan, and B. Brotman. 1983. (3-Pro- piolactone/ultraviolet irradiation: a review of its effectiveness for inactivation of virus in blood derivates. Rev. Infect. Dis. 5:92\u2013107.", "journal-title": "Rev. Infect. Dis."}, {"key": "39_CR224", "doi-asserted-by": "crossref", "first-page": "677", "DOI": "10.1136/bmj.2.4055.677", "volume": "2", "author": "SA Propert", "year": "1938", "unstructured": "Propert, S. A. 1938. Hepatitis after prophylactic serum. Br. Med. J. 2: 677\u2013679.", "journal-title": "Br. Med. J"}, {"key": "39_CR225", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1002/hep.1840050130", "volume": "5", "author": "RH Purcell", "year": "1985", "unstructured": "Purcell, R. H., and J. L. Gerin. 1985. Prospects for second and third generation hepatitis B vaccines. Hepatology 5: 159\u2013163.", "journal-title": "Hepatology"}, {"key": "39_CR226", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1093/infdis/121.2.222", "volume": "121", "author": "RH Purcell", "year": "1970", "unstructured": "Purcell, R. H., G. L. Gerin, P. V. Holland, W. L. Cline, and R. M. Chanock. 1970. Preparation and characterization of complement-fixing hepatitis-associated antigen and antiserum. J. Infect. Dis. 121: 222\u2013226.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR227", "doi-asserted-by": "crossref", "first-page": "249", "DOI": "10.1016/S0140-6736(82)90976-X", "volume": "1", "author": "G Raimondo", "year": "1982", "unstructured": "Raimondo, G., A. Smedile, L. Gallo, A. Balbo, A. Ponzetto, and M. Rizzetto. 1982. Multicentre study of prevalence of HBV associated delta infection and liver disease in drug addicts. Lancet 1: 249\u2013251.", "journal-title": "Lancet"}, {"key": "39_CR228", "first-page": "1766", "volume": "3", "author": "LB Rail", "year": "1983", "unstructured": "Rail, L. B., D. N. Standring, O. Laub, and W. J. Rutter. 1983. Transcription of HBV by RNA polymerase II. Mol. Cell. Biol. 3: 1766\u20131773.", "journal-title": "Biol"}, {"key": "39_CR229", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1016/0016-5085(80)90130-4", "volume": "79", "author": "G Realdi", "year": "1980", "unstructured": "Realdi, G., A. Alberti, M. Rugge, F. Bortolotti, A. M. Rigoli, F. Tremolada, and A. Ruol. 1980. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 79: 195\u2013199.", "journal-title": "Gastroenterology"}, {"key": "39_CR230", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1097/00000441-197507000-00003", "volume": "270", "author": "AG Redeker", "year": "1975", "unstructured": "Redeker, A. G. 1975. Viral hepatitis: clinical aspects. Am. J. Med. Sci. 270: 9\u201316.", "journal-title": "Am. J. Med. Sci"}, {"key": "39_CR231", "doi-asserted-by": "crossref", "first-page": "729", "DOI": "10.1002/hep.1840030518", "volume": "3", "author": "M Rizzetto", "year": "1983", "unstructured": "Rizzetto, M. 1983. The delta agent. Hepatology 3: 729\u2013737.", "journal-title": "The delta agent. Hepatology"}, {"key": "39_CR232", "doi-asserted-by": "crossref", "first-page": "997", "DOI": "10.1136/gut.18.12.997", "volume": "18", "author": "M Rizzetto", "year": "1977", "unstructured": "Rizzetto, M., M. G. Canese, S. Arico, O. Crivelli, C. Trepo, F. Bonino, and G. Verme. 1977. Immunofluorescence detection of new antigen-antibody system (8/anti- 8)associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut, 18: 997\u20131003.", "journal-title": "Gut"}, {"key": "39_CR233", "doi-asserted-by": "crossref", "first-page": "590", "DOI": "10.1093/infdis/141.5.590", "volume": "141", "author": "M Rizzetto", "year": "1980a", "unstructured": "Rizzetto, M., M. G. Canese, J. L. Gerin, W. T. London, O. L. Sly, and R. H. Purcell. 1980a. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J. Infect. Dis. 141: 590\u2013602.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR234", "doi-asserted-by": "crossref", "first-page": "6124", "DOI": "10.1073/pnas.77.10.6124", "volume": "77", "author": "M Rizzetto", "year": "1980b", "unstructured": "Rizzetto, M., B. Hoyer, M. G. Canese, J. W. K. Shih, R. H. Purcell, and J. L. Gerin. 1980b. Delta agent: the association of delta antigen with hepatitis B surface antigen and ribonucleic acid in the serum of delta-infected chimpanzees. Proc. Natl. Acad. Sci. USA 77: 6124\u20136128.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR235", "doi-asserted-by": "crossref", "first-page": "18", "DOI": "10.1093/infdis/145.1.18", "volume": "145", "author": "M Rizzetto", "year": "1982", "unstructured": "Rizzetto, M., C. Morello, P. M. Mannucci, D. J. Gocke, J. A. Spero, J. H. Lewis, D. H. van Thiel, C. Scaroni, and F. Peyretti. 1982. Delta infection and liver disease in haemophiliac carriers of hepatitis B surface antigen. J. Infect. Dis. 145: 18\u201322.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR236", "doi-asserted-by": "crossref", "first-page": "1215", "DOI": "10.1016/S0140-6736(80)91678-5", "volume": "1", "author": "M Rizzetto", "year": "1980c", "unstructured": "Rizzetto, M., R. H. Purcell, and J. L. Gerin. 1980c. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytrans-fused HBsAg carriers. Lancet 1: 1215\u20131218.", "journal-title": "Lancet"}, {"key": "39_CR237", "first-page": "318", "volume": "125", "author": "M Rizzetto", "year": "1980d", "unstructured": "Rizzetto, M., J. W. Shih, and J. L. Gerin. 1980d. The hepatitis B virus-associated 8antigen: isolation from liver, development of solid-phase radioimmunoassays for 8antigen and anti-S and partial characterization of 8antigen. J. Immunol. 125: 318\u2013324.", "journal-title": "J. Immunol"}, {"key": "39_CR238", "doi-asserted-by": "crossref", "first-page": "437", "DOI": "10.7326/0003-4819-98-4-437", "volume": "98", "author": "M Rizzetto", "year": "1983", "unstructured": "Rizzetto, M., G. Verme, S. Recchia, F. Bonino, P. Farci, S. Arico, R. Calzia, A. Picciotto, M. Colombo, and H. Popper. 1983. Chronic hepatitis in carriers of HBsAg with intra hepatic expression of the 8antigen. Ann. Int. Med. 98: 437\u2013441.", "journal-title": "Ann. Int. Med"}, {"key": "39_CR239", "doi-asserted-by": "crossref", "first-page": "151", "DOI": "10.1097/00000441-197507000-00021", "volume": "270", "author": "WS Robinson", "year": "1975", "unstructured": "Robinson, W. S. 1975. DNA and DNA polymerase in the core of the Dane particle of hepatitis B. Am. J. Med. Sci. 270: 151\u2013159.", "journal-title": "Am. J. Med. Sci"}, {"key": "39_CR240", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1146/annurev.mi.31.100177.002041", "volume": "31", "author": "WS Robinson", "year": "1977", "unstructured": "Robinson, W. S. 1977. The genome of hepatitis B virus. Ann. Rev. Microbiol. 31: 357\u2013377.", "journal-title": "Ann. Rev. Microbiol"}, {"key": "39_CR241", "author": "WS Robinson", "year": "1985", "unstructured": "Robinson, W. S. 1985. Hepatitis B virus, p. 1384\u20131406. InB.N. Fields, D. M. Knipe, R. M. Chanock, J. L. Melnick, B. Roizman, and R. E. Shope (ed.), Virology. Raven Press, New York.", "volume-title": "Virology"}, {"key": "39_CR242", "first-page": "384", "volume": "14", "author": "WS Robinson", "year": "1974", "unstructured": "Robinson, W. S., D. A. Clayton, and R. L. Greenman. 1974. DNA of a human hepatitis B virus candidate. J. Virol. 14: 384\u2013391.", "journal-title": "J. Virol"}, {"key": "39_CR243", "first-page": "1231", "volume": "13", "author": "WS Robinson", "year": "1974", "unstructured": "Robinson, W. S., and R. L. Greenman. 1974. DNA polymerase in the core of the human hepatitis B virus candidate. J. Virol. 13: 1231\u20131236.", "journal-title": "J. Virol"}, {"key": "39_CR244", "author": "WS Robinson", "year": "1976", "unstructured": "Robinson, W. S., and L. I. Lutwick. 1976. Hepatitis B virus: a cause of persistent virus infection in man, p. 787\u2013811. InD. Baltimore, A. Huang, and C. F. Fox (ed.), Animal virology. Academic Press, New York.", "volume-title": "Animal virology"}, {"key": "39_CR245", "author": "WS Robinson", "year": "1982", "unstructured": "Robinson, W. S., P. L. Marion, M. Feitelson, and A. Siddiqui. 1982. The hepadna virus group: hepatitis B and related viruses, p. 57\u201368. InW. Szmuness, H. J. Alter, and J. W. Maynard, (ed.), Viral hepatitis\u20141981 International Symposium, Franklin Institute Press, Philadelphia.", "volume-title": "Viral hepatitis\u20141981 International Symposium"}, {"key": "39_CR246", "doi-asserted-by": "crossref", "first-page": "347", "DOI": "10.1055/s-2008-1040664", "volume": "4", "author": "WS Robinson", "year": "1984a", "unstructured": "Robinson, W. S., P. L. Marion, and R. H. Miller. 1984a. The hepadna viruses of animals. Semin. Liver Dis. 4: 347\u2013351.", "journal-title": "Liver Dis"}, {"key": "39_CR247", "author": "WS Robinson", "year": "1984b", "unstructured": "Robinson, W. S., R. H. Miller, L. Klote, P. L. Marion, and S. C. Lee. 1984b. Hepatitis B virus and hepatocellular carcinoma, p. 245\u2013264. InG. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, (ed.), Viral hepatitis and liver disease. Grune and Stratton, New York.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "39_CR248", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1126/science.6867736", "volume": "221", "author": "JL Romet-Lemoune", "year": "1983", "unstructured": "Romet-Lemoune, J.-L., M. F. McLane, E. Elfassi, W. A. Haseltine, J. Azocar, and M. Essex. 1983. Hepatitis B virus infection in cultured human lymphoblastoid cells. Science 221: 667\u2013669.", "journal-title": "Science"}, {"key": "39_CR249", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1016/0092-8674(82)90097-6", "volume": "29", "author": "N Ruiz-Opazo", "year": "1982", "unstructured": "Ruiz-Opazo, N., P. R. Chakraborty, and D. A. Shafritz. 1982. Evidence for supercoiled hepatitis B virus DNA in chimpanzee liver and serum Dane particles: possible implications in persistent HBV infection. Cell 29: 129\u2013138.", "journal-title": "Cell"}, {"key": "39_CR250", "first-page": "226", "volume": "32", "author": "FR Sattler", "year": "1979", "unstructured": "Sattler, F. R., and W. S. Robinson. 1979. Hepatitis B viral DNA molecules have cohesive ends. J. Virol. 32: 226\u2013233.", "journal-title": "J. Virol"}, {"key": "39_CR251", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1016/0016-5085(80)90573-9", "volume": "78", "author": "AN Schulman", "year": "1980", "unstructured": "Schulman, A. N., N. D. Fagan, M. Brezing, H. Silver, A. Nitzze, D. Morton, and G. L. Gitnick. 1980. HBe-antigen in the course and prognosis of hepatitis B infection: a prospective study. Gastroenterology 78: 253\u2013258.", "journal-title": "Gastroenterology"}, {"key": "39_CR252", "doi-asserted-by": "crossref", "first-page": "279", "DOI": "10.1002/hep.1840030301", "volume": "3", "author": "J Scotto", "year": "1983", "unstructured": "Scotto, J., M. Hadhovel, C. Hery, J. Yvart, P. Tiollais, and C.Brechot. 1983. Detection of hepatitis B virus DNA in serum by a simple spot hybridization technique: comparison with results for other viral markers. Hepatology 3: 279\u2013284.", "journal-title": "Hepatology"}, {"key": "39_CR253", "doi-asserted-by": "crossref", "first-page": "939", "DOI": "10.1016/S0140-6736(75)90357-8", "volume": "2", "author": "LB Seeff", "year": "1975", "unstructured": "Seeff, L. B., H. J. Zimmerman, E. C. Wright, B. F. Felsher, J. D. Finkelstein, P. Garcia-Pout, H. B. Greenless, A. A. Dietz, J. Hamilton, R. S. Koff, C. M. Leevy, T. Kiernan, C. H. Tamburro, E. R. Schiff, Z. Vlahcevic, R. Zemel, D. S. Zimmon, and N. Nath. 1975. Efficacy of hepatitis B immune serum globulin after accidental exposure. Lancet 2: 939\u2013941.", "journal-title": "Lancet"}, {"key": "39_CR254", "doi-asserted-by": "crossref", "first-page": "5849", "DOI": "10.1073/pnas.81.18.5849", "volume": "81", "author": "C Seeger", "year": "1984", "unstructured": "Seeger, C., D. Ganem, and H. E. Vermus. 1984. The cloned genome of ground squirrel hepatitis virus is infectious in the animal. Proc. Natl. Acad. Sci. USA 81: 5849\u20135852.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR255", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1126/science.3961490", "volume": "232", "author": "C Seeger", "year": "1986", "unstructured": "Seeger, C., D. Ganem, and H. E. Varmus. 1986. Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 232: 477\u2013484.", "journal-title": "Science"}, {"key": "39_CR256", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1002/hep.1840010102", "volume": "1", "author": "DA Shafritz", "year": "1981", "unstructured": "Shafritz, D. A., and M. C. Kew. 1981. Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas. Hepatology 1: 1\u20138.", "journal-title": "Hepatology"}, {"key": "39_CR257", "doi-asserted-by": "crossref", "first-page": "5675", "DOI": "10.1073/pnas.79.18.5675", "volume": "79", "author": "DA Shafritz", "year": "1982", "unstructured": "Shafritz, D. A., H. M. Lieberman, K. J. Isselbacher, and J. R. Wands. 1982. Monoclonal radioimmunoassays for HBsAg: demonstration of HBV DNA or related se quences in serum and viral epitopes in immune complexes. Proc. Natl. Acad. Sci. USA 79: 5675\u20135679.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR258", "author": "DA Shafritz", "year": "1984", "unstructured": "Shafritz, D. A., C. E. Rogler. 1984. Molecular characterization of viral forms observed in persistent hepatitis infections, chronic liver disease and hepatocellular carcinoma in woodchucks and humans, p. 225\u2013244. InG. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, (ed.), Viral hepatitis and liver disease. Grune and Stratton, New York.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "39_CR259", "doi-asserted-by": "crossref", "first-page": "1067", "DOI": "10.1056/NEJM198110293051807", "volume": "305", "author": "DA Shafritz", "year": "1981", "unstructured": "Shafritz, D. A., D. Shouval, H. Sherman, S. Hadziyannis, and M. Kew. 1981. Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N. Engl. J. Med. 305: 1067\u20131073.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR260", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1002/jmv.1890130109", "volume": "13", "author": "AG Shattock", "year": "1984", "unstructured": "Shattock, A. G., and B. M. Morgan. 1984. Sensitive enzyme immunoassay for the detection of delta antigen and anti-delta, using serum as the delta antigen source. J. Med. Virol. 13: 73\u201382.", "journal-title": "J. Med. Virol"}, {"key": "39_CR261", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1016/S0140-6736(83)90086-7", "volume": "2", "author": "AG Shattock", "year": "1983", "unstructured": "Shattock, A. G., B. M. Morgan, J. Peutherer, M. J. Inglis, J. F. Fielding, and M. G. Kelly. 1983. High incidence of delta antigen in serum. Lancet 2: 104\u2013105.", "journal-title": "Lancet"}, {"key": "39_CR262", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1002/hep.1840030327", "volume": "3", "author": "S Sherlock", "year": "1983", "unstructured": "Sherlock, S., and H. C. Thomas. 1983. Hepatitis B virus infection: the impact of molecular biology. Hepatology 3: 455\u2013456.", "journal-title": "Hepatology"}, {"key": "39_CR263", "doi-asserted-by": "crossref", "first-page": "242", "DOI": "10.1093/infdis/138.2.242", "volume": "138", "author": "T Shikata", "year": "1978", "unstructured": "Shikata, T., T. Karasawa, K. Abe, T. Takahashi, M. Mayumi, and T. Oda. 1978. Incomplete inactivation of hepatitis B virus after heat treatment at 60\u00b0C for 10 hours. J. Infect. Dis. 138: 242\u2013244.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR264", "doi-asserted-by": "crossref", "first-page": "604", "DOI": "10.1016/0016-5085(83)90086-0", "volume": "84", "author": "M Shimuzu", "year": "1983", "unstructured": "Shimuzu, M., M. Ohyama, Y. Takahashi, K. Udo, M. Kojima, M. Kametani, F. Tsuda, E. Takai, Y. Miyakawa, and M. Mayumi. 1983. Immunoglobulin M antibody against hepatitis B core antigen for the diagnosis of fulminant type B hepatitis. Gastroenterology 84: 604\u2013610.", "journal-title": "Gastroenterology"}, {"key": "39_CR265", "doi-asserted-by": "crossref", "first-page": "4861", "DOI": "10.1073/pnas.80.15.4861", "volume": "80", "author": "A Siddiqui", "year": "1983", "unstructured": "Siddiqui, A. 1983. Hepatitis B virus DNA in Kaposi sarcoma. Proc. Natl. Acad. Sci. USA 80: 4861\u20134864.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR266", "first-page": "393", "volume": "38", "author": "A Siddiqui", "year": "1981", "unstructured": "Siddiqui, A., P. L. Marion, and W. S. Robinson. 1981. Ground squirrel hepatitis virus DNA; molecular cloning and comparison with hepatitis B virus DNA. J. Virol. 38: 393\u2013397.", "journal-title": "J. Virol"}, {"key": "39_CR267", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1016/0016-5085(85)90323-3", "volume": "89", "author": "M Sjogren", "year": "1985", "unstructured": "Sjogren, M., and J. H. Hoofnagle. 1985. Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis. Gastroenterology 89: 252\u2013258.", "journal-title": "Gastroenterology"}, {"key": "39_CR268", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1093/infdis/148.3.445", "volume": "148", "author": "MH Sjogren", "year": "1983", "unstructured": "Sjogren, M. H., and S. M. Lemon. 1983. Low molecular weight IgM antibody to hepatitis B core antigen in chronic hepatitis B virus infection. J. Infect. Dis. 148: 445\u2013451.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR269", "doi-asserted-by": "crossref", "first-page": "2812", "DOI": "10.1001/jama.1984.03340450028021", "volume": "251", "author": "EM Skolnick", "year": "1985", "unstructured": "Skolnick, E. M., A. A. McLean, D. West, W. J. McAlleer, W. J. Miller, and E. B. Buynak. 1985. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. J. Am. Med. Assoc. 251: 2812\u20132815.", "journal-title": "J. Am. Med. Assoc"}, {"key": "39_CR270", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1002/jmv.1890090208", "volume": "9", "author": "A Smedile", "year": "1982", "unstructured": "Smedile, A., C. Lavarini, O. Crivelli, G. Raimondo, M. Fassone, and M. Rizzetto. 1982. Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (8) antigen: clinical significance in 8 infection. J. Med. Virol. 9: 131\u2013138.", "journal-title": "J. Med. Virol"}, {"key": "39_CR271", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1093/oxfordjournals.aje.a113533", "volume": "117", "author": "A Smedile", "year": "1983", "unstructured": "Smedile, A., C. Lavarini, P. Farci, S. Arico, G. Marinucci, P. Dentico, G. Giuliani, A. Gargnel, C. U. Blanco, and M. Rizzetto. 1983. Epidemiologic patterns of infection with hepatitis B virus associated delta agent in Italy. Am. J. Epidemiol. 117: 223\u2013229.", "journal-title": "Am. J. Epidemiol"}, {"key": "39_CR272", "author": "A Smedile", "year": "1984", "unstructured": "Smedile, A., M. Rizzetto, F. Bonino, J. Gerin, and B. Hoyer. 1984. Serum delta-associated RNA (DAR) in chronic HBV carriers infected with the delta agent, p. 613\u2013614. InG. N. Vyas, J. L. Dienstag, and J. F. Hoofnagle, (ed.), Viral hepatitis and liver disease. Grune and Stratton, New York.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "39_CR273", "doi-asserted-by": "crossref", "first-page": "490", "DOI": "10.1038/302490a0", "volume": "302", "author": "GL Smith", "year": "1983", "unstructured": "Smith, G. L., M. Mackett, and B. Moss. 1983. Infectious vaccinia virus recombinants that express hepatitis B surface antigen. Nature (London) 302: 490\u2013495.", "journal-title": "Nature (London)"}, {"key": "39_CR274", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1038/279346a0", "volume": "279", "author": "JJ Sninsky", "year": "1979", "unstructured": "Sninsky, J. J., A. Siddiqui, W. S. Robinson, and S. N. Cohen. 1979. Cloning and endonuclease mapping of the hepatitis B virus genome. Nature 279: 346\u2013348.", "journal-title": "Nature"}, {"key": "39_CR275", "first-page": "429", "volume": "123", "author": "JP Soulier", "year": "1972", "unstructured": "Soulier, J. P., C. Blatix, A. M. Courouce, D. Benamon-Djiane, P. Amouch, and J. Drouet. 1972. Prevention of virus B hepatitis (SH virus). Am. J. Dis. Child. 123: 429\u2013434.", "journal-title": "Am. J. Dis. Child"}, {"key": "39_CR276", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1016/S0022-2836(75)80083-0", "volume": "98", "author": "EM Southern", "year": "1975", "unstructured": "Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98: 503\u2013517.", "journal-title": "J. Mol. Biol"}, {"key": "39_CR277", "first-page": "932", "volume": "52", "author": "R Sprengel", "year": "1984", "unstructured": "Sprengel, R., C. Kuhn, C. Manso, and H. Will. 1984. Cloned duck hepatitis B virus DNA is infectious in Pekin ducks. J. Virol. 52: 932\u2013937.", "journal-title": "J. Virol"}, {"key": "39_CR278", "first-page": "1774", "volume": "3", "author": "PN Standring", "year": "1983", "unstructured": "Standring, P. N., L. B. Rail, O. Laub, and W. J. Rutter. 1983. Hepatitis B virus encodes an RNA polymerase III transcript. Mol. Cell. Biol. 3: 1774\u20131782.", "journal-title": "Biol"}, {"key": "39_CR279", "author": "CE Stevens", "first-page": "1981", "year": "1982", "unstructured": "Stevens, C. E., R. P. Beasley, C.-C. Lin, L.-Y. Huang, T.-S. Sun, F.-J. Hsieh, K.-Y. Wang, and W. Szmuness. 1982. Perinatal hepatitis B virus infection: use of hepatitis B immune globulin, p. 527\u2013535. InW. Szmuness, H. J. Alter, and J. E. Maynard (ed.), Viral Hepatitis\u2014 1981 International Symposium. Franklin Institute Press, Philadelphia.", "volume-title": "Viral Hepatitis\u2014"}, {"key": "39_CR280", "doi-asserted-by": "crossref", "first-page": "1211", "DOI": "10.1016/S0140-6736(80)92477-0", "volume": "2", "author": "CE Stevens", "year": "1980", "unstructured": "Stevens, C. E., W. Szmuness, A. I. Goodman, S. A. Weseley, and M. Fotino. 1980. Hepatitis B vaccine: immune responses in haemodialysis patients. Lancet 2: 1211\u20131213.", "journal-title": "Lancet"}, {"key": "39_CR281", "doi-asserted-by": "crossref", "first-page": "1740", "DOI": "10.1001/jama.1985.03350360066020", "volume": "253", "author": "CE Stevens", "year": "1985", "unstructured": "Stevens, C. E., P. T. Toy, M. J. Tong, P. E. Taylor, G. N. Vyas, P. V. Nair, M. Gudavalli, and S. Krugman. 1985. Perinatal hepatitis B virus transmission in the United States. J. Am. Med. Assoc. 253: 1740\u20131745.", "journal-title": "J. Am. Med. Assoc"}, {"key": "39_CR282", "first-page": "626", "volume": "46", "author": "W Stibbe", "year": "1982", "unstructured": "Stibbe, W., and W. H. Gerlich. 1982. Structural relationships between minor and major proteins of hepatitis B surface antigen. J. Virol. 46: 626\u2013628.", "journal-title": "J. Virol"}, {"key": "39_CR283", "first-page": "521", "volume": "26", "author": "JH Stokes", "year": "1926", "unstructured": "Stokes, J. H., R. Ruedemann, Jr., and W. S. Lemon. 1926. Epidemic infectious jaundice and its relation to the therapy of syphilis. Arch. Int. Med. 26: 521\u2013525.", "journal-title": "Int. Med"}, {"key": "39_CR284", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1016/0092-8674(82)90157-X", "volume": "29", "author": "J Summers", "year": "1982", "unstructured": "Summers, J., and W. S. Mason. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29: 403\u2013415.", "journal-title": "Cell"}, {"key": "39_CR285", "doi-asserted-by": "crossref", "first-page": "4533", "DOI": "10.1073/pnas.75.9.4533", "volume": "75", "author": "J Summers", "year": "1978", "unstructured": "Summers, J., J. M. Smolec, and R. Snyder. 1978. A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc. Natl. Acad. Sci. USA 75: 4533\u20134537.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR286", "doi-asserted-by": "crossref", "first-page": "4597", "DOI": "10.1073/pnas.72.11.4597", "volume": "72", "author": "JA Summers", "year": "1975", "unstructured": "Summers, J. A., A. O\u2019Connell, and L. Millman. 1975. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc. Natl. Acad. Sci. USA 72: 4597\u20134601.", "journal-title": "Proc. Natl. Acad. Sci. USA"}, {"key": "39_CR287", "first-page": "40", "volume": "24", "author": "W Szmuness", "year": "1978", "unstructured": "Szmuness, W. 1978. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog. Med. Virol. 24: 40\u201369.", "journal-title": "Virol"}, {"key": "39_CR288", "author": "W Szmuness", "year": "1978", "unstructured": "Szmuness, W., E. J. Harley, H. Ikram, and C. E. Stevens. 1978. Sociodemographic aspects of the epidemiology of hepatitis B, p. 297\u2013320. InG. N. Vyas, S. N. Cohen, and R. Schmid. (ed.), Viral hepatitis. Franklin Institute Press, Philadelphia.", "volume-title": "Viral hepatitis"}, {"key": "39_CR289", "doi-asserted-by": "crossref", "first-page": "701", "DOI": "10.1056/NEJM197403282901302", "volume": "290", "author": "W Szmuness", "year": "1974", "unstructured": "Szmuness, W., A. Prince, M. Goodman, C. Ehrich, R. Pick, and M. Ansari. 1974. Hepatitis B immune serum globulin in prevention of nonparenterally transmitted hepatitis B. N. Engl. J. Med. 290: 701\u2013706.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR290", "doi-asserted-by": "crossref", "first-page": "833", "DOI": "10.1056/NEJM198010093031501", "volume": "303", "author": "W Szmuness", "year": "1980", "unstructured": "Szmuness, W., C. E. Stevens, E. J. Harley, E. A. Zang, W. R. Oleszko, D. C. William, R. Sadovsky, J. M. Morrison, and A. Kellner. 1980. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N. Engl. J. Med. 303: 833\u2013841.", "journal-title": "N. Engl. J. Med"}, {"key": "39_CR291", "first-page": "2903", "volume": "130", "author": "K Takahashi", "year": "1983", "unstructured": "Takahashi, K., A. Machida, G. Funatsu, M. Nomura, S. Usuda, S. Aoyagi, K. Tachibaua, H. Miyamoto, M. Imai, T. Nakamura, Y. Miyakawa, and M. Mayumi. 1983. Immunochemical structure of hepatitis B e antigen in the serum. J. Immunol. 130: 2903\u20132907.", "journal-title": "J. Immunol"}, {"key": "39_CR292", "doi-asserted-by": "crossref", "first-page": "36", "DOI": "10.1055/s-2008-1040644", "volume": "4", "author": "HC Thomas", "year": "1984", "unstructured": "Thomas, H. C., and A. S. F. Lok. 1984. The immunopathology of autoimmune and hepatitis B virus-induced chronic hepatitis. Semin. Liver Dis. 4: 36\u201341.", "journal-title": "Liver Dis"}, {"key": "39_CR293", "author": "HC Thomas", "year": "1984", "unstructured": "Thomas, H. C., M. Pignatelli, A. Goodall, J. Waters, P. Karayiannis, and D. Brown. 1984. Immunologic mechanisms of cell lysis in hepatitis B virus infection, p. 167\u2013177. InG. N. Vyas, J. L. Dientstag, and J. H. Hoofnagle (ed.), Viral hepatitis and liver disease. Grune and Stratton, New York.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "39_CR294", "doi-asserted-by": "crossref", "first-page": "260", "DOI": "10.1016/0016-5085(81)90712-5", "volume": "80", "author": "SN Thung", "year": "1981", "unstructured": "Thung, S. N., and M. A. Gerber. 1981. HBsAg-associated albumin receptors and antialbumin antibodies in sera of patients with liver disease. Gastroenterology 80: 260\u2013264.", "journal-title": "Gastroenterology"}, {"key": "39_CR295", "doi-asserted-by": "crossref", "first-page": "290", "DOI": "10.1111/j.1600-0676.1983.tb00880.x", "volume": "3", "author": "SN Thung", "year": "1983a", "unstructured": "Thung, S. N., and M. A. Gerber. 1983a. Albumin binding sites on human hepatocytes. Liver 3: 290\u2013294.", "journal-title": "Liver"}, {"key": "39_CR296", "doi-asserted-by": "crossref", "first-page": "392", "DOI": "10.1111/j.1600-0676.1983.tb00893.x", "volume": "3", "author": "SN Thung", "year": "1983b", "unstructured": "Thung, S. N., and M. A. Gerber. 1983b. Immunohisto-chemical study of delta antigen in an American metropolitan population. Liver 3: 392\u2013397.", "journal-title": "Liver"}, {"key": "39_CR297", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.1055/s-2008-1040647", "volume": "4", "author": "SN Thung", "year": "1984", "unstructured": "Thung, S. N., and M. A. Gerber. 1984. Polyalbumin receptors: their role in the attachment of hepatitis B virus to hepatocytes. Semin. Liver Dis. 4: 69\u201373", "journal-title": "Liver Dis"}, {"key": "39_CR298", "doi-asserted-by": "crossref", "first-page": "406", "DOI": "10.1126/science.6264599", "volume": "213", "author": "P Tiollais", "year": "1981", "unstructured": "Tiollais, P., P. Charnay, G. N. Vyas. 1981. Biology of hepatitis B virus. Science 213: 406\u2013411.", "journal-title": "Science"}, {"key": "39_CR299", "author": "P Tiollais", "first-page": "489", "year": "1984", "unstructured": "Tiollais, P., A. Dejean, C. Brechot, M.-L. Michel, P. Sonigo, and S. Wain-Hobson. 1984. Structure of hepatitis B virus DNA, p. 49\u201365. InG. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, (ed.), Viral hepatitis and liver disease. Grune and Stratton, New York. Tiollais, P., C. Pourcel, and A. Dejean. 1985. The hepatitis B virus. Nature (London) 317: 489\u2013495.", "volume-title": "Viral hepatitis and liver disease. Grune and Stratton, New York. Tiollais, P., C. Pourcel, and A. Dejean. 1985. The hepatitis B virus. Nature (London)"}, {"key": "39_CR300", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1038/305827a0", "volume": "305", "author": "H Toh", "year": "1983", "unstructured": "Toh, H., H. Hayashida, and T. Miyata. 1983. Sequence homology between retroviral reverse transcriptase and putative polymerase of hepatitis B virus and cauliflower mosaic virus. Nature (London) 305: 827\u2013828.", "journal-title": "Nature (London)"}, {"key": "39_CR301", "doi-asserted-by": "crossref", "first-page": "980", "DOI": "10.1093/infdis/135.6.980", "volume": "135", "author": "MJ Tong", "year": "1977", "unstructured": "Tong, M. J., D. Stevenson, and I. Gordon. 1977. Correlation of e antigen, DNA polymerase activity and Dane particles in chronic benign and chronic active type B hepatitis B infection. J. Infect. Dis. 135: 980\u2013984.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR302", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1016/0016-5085(82)90007-5", "volume": "82", "author": "A Trevisan", "year": "1982", "unstructured": "Trevisan, A., G. Realdi, A. Alberti, G. Ongaro, E. Pornaro, and R. Meliconi. 1982. Core antigen-specific immuno-gloublin G bound to the liver cell membrane in chronic hepatitis B. Gastroenterology 82: 218\u2013222.", "journal-title": "Gastroenterology"}, {"key": "39_CR303", "doi-asserted-by": "crossref", "first-page": "159", "DOI": "10.1016/0016-5085(84)90139-2", "volume": "87", "author": "F Tsuda", "year": "1984", "unstructured": "Tsuda, F., S. Naito, E. Takai, Y. Akahane, S. Furuta, Y. Miyakawa, and M. Mayumi. 1984. Low molecular weight (7S) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection. Gastroenterology 87: 159\u2013164.", "journal-title": "Gastroenterology"}, {"key": "39_CR304", "first-page": "17", "volume": "58", "author": "J. S. Tuttleman", "year": "1986", "unstructured": "Tuttleman, J. S., J. C. Pugh, and J. W. Summers. 1986. In vitro experimental infection of primary duck hepatocytic cultures with duck hepatitis B virus. J. Virol. 58:17\u201325.", "journal-title": "J. Virol."}, {"issue": "35", "key": "39_CR305", "first-page": "493", "volume": "33", "author": "U.S. Department of Health and Human Services", "year": "1984", "unstructured": "U.S. Department of Health and Human Services. 1984. Morbidity and Mortality Weekly Report. 33(35):493\u2013494.", "journal-title": "Morbidity and Mortality Weekly Report."}, {"key": "39_CR306", "author": "P Valenzuela", "year": "1980", "unstructured": "Valenzuela, P., M. Quiroga, J. Zaldivar, P. Gray, and W. J. Rutter. 1980. The nucleotide sequence of the hepatitis B genome and the identification of the major viral genes, p. 57\u201370. InB. Fields, R. Jaenisch, and C. F. Fox (ed.), Animal virus genetics. Academic Press, New York.", "volume-title": "Animal virus genetics"}, {"key": "39_CR307", "author": "H Varmus", "year": "1982", "unstructured": "Varmus, H., and R. Swanstrom. 1982. Replication of retroviruses, p. 369\u2013512. InR. Weiss, N. Teich, H. Varmus, and J. Coffin, (ed.), RNA Tumour Viruses. Cold Spring Harbor Press, Cold Spring Harbor, New York.", "volume-title": "RNA Tumour Viruses"}, {"key": "39_CR308", "first-page": "601", "volume": "21", "author": "M Walker", "year": "1981", "unstructured": "Walker, M., W. Szmuness, C. Stevens, and P. Rubinstein. 1981. Genetics of anti-HBs responsiveness I. HLA-DR7 and non-responsiveness to hepatitis vaccination. Transfusion 21: 601.", "journal-title": "Transfusion"}, {"key": "39_CR309", "first-page": "867", "volume": "21", "author": "C Wallis", "year": "1971", "unstructured": "Wallis, C., and J. L. Melnick. 1971. Enhanced detection of Australia antigen in serum hepatitis patients by discontinuous counter-immunoelectrophoresis. Appl. Microbiol. 21: 867\u2013869.", "journal-title": "Microbiol"}, {"key": "39_CR310", "author": "JR Wands", "year": "1984", "unstructured": "Wands, J. R., E. Ben-Porath, and M.-A. Wong. 1984. Monoclonal antibodies and hepatitis B: a new perspective using highly sensitive and specific radioimmunoassays, p. 543\u2013559. InG. N. Vyas, J. L. Dienstag and J. H. Hoofnagle (ed.), Viral hepatitis and liver disease. Grune and Stratton, New York.", "volume-title": "Viral hepatitis and liver disease"}, {"key": "39_CR311", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1016/0016-5085(81)90708-3", "volume": "80", "author": "JR Wands", "year": "1981", "unstructured": "Wands, J. R., and V. R. Zurawski. 1981. High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology 80: 225\u2013232.", "journal-title": "Gastroenterology"}, {"key": "39_CR312", "doi-asserted-by": "crossref", "first-page": "508", "DOI": "10.1038/323508a0", "volume": "323", "author": "KS Wang", "year": "1986", "unstructured": "Wang, K.-S., Q.-L. Choo, A. J. Weiner, J.-H. Ou, R. C. Najarian, R. M. Thayer, G. T. Mullenbach, K. J. Denniston, J. L. Gerin, and M. Houghton. 1986. Structure, sequence and expression of the hepatitis delta (8) viral genome. Nature (London) 323: 508\u2013514.", "journal-title": "Nature (London)"}, {"key": "39_CR313", "first-page": "1", "volume": "48", "author": "B Weiser", "year": "1983", "unstructured": "Weiser, B., D. Ganem, C. Seeger, and H. E. Varmus. 1983. Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with GSHV. J. Virol. 48: 1\u20139.", "journal-title": "J. Virol"}, {"key": "39_CR314", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/0092-8674(75)90017-3", "volume": "5", "author": "A Weissbach", "year": "1975", "unstructured": "Weissbach, A. 1975. Vertebrate DNA polymerases. Cell 5: 101\u2013108.", "journal-title": "Cell"}, {"key": "39_CR315", "doi-asserted-by": "crossref", "first-page": "1061", "DOI": "10.1136/gut.24.11.1061", "volume": "24", "author": "IVD Weller", "year": "1983", "unstructured": "Weller, I. V. D., P. Karayiannis, A. S. F. Lok, L. Montano, M. Bamber, H. C. Thomas, and S. Sherlock. 1983. Significance of delta agent infection in chronic hepatitis B infection: a study on British carriers. Gut 24: 1061\u20131063.", "journal-title": "Gut"}, {"key": "39_CR316", "first-page": "1361", "volume": "39", "author": "YM Wen", "year": "1983", "unstructured": "Wen, Y.-M., K. Mitamura, and B. Merchant. 1983. Nuclear antigen detected in hepatoma cell lines containing integrated hepatitis B virus DNA. Infect. Immun. 39: 1361\u20131367.", "journal-title": "Immun"}, {"key": "39_CR317", "first-page": "314", "volume": "32", "author": "BG Werner", "year": "1979", "unstructured": "Werner, B. G., J. M. Smolec, R. Snyder, and J. Summers. 1979. Serological relationship of woodchuck hepatitis virus to human hepatitis B virus. J. Virol. 32: 314\u2013322.", "journal-title": "J. Virol"}, {"key": "39_CR318", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1097/00000441-198403000-00006", "volume": "287", "author": "DJ West", "year": "1984", "unstructured": "West, D. J. 1984. The risk of hepatitis B infection among health professionals in the United States: a review. Am. J. Med. Sci. 287: 26\u201333.", "journal-title": "Am. J. Med. Sci"}, {"key": "39_CR319", "author": "DA White", "year": "1986", "edition": "3", "unstructured": "White, D. A., and F. F. Fenner. 1986. Medical virology, 3rd ed. Academic Press, New York.", "volume-title": "Medical virology"}, {"key": "39_CR320", "author": "L Wilde", "year": "1970", "unstructured": "Wilde, L. 1970. Solid phase antigen-antibody systems, p. 199\u2013206. InK. E. Kirkham and W. M. Hunter, (ed.), Radioimmunoassay methods. E. & S. Livingston, Edinburgh.", "volume-title": "Radioimmunoassay methods"}, {"key": "39_CR321", "doi-asserted-by": "crossref", "first-page": "740", "DOI": "10.1038/299740a0", "volume": "299", "author": "H Will", "year": "1982", "unstructured": "Will, H., R. Cattaneo, H. G. Koch, G. Darai, H. Schaller, H. Schellekens, M. C. A. van Eerd Pan, and F. Deinhardt. 1982. Cloned HBV DNA causes hepatitis in chimpanzees. Nature (London) 299: 740\u2013742.", "journal-title": "Nature (London)"}, {"key": "39_CR322", "doi-asserted-by": "crossref", "first-page": "30", "DOI": "10.1111/j.1445-5994.1982.tb02421.x", "volume": "12", "author": "HG Williamson", "year": "1982", "unstructured": "Williamson, H. G., N. I. Lehmann, M. Dimitrakakis, D. L. B. Sharma, and I. D. Gust. 1982. A longitudinal study of hepatitis infection in an institution for the mentally retarded. Aust. N. Z. J. Med. 12: 30\u201334.", "journal-title": "Aust. N. Z. J. Med"}, {"issue": "(Suppl.)", "key": "39_CR323", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1093/infdis/136.Supplement_2.S311", "volume": "136", "author": "G Wolters", "year": "1977", "unstructured": "Wolters, G., L. P. C. Kuijpers, J. Kacaki, and A. H. W. M. Shuurs. 1977. Enzyme-linked immunosorbent assay for hepatitis B surface antigen. J. Infect. Dis. 136(Suppl.): 311\u2013317.", "journal-title": "J. Infect. Dis"}, {"key": "39_CR324", "first-page": "649", "volume": "36", "author": "G Yamada", "year": "1977", "unstructured": "Yamada, G., and P. L. Nakane. 1977. Hepatitis B core and surface antigen in liver tissue. Lab. Invest. 36: 649\u2013659.", "journal-title": "Invest"}, {"key": "39_CR325", "doi-asserted-by": "crossref", "first-page": "171", "DOI": "10.1007/BF01242652", "volume": "40", "author": "E Zalan", "year": "1973", "unstructured": "Zalan, E., C. Wilson, and N. A. Labzoffsky. 1973. Elimination of non-specific reaction in latex agglutination test for the detection of hepatitis-associated antigen. Arch. Gesamte Virusforsch. 40: 171\u2013175.", "journal-title": "Gesamte Virusforsch"}, {"key": "39_CR326", "first-page": "641", "volume": "3", "author": "YZ Zhou", "year": "1980", "unstructured": "Zhou, Y.-Z. 1980. A virus possibly associated with hepatitis and hepatoma in ducks. Shanghai Inst. Biochem. Acad. Sinica 3: 641\u2013644.", "journal-title": "Sinica"}, {"key": "39_CR327", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1097/00000441-197507000-00027", "volume": "270", "author": "AJ Zuckerman", "year": "1975", "unstructured": "Zuckerman, A. J. 1975. Tissue and organ culture studies of hepatitis B virus. Am. J. Med. Sci. 270: 197\u2013204.", "journal-title": "Am. J. Med. Sci"}], "container-title": ["Laboratory Diagnosis of Infectious Diseases Principles and Practice"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4612-3900-0_39", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 15]], "date-time": "2019-06-15T11:00:33Z", "timestamp": 1560596433000}, "score": 30.047398, "issued": {"date-parts": [[1988]]}, "ISBN": ["9781461283942", "9781461239000"], "references-count": 327, "URL": "http://dx.doi.org/10.1007/978-1-4612-3900-0_39", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:15:46Z", "timestamp": 1574129746131}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "16", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Virology"], "published-print": {"date-parts": [[2001, 8, 15]]}, "DOI": "10.1128/jvi.75.16.7651-7661.2001", "type": "journal-article", "created": {"date-parts": [[2002, 7, 27]], "date-time": "2002-07-27T09:55:53Z", "timestamp": 1027763753000}, "page": "7651-7661", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Duck Hepatitis B Virus Replication in Primary Bile Duct Epithelial Cells"], "prefix": "10.1128", "volume": "75", "author": [{"given": "J.-Y.", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "J. G.", "family": "Culvenor", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Angus", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Smallwood", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Nicoll", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Locarnini", "sequence": "additional", "affiliation": []}], "member": "235", "container-title": ["Journal of Virology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/JVI.75.16.7651-7661.2001", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T13:07:43Z", "timestamp": 1482498463000}, "score": 29.819687, "issued": {"date-parts": [[2001, 8, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2001, 8, 15]]}, "issue": "16"}, "URL": "http://dx.doi.org/10.1128/jvi.75.16.7651-7661.2001", "ISSN": ["0022-538X"], "issn-type": [{"value": "0022-538X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T04:41:49Z", "timestamp": 1574743309336}, "publisher-location": "Cham", "reference-count": 130, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319223292", "type": "print"}, {"value": "9783319223308", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2016, 1, 1]], "date-time": "2016-01-01T00:00:00Z", "timestamp": 1451606400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2016]]}, "DOI": "10.1007/978-3-319-22330-8_14", "type": "book-chapter", "created": {"date-parts": [[2015, 11, 13]], "date-time": "2015-11-13T08:11:39Z", "timestamp": 1447402299000}, "page": "303-324", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The Basis for Antiviral Therapy: Drug Targets, Cross-Resistance, and Novel Small Molecule Inhibitors"], "prefix": "10.1007", "author": [{"given": "Peter", "family": "Revill", "sequence": "first", "affiliation": []}, {"given": "Stephen", "family": "Locarnini", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "6", "key": "14_CR1", "doi-asserted-by": "crossref", "first-page": "1759", "DOI": "10.1002/hep.21896", "volume": "46", "author": "A Schulze", "year": "2007", "unstructured": "Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology. 2007;46(6):1759\u201368. Epub 2007/11/30.", "journal-title": "Hepatology"}, {"issue": "3", "key": "14_CR2", "doi-asserted-by": "crossref", "first-page": "985", "DOI": "10.1002/hep.26125", "volume": "57", "author": "C Sureau", "year": "2013", "unstructured": "Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology. 2013;57(3):985\u201394. Epub 2012/11/20.", "journal-title": "Hepatology"}, {"key": "14_CR3", "author": "H Yan", "volume": "1", "year": "2012", "unstructured": "Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife. 2012;1, e00049. Epub 2012/11/15.", "journal-title": "eLife"}, {"issue": "10", "key": "14_CR4", "volume": "6", "author": "HC Li", "year": "2010", "unstructured": "Li HC, Huang EY, Su PY, Wu SY, Yang CC, Lin YS, et al. Nuclear export and import of human hepatitis B virus capsid protein and particles. PLoS Pathog. 2010;6(10), e1001162. Epub 2010/11/10.", "journal-title": "PLoS Pathog"}, {"issue": "17", "key": "14_CR5", "doi-asserted-by": "crossref", "first-page": "9849", "DOI": "10.1073/pnas.1730940100", "volume": "100", "author": "B Rabe", "year": "2003", "unstructured": "Rabe B, Vlachou A, Pante N, Helenius A, Kann M. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A. 2003;100(17):9849\u201354. Epub 2003/08/12.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "8", "key": "14_CR6", "first-page": "4867", "volume": "67", "author": "J Kock", "year": "1993", "unstructured": "Kock J, Schlicht HJ. Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J Virol. 1993;67(8):4867\u201374. Epub 1993/08/01.", "journal-title": "J Virol"}, {"issue": "6", "key": "14_CR7", "first-page": "3350", "volume": "69", "author": "JE Newbold", "year": "1995", "unstructured": "Newbold JE, Xin H, Tencza M, Sherman G, Dean J, Bowden S, et al. The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol. 1995;69(6):3350\u20137. Epub 1995/06/01.", "journal-title": "J Virol"}, {"issue": "1", "key": "14_CR8", "first-page": "345", "volume": "71", "author": "PP Scaglioni", "year": "1997", "unstructured": "Scaglioni PP, Melegari M, Wands JR. Posttranscriptional regulation of hepatitis B virus replication by the precore protein. J Virol. 1997;71(1):345\u201353.", "journal-title": "J Virol"}, {"issue": "1", "key": "14_CR9", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1016/j.str.2012.10.017", "volume": "21", "author": "MA DiMattia", "year": "2013", "unstructured": "DiMattia MA, Watts NR, Stahl SJ, Grimes JM, Steven AC, Stuart DI, et al. Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein. Structure. 2013;21(1):133\u201342. Epub 2012/12/12.", "journal-title": "Structure"}, {"issue": "6", "key": "14_CR10", "doi-asserted-by": "crossref", "first-page": "771", "DOI": "10.1016/S1097-2765(01)80009-5", "volume": "3", "author": "SA Wynne", "year": "1999", "unstructured": "Wynne SA, Crowther RA, Leslie AG. The crystal structure of the human hepatitis B virus capsid. Mol Cell. 1999;3(6):771\u201380. Epub 1999/07/08.", "journal-title": "Mol Cell"}, {"issue": "5", "key": "14_CR11", "doi-asserted-by": "crossref", "first-page": "1022", "DOI": "10.1016/j.jhep.2013.06.018", "volume": "59", "author": "J Bayliss", "year": "2013", "unstructured": "Bayliss J, Lim L, Thompson AJ, Desmond P, Angus P, Locarnini S, et al. Hepatitis B virus splicing is enhanced prior to development of hepatocellular carcinoma. J Hepatol. 2013;59(5):1022\u20138. Epub 2013/07/03.", "journal-title": "J Hepatol"}, {"key": "14_CR12", "year": "2004", "unstructured": "Soussan P, Garreau F, Arnufl B, Pol S, Kremsdorf D, editors. HBSP protein and related defective particles is associated to liver fibrosis The Molecular Biology of Hepatitis B Viruses. Woodshole, MA: Springer; 2004.", "volume-title": "HBSP protein and related defective particles is associated to liver fibrosis The Molecular Biology of Hepatitis B Viruses"}, {"issue": "1", "key": "14_CR13", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1172/JCI8098", "volume": "105", "author": "P Soussan", "year": "2000", "unstructured": "Soussan P, Garreau F, Zylberberg H, Ferray C, Brechot C, Kremsdorf D. In vivo expression of a new hepatitis B virus protein encoded by a spliced RNA. J Clin Invest. 2000;105(1):55\u201360. Epub 2000/01/05.", "journal-title": "J Clin Invest"}, {"issue": "2", "key": "14_CR14", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1086/589623", "volume": "198", "author": "P Soussan", "year": "2008", "unstructured": "Soussan P, Pol J, Garreau F, Schneider V, Le Pendeven C, Nalpas B, et al. Expression of defective hepatitis B virus particles derived from singly spliced RNA is related to liver disease. J Infect Dis. 2008;198(2):218\u201325. Epub 2008/06/06.", "journal-title": "J Infect Dis"}, {"issue": "3", "key": "14_CR15", "doi-asserted-by": "crossref", "first-page": "343", "DOI": "10.1016/S0168-8278(02)00422-1", "volume": "38", "author": "P Soussan", "year": "2003", "unstructured": "Soussan P, Tuveri R, Nalpas B, Garreau F, Zavala F, Masson A, et al. The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J Hepatol. 2003;38(3):343\u20138.", "journal-title": "J Hepatol"}, {"issue": "8", "key": "14_CR16", "doi-asserted-by": "crossref", "first-page": "1169", "DOI": "10.3851/IMP1982", "volume": "16", "author": "BK Kim", "year": "2011", "unstructured": "Kim BK, Revill PA, Ahn SH. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther. 2011;16(8):1169\u201386. Epub 2011/12/14.", "journal-title": "Antivir Ther"}, {"issue": "4", "key": "14_CR17", "doi-asserted-by": "crossref", "first-page": "513", "DOI": "10.1002/jmv.20311", "volume": "75", "author": "MC Kew", "year": "2005", "unstructured": "Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-Saharan Africans. J Med Virol. 2005;75(4):513\u201321.", "journal-title": "J Med Virol"}, {"issue": "s1", "key": "14_CR18", "doi-asserted-by": "crossref", "first-page": "S27", "DOI": "10.1111/j.1872-034X.2007.00100.x", "volume": "37", "author": "A Kramvis", "year": "2007", "unstructured": "Kramvis A, Kew MC. Molecular characterization of subgenotype A1 (subgroup Aa) of hepatitis B virus. Hepatol Res. 2007;37(s1):S27\u201332. Epub 2007/07/14.", "journal-title": "Hepatol Res"}, {"issue": "5", "key": "14_CR19", "doi-asserted-by": "crossref", "first-page": "1593", "DOI": "10.1053/j.gastro.2009.08.063", "volume": "137", "author": "F Zoulim", "year": "2009", "unstructured": "Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology. 2009;137(5):1593\u2013608 e1\u20132.", "journal-title": "Gastroenterology"}, {"issue": "2", "key": "14_CR20", "doi-asserted-by": "crossref", "first-page": "595", "DOI": "10.1016/0042-6822(89)90455-8", "volume": "170", "author": "R Girones", "year": "1989", "unstructured": "Girones R, Miller RH. Mutation rate of the hepadnavirus genome. Virology. 1989;170(2):595\u20137. Epub 1989/06/01.", "journal-title": "Virology"}, {"issue": "6", "key": "14_CR21", "doi-asserted-by": "crossref", "first-page": "687", "DOI": "10.1086/368083", "volume": "36", "author": "CL Lai", "year": "2003", "unstructured": "Lai CL, Dienstag J, Schiff E, Leung NW, Atkins M, Hunt C, et al. Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B. Clin Infect Dis. 2003;36(6):687\u201396.", "journal-title": "Clin Infect Dis"}, {"key": "14_CR22", "unstructured": "Marcellin P, Buti M, Krastev Z, de Man RA, Zeuzem S, Lou L, et al. Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate. J Hepatol. 2014. Epub 2014/07/22."}, {"issue": "23", "key": "14_CR23", "doi-asserted-by": "crossref", "first-page": "2442", "DOI": "10.1056/NEJMoa0802878", "volume": "359", "author": "P Marcellin", "year": "2008", "unstructured": "Marcellin P, Heathcote EJ, Buti M, Gane E, de Man RA, Krastev Z, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med. 2008;359(23):2442\u201355. Epub 2008/12/05.", "journal-title": "N Engl J Med"}, {"issue": "25", "key": "14_CR24", "doi-asserted-by": "crossref", "first-page": "2576", "DOI": "10.1056/NEJMoa066422", "volume": "357", "author": "CL Lai", "year": "2007", "unstructured": "Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med. 2007;357(25):2576\u201388. Epub 2007/12/21.", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "14_CR25", "doi-asserted-by": "crossref", "first-page": "486", "DOI": "10.1053/j.gastro.2008.10.026", "volume": "136", "author": "YF Liaw", "year": "2009", "unstructured": "Liaw YF, Gane E, Leung N, Zeuzem S, Wang Y, Lai CL, et al. 2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B. Gastroenterology. 2009;136(2):486\u201395. Epub 2008/11/26.", "journal-title": "Gastroenterology"}, {"issue": "6", "key": "14_CR26", "doi-asserted-by": "crossref", "first-page": "1743", "DOI": "10.1053/j.gastro.2006.09.020", "volume": "131", "author": "SJ Hadziyannis", "year": "2006", "unstructured": "Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, et al. Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology. 2006;131(6):1743\u201351. Epub 2006/11/08.", "journal-title": "Gastroenterology"}, {"issue": "3", "key": "14_CR27", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1002/hep.22414", "volume": "48", "author": "P Marcellin", "year": "2008", "unstructured": "Marcellin P, Chang TT, Lim SG, Sievert W, Tong M, Arterburn S, et al. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. Hepatology. 2008;48(3):750\u20138. Epub 2008/08/30.", "journal-title": "Hepatology"}, {"issue": "5", "key": "14_CR28", "doi-asserted-by": "crossref", "first-page": "1503", "DOI": "10.1002/hep.22841", "volume": "49", "author": "DJ Tenney", "year": "2009", "unstructured": "Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology. 2009;49(5):1503\u201314. Epub 2009/03/13.", "journal-title": "Hepatology"}, {"issue": "6", "key": "14_CR29", "doi-asserted-by": "crossref", "first-page": "1385", "DOI": "10.1002/hep.21189", "volume": "43", "author": "YS Lee", "year": "2006", "unstructured": "Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, et al. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology. 2006;43(6):1385\u201391. Epub 2006/05/27.", "journal-title": "Hepatology"}, {"issue": "4", "key": "14_CR30", "doi-asserted-by": "crossref", "first-page": "1574", "DOI": "10.1053/j.gastro.2007.02.039", "volume": "132", "author": "M Ghany", "year": "2007", "unstructured": "Ghany M, Liang TJ. Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B. Gastroenterology. 2007;132(4):1574\u201385. Epub 2007/04/06.", "journal-title": "Gastroenterology"}, {"issue": "Suppl 1", "key": "14_CR31", "doi-asserted-by": "crossref", "first-page": "S112", "DOI": "10.1016/S0168-8278(12)60012-9", "volume": "56", "author": "F Zoulim", "year": "2012", "unstructured": "Zoulim F, Locarnini S. Management of treatment failure in chronic hepatitis B. J Hepatol. 2012;56 Suppl 1:S112\u201322. Epub 2012/02/04.", "journal-title": "J Hepatol"}, {"key": "14_CR32", "unstructured": "Agarwal K, Fung SK, Nguyen TT, Cheng W, Sicard E, Ryder SD, et al. Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection. J Hepatol. 2014. Epub 2014/12/03."}, {"issue": "51", "key": "14_CR33", "first-page": "675", "volume": "58", "author": "K Agarwal", "year": "2013", "unstructured": "Agarwal K, Fung SK, Nguyen TT, Cheng W, Sicard E, Ryder SD, et al. Twenty eight day safety and efficacy of tenofovir alafe-namide (TAF) fumarate in chronic hepatitis B (CHB) patients. Hepatology. 2013;58(51):675.", "journal-title": "Hepatology"}, {"issue": "4", "key": "14_CR34", "doi-asserted-by": "crossref", "first-page": "902", "DOI": "10.1053/j.gastro.2014.02.024", "volume": "146", "author": "S Tong", "year": "2014", "unstructured": "Tong S, Li J. Identification of NTCP as an HBV receptor: the beginning of the end or the end of the beginning? Gastroenterology. 2014;146(4):902\u20135. Epub 2014/03/01.", "journal-title": "Gastroenterology"}, {"issue": "2", "key": "14_CR35", "doi-asserted-by": "crossref", "first-page": "2892", "DOI": "10.3390/ijms15022892", "volume": "15", "author": "K Watashi", "year": "2014", "unstructured": "Watashi K, Urban S, Li W, Wakita T. NTCP and beyond: opening the door to unveil hepatitis B virus entry. Int J Mol Sci. 2014;15(2):2892\u2013905. Epub 2014/02/22.", "journal-title": "Int J Mol Sci"}, {"issue": "4", "key": "14_CR36", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1002/hep.21112", "volume": "43", "author": "M Engelke", "year": "2006", "unstructured": "Engelke M, Mills K, Seitz S, Simon P, Gripon P, Schnolzer M, et al. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology. 2006;43(4):750\u201360. Epub 2006/03/25.", "journal-title": "Hepatology"}, {"issue": "1", "key": "14_CR37", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1053/j.gastro.2005.03.090", "volume": "129", "author": "D Glebe", "year": "2005", "unstructured": "Glebe D, Urban S, Knoop EV, Cag N, Krass P, Grun S, et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology. 2005;129(1):234\u201345. Epub 2005/07/14.", "journal-title": "Gastroenterology"}, {"issue": "24", "key": "14_CR38", "doi-asserted-by": "crossref", "first-page": "15655", "DOI": "10.1073/pnas.232137699", "volume": "99", "author": "P Gripon", "year": "2002", "unstructured": "Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, et al. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A. 2002;99(24):15655\u201360. Epub 2002/11/15.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "4", "key": "14_CR39", "doi-asserted-by": "crossref", "first-page": "1986", "DOI": "10.1128/JVI.76.4.1986-1990.2002", "volume": "76", "author": "S Urban", "year": "2002", "unstructured": "Urban S, Gripon P. Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein. J Virol. 2002;76(4):1986\u201390. Epub 2002/01/19.", "journal-title": "J Virol"}, {"issue": "5", "key": "14_CR40", "doi-asserted-by": "crossref", "first-page": "861", "DOI": "10.1016/j.jhep.2012.12.008", "volume": "58", "author": "T Volz", "year": "2013", "unstructured": "Volz T, Allweiss L, Ben MM, Warlich M, Lohse AW, Pollok JM, et al. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus. J Hepatol. 2013;58(5):861\u20137. Epub 2012/12/19.", "journal-title": "J Hepatol"}, {"issue": "6669", "key": "14_CR41", "doi-asserted-by": "crossref", "first-page": "806", "DOI": "10.1038/35888", "volume": "391", "author": "A Fire", "year": "1998", "unstructured": "Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998;391(6669):806\u201311. Epub 1998/03/05.", "journal-title": "Nature"}, {"issue": "1", "key": "14_CR42", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1007/s11095-007-9504-0", "volume": "25", "author": "Y Chen", "year": "2008", "unstructured": "Chen Y, Cheng G, Mahato RI. RNAi for treating hepatitis B viral infection. Pharm Res. 2008;25(1):72\u201386. Epub 2007/12/13.", "journal-title": "Pharm Res"}, {"issue": "1", "key": "14_CR43", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0016-5085(03)00720-0", "volume": "125", "author": "C Klein", "year": "2003", "unstructured": "Klein C, Bock CT, Wedemeyer H, Wustefeld T, Locarnini S, Dienes HP, et al. Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA. Gastroenterology. 2003;125(1):9\u201318. Epub 2003/07/10.", "journal-title": "Gastroenterology"}, {"issue": "6", "key": "14_CR44", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.1038/nbt824", "volume": "21", "author": "AP McCaffrey", "year": "2003", "unstructured": "McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H, et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol. 2003;21(6):639\u201344. Epub 2003/05/13.", "journal-title": "Nat Biotechnol"}, {"issue": "5", "key": "14_CR45", "doi-asserted-by": "crossref", "first-page": "973", "DOI": "10.1038/mt.2013.31", "volume": "21", "author": "CI Wooddell", "year": "2013", "unstructured": "Wooddell CI, Rozema DB, Hossbach M, John M, Hamilton HL, Chu Q, et al. Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Mol Ther. 2013;21(5):973\u201385. Epub 2013/02/27.", "journal-title": "Mol Ther"}, {"issue": "S1", "key": "14_CR46", "doi-asserted-by": "crossref", "first-page": "705A", "DOI": "10.1002/hep.26857", "volume": "58", "author": "R Lanford", "year": "2013", "unstructured": "Lanford R, Wooddell CI, Chavez D, Oropeza CE, Chu Q, Hamilton HL, et al. ARC-520 RNAi therapeutic reduces hepatitis B virus DNA, S antigen and e antigen in a chimpanzee with a very high viral titer. Hepatology. 2013;58(S1):705A\u201330A.", "journal-title": "Hepatology"}, {"key": "14_CR47", "doi-asserted-by": "crossref", "first-page": "1267A", "DOI": "10.1002/hep.27588", "volume": "60", "author": "M-F Yuen", "year": "2014", "unstructured": "Yuen M-F, Chan HL-Y, Given B, Hamilton J, Schluep T, Lewis DL, et al. Phase II, dose ranging study of ARC-520, a siRNA-based therapeutic, in patients with chronic hepatitis B virus infection. Hepatology. 2014;60:1267A\u201390A (LB-21).", "journal-title": "Hepatology"}, {"issue": "9663", "key": "14_CR48", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.1016/S0140-6736(09)60207-5", "volume": "373", "author": "YF Liaw", "year": "2009", "unstructured": "Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373(9663):582\u201392.", "journal-title": "Lancet"}, {"issue": "3", "key": "14_CR49", "doi-asserted-by": "crossref", "first-page": "823", "DOI": "10.1053/j.gastro.2006.01.001", "volume": "130", "author": "T Pollicino", "year": "2006", "unstructured": "Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, et al. Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones. Gastroenterology. 2006;130(3):823\u201337. Epub 2006/03/15.", "journal-title": "Gastroenterology"}, {"issue": "1", "key": "14_CR50", "doi-asserted-by": "crossref", "first-page": "183", "DOI": "10.1006/jmbi.2000.4481", "volume": "307", "author": "CT Bock", "year": "2001", "unstructured": "Bock CT, Schwinn S, Locarnini S, Fyfe J, Manns MP, Trautwein C, et al. Structural organization of the hepatitis B virus minichromosome. J Mol Biol. 2001;307(1):183\u201396. Epub 2001/03/13.", "journal-title": "J Mol Biol"}, {"issue": "12", "key": "14_CR51", "doi-asserted-by": "crossref", "first-page": "3179", "DOI": "10.1128/AAC.42.12.3179", "volume": "42", "author": "RW King", "year": "1998", "unstructured": "King RW, Ladner SK, Miller TJ, Zaifert K, Perni RB, Conway SC, et al. Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-l-2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine. Antimicrob Agents Chemother. 1998;42(12):3179\u201386. Epub 1998/12/03.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "2", "key": "14_CR52", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1016/j.antiviral.2007.06.014", "volume": "76", "author": "JJ Feld", "year": "2007", "unstructured": "Feld JJ, Colledge D, Sozzi V, Edwards R, Littlejohn M, Locarnini SA. The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging. Antiviral Res. 2007;76(2):168\u201377. Epub 2007/08/22.", "journal-title": "Antiviral Res"}, {"issue": "9", "key": "14_CR53", "doi-asserted-by": "crossref", "first-page": "3057", "DOI": "10.1128/AAC.46.9.3057-3060.2002", "volume": "46", "author": "WE Delaney", "year": "2002", "unstructured": "Delaney WE, Edwards R, Colledge D, Shaw T, Furman P, Painter G, et al. Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro. Antimicrob Agents Chemother. 2002;46(9):3057\u201360. Epub 2002/08/17.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "2", "key": "14_CR54", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1016/j.antiviral.2011.08.012", "volume": "92", "author": "G Billioud", "year": "2011", "unstructured": "Billioud G, Pichoud C, Puerstinger G, Neyts J, Zoulim F. The main hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication. Antiviral Res. 2011;92(2):271\u20136. Epub 2011/08/30.", "journal-title": "Antiviral Res"}, {"issue": "12", "key": "14_CR55", "doi-asserted-by": "crossref", "first-page": "1125", "DOI": "10.1021/cb100275b", "volume": "5", "author": "SP Katen", "year": "2010", "unstructured": "Katen SP, Chirapu SR, Finn MG, Zlotnick A. Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators. ACS Chem Biol. 2010;5(12):1125\u201336. Epub 2010/09/18.", "journal-title": "ACS Chem Biol"}, {"issue": "8", "key": "14_CR56", "doi-asserted-by": "crossref", "first-page": "1406", "DOI": "10.1016/j.str.2013.06.013", "volume": "21", "author": "SP Katen", "year": "2013", "unstructured": "Katen SP, Tan Z, Chirapu SR, Finn MG, Zlotnick A. Assembly-directed antivirals differentially bind quasiequivalent pockets to modify hepatitis B virus capsid tertiary and quaternary structure. Structure. 2013;21(8):1406\u201316. Epub 2013/07/23.", "journal-title": "Structure"}, {"key": "14_CR57", "author": "L Belloni", "volume": "46", "year": "2014", "unstructured": "Belloni L, Li L, Palumbo GA, Chirapu SR, Calvo L, Finn MG, et al. HAPS hepatitis B virus (HBV) capsid inhibitors prevent HBC interaction with the viral minichromosome and selected host cells to inhibit transcription and affect cccDNA stability. Dig Liver Dis. 2014;46, e9.", "journal-title": "Dig Liver Dis", "DOI": "10.1016/j.dld.2014.01.024", "doi-asserted-by": "crossref"}, {"issue": "47", "key": "14_CR58", "doi-asserted-by": "crossref", "first-page": "19975", "DOI": "10.1073/pnas.0908365106", "volume": "106", "author": "L Belloni", "year": "2009", "unstructured": "Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci U S A. 2009;106(47):19975\u20139. Epub 2009/11/13.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "20", "key": "14_CR59", "doi-asserted-by": "crossref", "first-page": "10262", "DOI": "10.1128/JVI.01360-08", "volume": "82", "author": "C Bourne", "year": "2008", "unstructured": "Bourne C, Lee S, Venkataiah B, Lee A, Korba B, Finn MG, et al. Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle. J Virol. 2008;82(20):10262\u201370. Epub 2008/08/08.", "journal-title": "J Virol"}, {"issue": "5608", "key": "14_CR60", "doi-asserted-by": "crossref", "first-page": "893", "DOI": "10.1126/science.1077215", "volume": "299", "author": "K Deres", "year": "2003", "unstructured": "Deres K, Schroder CH, Paessens A, Goldmann S, Hacker HJ, Weber O, et al. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science. 2003;299(5608):893\u20136. Epub 2003/02/08.", "journal-title": "Science"}, {"issue": "3", "key": "14_CR61", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1016/j.jhep.2009.05.022", "volume": "51", "author": "M Levrero", "year": "2009", "unstructured": "Levrero M, Pollicino T, Petersen J, Belloni L, Raimondo G, Dandri M. Control of cccDNA function in hepatitis B virus infection. J Hepatol. 2009;51(3):581\u201392. Epub 2009/07/21.", "journal-title": "J Hepatol"}, {"issue": "17", "key": "14_CR62", "doi-asserted-by": "crossref", "first-page": "4247", "DOI": "10.1016/j.bmcl.2014.07.032", "volume": "24", "author": "X Yang", "year": "2014", "unstructured": "Yang X, Xu X, Guan H, Wang L, Wu Q, Zhao G, et al. A new series of HAPs as anti-HBV agents targetting at capsid assembly. Biorog Med Chem Lett. 2014;24(17):4247\u20139.", "journal-title": "Biorog Med Chem Lett"}, {"key": "14_CR63", "doi-asserted-by": "crossref", "first-page": "1267A", "DOI": "10.1002/hep.27588", "volume": "60", "author": "E Gane", "year": "2014", "unstructured": "Gane E, Schwabe C, Walker K, Flores L, Hartman G, Klumpp K, et al. Phase 1a safety and pharmacokinetics of NVR 3-778, a potential first-in-class HBV core inhibitor. Hepatology. 2014;60:1267A\u201390A (LB-19).", "journal-title": "Hepatology"}, {"issue": "12", "key": "14_CR64", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1111/jvh.12214", "volume": "21", "author": "MH Cho", "year": "2014", "unstructured": "Cho MH, Jeong H, Kim YS, Kim JW, Jung G. 2-Amino-N-(2,6-dichloropyridin-3-yl)acetamide derivatives as a novel class of HBV capsid assembly inhibitor. J Viral Hepat. 2014;21(12):843\u201352. Epub 2014/01/01.", "journal-title": "J Viral Hepat"}, {"issue": "4", "key": "14_CR65", "doi-asserted-by": "crossref", "first-page": "1393", "DOI": "10.1002/hep.24252", "volume": "53", "author": "MR Alison", "year": "2011", "unstructured": "Alison MR, Lin WR. Hepatocyte turnover and regeneration: virtually a virtuoso performance. Hepatology. 2011;53(4):1393\u20136. Epub 2011/04/12.", "journal-title": "Hepatology"}, {"issue": "4", "key": "14_CR66", "doi-asserted-by": "crossref", "first-page": "1778", "DOI": "10.1128/JVI.01587-08", "volume": "83", "author": "WS Mason", "year": "2009", "unstructured": "Mason WS, Xu C, Low HC, Saputelli J, Aldrich CE, Scougall C, et al. The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir. J Virol. 2009;83(4):1778\u201389. Epub 2008/12/17.", "journal-title": "J Virol"}, {"issue": "Suppl 1", "key": "14_CR67", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1111/j.1365-2893.2007.00911.x", "volume": "14", "author": "WS Mason", "year": "2007", "unstructured": "Mason WS, Litwin S, Xu C, Jilbert AR. Hepatocyte turnover in transient and chronic hepadnavirus infections. J Viral Hepat. 2007;14 Suppl 1:22\u20138. Epub 2007/11/21.", "journal-title": "J Viral Hepat"}, {"issue": "6", "key": "14_CR68", "doi-asserted-by": "crossref", "first-page": "2143", "DOI": "10.1111/j.1523-1755.2005.00319.x", "volume": "67", "author": "C Esposito", "year": "2005", "unstructured": "Esposito C, Parrilla B, De Mauri A, Cornacchia F, Fasoli G, Foschi A, et al. Hepatocyte growth factor (HGF) modulates matrix turnover in human glomeruli. Kidney Int. 2005;67(6):2143\u201350. Epub 2005/05/11.", "journal-title": "Kidney Int"}, {"issue": "20", "key": "14_CR69", "doi-asserted-by": "crossref", "first-page": "11652", "DOI": "10.1073/pnas.1635109100", "volume": "100", "author": "J Summers", "year": "2003", "unstructured": "Summers J, Jilbert AR, Yang W, Aldrich CE, Saputelli J, Litwin S, et al. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci U S A. 2003;100(20):11652\u20139.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "1", "key": "14_CR70", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1053/jhep.2000.8701", "volume": "32", "author": "M Dandri", "year": "2000", "unstructured": "Dandri M, Burda MR, Will H, Petersen J. Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA. Hepatology. 2000;32(1):139\u201346. Epub 2000/06/28.", "journal-title": "Hepatology"}, {"issue": "12", "key": "14_CR71", "first-page": "8321", "volume": "68", "author": "I Fourel", "year": "1994", "unstructured": "Fourel I, Cullen JM, Saputelli J, Aldrich CE, Schaffer P, Averett DR, et al. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J Virol. 1994;68(12):8321\u201330. Epub 1994/12/01.", "journal-title": "J Virol"}, {"issue": "7", "key": "14_CR72", "doi-asserted-by": "crossref", "first-page": "883", "DOI": "10.1097/00007890-199810150-00012", "volume": "66", "author": "C Blanpain", "year": "1998", "unstructured": "Blanpain C, Knoop C, Delforge ML, Antoine M, Peny MO, Liesnard C, et al. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. Transplantation. 1998;66(7):883\u20136.", "journal-title": "Transplantation"}, {"issue": "5 Suppl S1", "key": "14_CR73", "first-page": "56", "volume": "49", "author": "JH Hoofnagle", "year": "2009", "unstructured": "Hoofnagle JH. Reactivation of hepatitis B. Hepatology. 2009;49(5 Suppl S1):56\u201365. Epub 2009/04/29.", "journal-title": "Hepatology"}, {"issue": "3", "key": "14_CR74", "doi-asserted-by": "crossref", "first-page": "463", "DOI": "10.1016/j.jhep.2009.11.023", "volume": "52", "author": "HH Hung", "year": "2010", "unstructured": "Hung HH, Su CW, Wu JC, Lee SD. Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigen. J Hepatol. 2010;52(3):463\u20135. Epub 2010/02/05.", "journal-title": "J Hepatol"}, {"issue": "9", "key": "14_CR75", "doi-asserted-by": "crossref", "first-page": "1277", "DOI": "10.1086/496924", "volume": "41", "author": "A Kempinska", "year": "2005", "unstructured": "Kempinska A, Kwak EJ, Angel JB. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin Infect Dis. 2005;41(9):1277\u201382.", "journal-title": "Clin Infect Dis"}, {"issue": "10", "key": "14_CR76", "doi-asserted-by": "crossref", "first-page": "1130", "DOI": "10.1016/j.cgh.2009.06.027", "volume": "7", "author": "TN Palmore", "year": "2009", "unstructured": "Palmore TN, Shah NL, Loomba R, Borg BB, Lopatin U, Feld JJ, et al. Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression. Clin Gastroenterol Hepatol. 2009;7(10):1130\u20137. Epub 2009/07/07.", "journal-title": "Clin Gastroenterol Hepatol"}, {"issue": "3", "key": "14_CR77", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.1007/BF01703079", "volume": "8", "author": "CT Bock", "year": "1994", "unstructured": "Bock CT, Schranz P, Schroder CH, Zentgraf H. Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell. Virus Genes. 1994;8(3):215\u201329. Epub 1994/07/01.", "journal-title": "Virus Genes"}, {"issue": "7408", "key": "14_CR78", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1038/487439a", "volume": "487", "author": "SG Deeks", "year": "2012", "unstructured": "Deeks SG. HIV: shock and kill. Nature. 2012;487(7408):439\u201340. Epub 2012/07/28.", "journal-title": "Nature"}, {"issue": "5", "key": "14_CR79", "doi-asserted-by": "crossref", "first-page": "989", "DOI": "10.1016/j.cell.2014.07.043", "volume": "158", "author": "A Halper-Stromberg", "year": "2014", "unstructured": "Halper-Stromberg A, Lu CL, Klein F, Horwitz JA, Bournazos S, Nogueira L, et al. Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice. Cell. 2014;158(5):989\u201399. Epub 2014/08/19.", "journal-title": "Cell"}, {"issue": "9939", "key": "14_CR80", "doi-asserted-by": "crossref", "first-page": "223", "DOI": "10.1016/S0140-6736(14)61198-3", "volume": "384", "author": "S Lo", "year": "2014", "unstructured": "Lo S. Sharon Lewin: guiding us towards a cure for HIV. Lancet. 2014;384(9939):223. Epub 2014/07/22.", "journal-title": "Lancet"}, {"issue": "2", "key": "14_CR81", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1172/JCI58847", "volume": "122", "author": "L Belloni", "year": "2012", "unstructured": "Belloni L, Allweiss L, Guerrieri F, Pediconi N, Volz T, Pollicino T, et al. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest. 2012;122(2):529\u201337. Epub 2012/01/19.", "journal-title": "J Clin Invest"}, {"key": "14_CR82", "first-page": "S56", "volume": "58", "author": "GA Pallumbo", "year": "2013", "unstructured": "Pallumbo GA, Belloni L, Valente S, Rotili D, Pediconi N, Mai A, et al. Suppression of hepatitis B virus (HBV) transcription and replication by small molecules that target the epigenetic control of nuclear cccDNA minichromosome. J Hepatol. 2013;58:S56.", "journal-title": "J Hepatol"}, {"issue": "5", "key": "14_CR83", "doi-asserted-by": "crossref", "first-page": "2442", "DOI": "10.1128/JVI.02861-13", "volume": "88", "author": "JH Ren", "year": "2014", "unstructured": "Ren JH, Tao Y, Zhang ZZ, Chen WX, Cai XF, Chen K, et al. Sirtuin 1 regulates hepatitis B virus transcription and replication by targeting transcription factor AP-1. J Virol. 2014;88(5):2442\u201351. Epub 2013/12/18.", "journal-title": "J Virol"}, {"issue": "9", "key": "14_CR84", "doi-asserted-by": "crossref", "first-page": "1286", "DOI": "10.1086/597614", "volume": "199", "author": "P Vivekanandan", "year": "2009", "unstructured": "Vivekanandan P, Thomas D, Torbenson M. Methylation regulates hepatitis B viral protein expression. J Infect Dis. 2009;199(9):1286\u201391. Epub 2009/03/24.", "journal-title": "J Infect Dis"}, {"issue": "8", "key": "14_CR85", "doi-asserted-by": "crossref", "first-page": "1166", "DOI": "10.1002/jmv.23328", "volume": "84", "author": "LM Cabuang", "year": "2012", "unstructured": "Cabuang LM, Shaw T, Littlejohn M, Colledge D, Sozzi V, Soppe S, et al. In vitro replication phenotype of a novel (-1G) hepatitis B virus variant associated with HIV co-infection. J Med Virol. 2012;84(8):1166\u201376. Epub 2012/06/20.", "journal-title": "J Med Virol"}, {"issue": "17", "key": "14_CR86", "doi-asserted-by": "crossref", "first-page": "8920", "DOI": "10.1128/JVI.00052-12", "volume": "86", "author": "JT Schiffer", "year": "2012", "unstructured": "Schiffer JT, Aubert M, Weber ND, Mintzer E, Stone D, Jerome KR. Targeted DNA mutagenesis for the cure of chronic viral infections. J Virol. 2012;86(17):8920\u201336. Epub 2012/06/22.", "journal-title": "J Virol"}, {"issue": "10", "key": "14_CR87", "doi-asserted-by": "crossref", "first-page": "1889", "DOI": "10.1038/mt.2013.170", "volume": "21", "author": "K Bloom", "year": "2013", "unstructured": "Bloom K, Ely A, Mussolino C, Cathomen T, Arbuthnot P. Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther. 2013;21(10):1889\u201397. Epub 2013/07/26.", "journal-title": "Mol Ther"}, {"key": "14_CR88", "author": "C Seeger", "volume": "3", "year": "2014", "unstructured": "Seeger C, Sohn JA. Targeting hepatitis B virus with CRISPR/Cas9. Mol Ther Nucleic acids. 2014;3, e216. Epub 2014/12/17.", "journal-title": "Mol Ther Nucleic acids", "DOI": "10.1038/mtna.2014.68", "doi-asserted-by": "crossref"}, {"key": "14_CR89", "author": "SR Lin", "volume": "3", "year": "2014", "unstructured": "Lin SR, Yang HC, Kuo YT, Liu CJ, Yang TY, Sung KC, et al. The CRISPR/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Mol Ther Nucleic acids. 2014;3, e186. Epub 2014/08/20.", "journal-title": "Mol Ther Nucleic acids"}, {"issue": "1", "key": "14_CR90", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1038/nrm3486", "volume": "14", "author": "JK Joung", "year": "2013", "unstructured": "Joung JK, Sander JD. TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol. 2013;14(1):49\u201355. Epub 2012/11/22.", "journal-title": "Nat Rev Mol Cell Biol"}, {"issue": "1", "key": "14_CR91", "doi-asserted-by": "crossref", "first-page": "36", "DOI": "10.1089/aid.2014.0236", "volume": "31", "author": "JL Anderson", "year": "2015", "unstructured": "Anderson JL, Fromentin R, Corbelli GM, Ostergaard L, Ross AL. Progress towards an HIV cure: update from the 2014 International AIDS Society symposium. AIDS Res Hum Retroviruses. 2015;31(1):36\u201344.", "journal-title": "AIDS Res Hum Retroviruses"}, {"issue": "2", "key": "14_CR92", "first-page": "110", "volume": "36", "author": "J Nunes", "year": "2011", "unstructured": "Nunes J, Marinho RT, Fonseca JE, Pereira da Silva JA, Velosa J. Prophylaxis of hepatitis B reactivation with immunosuppressive therapy in rheumatic diseases. Orientations for clinical practice. Acta Reumatol Port. 2011;36(2):110\u20138. Epub 2011/08/16.", "journal-title": "Acta Reumatol Port"}, {"issue": "1", "key": "14_CR93", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1203/00006450-199101000-00002", "volume": "29", "author": "S Terazawa", "year": "1991", "unstructured": "Terazawa S, Kojima M, Yamanaka T, Yotsumoto S, Okamoto H, Tsuda F, et al. Hepatitis B virus mutants with precore-region defects in two babies with fulminant hepatitis and their mothers positive for antibody to hepatitis B e antigen. Pediatr Res. 1991;29(1):5\u20139. Epub 1991/01/01.", "journal-title": "Pediatr Res"}, {"issue": "2", "key": "14_CR94", "doi-asserted-by": "crossref", "first-page": "428", "DOI": "10.1002/hep.22065", "volume": "47", "author": "MW Fried", "year": "2008", "unstructured": "Fried MW, Piratvisuth T, Lau GK, Marcellin P, Chow WC, Cooksley G, et al. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B. Hepatology. 2008;47(2):428\u201334.", "journal-title": "Hepatology"}, {"issue": "2", "key": "14_CR95", "first-page": "1332", "volume": "268", "author": "F Schodel", "year": "1993", "unstructured": "Schodel F, Peterson D, Zheng J, Jones JE, Hughes JL, Milich DR. Structure of hepatitis B virus core and e-antigen. A single precore amino acid prevents nucleocapsid assembly. J Biol Chem. 1993;268(2):1332\u20137. Epub 1993/01/15.", "journal-title": "J Biol Chem"}, {"issue": "41", "key": "14_CR96", "doi-asserted-by": "crossref", "first-page": "14913", "DOI": "10.1073/pnas.0406282101", "volume": "101", "author": "MT Chen", "year": "2004", "unstructured": "Chen MT, Billaud JN, Sallberg M, Guidotti LG, Chisari FV, Jones J, et al. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci U S A. 2004;101(41):14913\u20138. Epub 2004/10/08.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "17", "key": "14_CR97", "doi-asserted-by": "crossref", "first-page": "6599", "DOI": "10.1073/pnas.87.17.6599", "volume": "87", "author": "DR Milich", "year": "1990", "unstructured": "Milich DR, Jones JE, Hughes JL, Price J, Raney AK, McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A. 1990;87(17):6599\u2013603.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "1", "key": "14_CR98", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1002/jmv.21645", "volume": "82", "author": "P Revill", "year": "2010", "unstructured": "Revill P, Yuen L, Walsh R, Perrault M, Locarnini S, Kramvis A. Bioinformatic analysis of the hepadnavirus e-antigen and its precursor identifies remarkable sequence conservation in all orthohepadnaviruses. J Med Virol. 2010;82(1):104\u201315. Epub 2009/12/02.", "journal-title": "J Med Virol"}, {"issue": "2", "key": "14_CR99", "doi-asserted-by": "crossref", "first-page": "891", "DOI": "10.1074/jbc.M207634200", "volume": "278", "author": "F Messageot", "year": "2003", "unstructured": "Messageot F, Salhi S, Eon P, Rossignol JM. Proteolytic processing of the hepatitis B virus e antigen precursor. Cleavage at two furin consensus sequences. J Biol Chem. 2003;278(2):891\u20135.", "journal-title": "J Biol Chem"}, {"issue": "2", "key": "14_CR100", "first-page": "295", "volume": "64", "author": "K Baba", "year": "1986", "unstructured": "Baba K, Ise I, Aihara S, Kishimoto S, Tsuda F, Tachibana K, et al. Small and large forms of hepatitis B e antigen in the serum: determination by two-site sandwich radioimmunoassay with monoclonal antibodies. Clin Exp Immunol. 1986;64(2):295\u2013301. Epub 1986/05/01.", "journal-title": "Clin Exp Immunol"}, {"issue": "5", "key": "14_CR101", "doi-asserted-by": "crossref", "first-page": "3016", "DOI": "10.1128/JVI.79.5.3016-3027.2005", "volume": "79", "author": "M Chen", "year": "2005", "unstructured": "Chen M, Sallberg M, Hughes J, Jones J, Guidotti LG, Chisari FV, et al. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol. 2005;79(5):3016\u201327.", "journal-title": "J Virol"}, {"issue": "26", "key": "14_CR102", "doi-asserted-by": "crossref", "first-page": "14648", "DOI": "10.1073/pnas.94.26.14648", "volume": "94", "author": "DR Milich", "year": "1997", "unstructured": "Milich DR, Chen M, Schodel F, Peterson DL, Jones JE, Hughes JL. Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci U S A. 1997;94(26):14648\u201353. Epub 1998/02/07.", "journal-title": "Proc Natl Acad Sci U S A"}, {"issue": "4782", "key": "14_CR103", "doi-asserted-by": "crossref", "first-page": "1398", "DOI": "10.1126/science.3491425", "volume": "234", "author": "DR Milich", "year": "1986", "unstructured": "Milich DR, McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science. 1986;234(4782):1398\u2013401. Epub 1986/12/12.", "journal-title": "Science"}, {"issue": "3", "key": "14_CR104", "first-page": "2192", "volume": "71", "author": "DR Milich", "year": "1997", "unstructured": "Milich DR, Schodel F, Hughes JL, Jones JE, Peterson DL. The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype. J Virol. 1997;71(3):2192\u2013201. Epub 1997/03/01.", "journal-title": "J Virol"}, {"key": "14_CR105", "unstructured": "Jegaskanda S, Ahn SH, Skinner N, Thompson AJ, Ngyuen T, Holmes J, et al. Down-regulation of IL-18 mediated cell signalling and IFN-gamma expression by the hepatitis B virus e antigen. J Virol. 2014. Epub 2014/05/30."}, {"issue": "4", "key": "14_CR106", "doi-asserted-by": "crossref", "first-page": "762", "DOI": "10.1016/j.jhep.2010.12.042", "volume": "55", "author": "T Lang", "year": "2011", "unstructured": "Lang T, Lo C, Skinner N, Locarnini S, Visvanathan K, Mansell A. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway. J Hepatol. 2011;55(4):762\u20139. Epub 2011/02/22.", "journal-title": "J Hepatol"}, {"issue": "1", "key": "14_CR107", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1002/hep.21482", "volume": "45", "author": "K Visvanathan", "year": "2007", "unstructured": "Visvanathan K, Skinner NA, Thompson AJ, Riordan SM, Sozzi V, Edwards R, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology. 2007;45(1):102\u201310.", "journal-title": "Hepatology"}, {"issue": "1", "key": "14_CR108", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.4161/mabs.1.1.7377", "volume": "1", "author": "CM Lynch", "year": "2009", "unstructured": "Lynch CM, Hart BW, Grewal IS. Practical considerations for nonclinical safety evaluation of therapeutic monoclonal antibodies. MAbs. 2009;1(1):2\u201311. Epub 2010/01/05.", "journal-title": "MAbs"}, {"issue": "1", "key": "14_CR109", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1016/j.virol.2010.12.034", "volume": "411", "author": "R Walsh", "year": "2011", "unstructured": "Walsh R, Nuttall S, Revill P, Colledge D, Cabuang L, Soppe S, et al. Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody. Virology. 2011;411(1):132\u201341. Epub 2011/01/18.", "journal-title": "Virology"}, {"issue": "16", "key": "14_CR110", "doi-asserted-by": "crossref", "first-page": "8882", "DOI": "10.1128/JVI.77.16.8882-8892.2003", "volume": "77", "author": "R Schilling", "year": "2003", "unstructured": "Schilling R, Ijaz S, Davidoff M, Lee JY, Locarnini S, Williams R, et al. Endocytosis of hepatitis B immune globulin into hepatocytes inhibits the secretion of hepatitis B virus surface antigen and virions. J Virol. 2003;77(16):8882\u201392. Epub 2003/07/30.", "journal-title": "J Virol"}, {"issue": "5", "key": "14_CR111", "doi-asserted-by": "crossref", "first-page": "996", "DOI": "10.1016/j.jhep.2011.02.015", "volume": "55", "author": "J Lucifora", "year": "2011", "unstructured": "Lucifora J, Arzberger S, Durantel D, Belloni L, Strubin M, Levrero M, et al. Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection. J Hepatol. 2011;55(5):996\u20131003. Epub 2011/03/08.", "journal-title": "J Hepatol"}, {"issue": "7", "key": "14_CR112", "doi-asserted-by": "crossref", "first-page": "4277", "DOI": "10.1074/jbc.M606774200", "volume": "282", "author": "D Cougot", "year": "2007", "unstructured": "Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Levy L, et al. The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J Biol Chem. 2007;282(7):4277\u201387. Epub 2006/12/13.", "journal-title": "J Biol Chem"}, {"issue": "13", "key": "14_CR113", "volume": "37", "author": "A Ely", "year": "2009", "unstructured": "Ely A, Naidoo T, Arbuthnot P. Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles. Nucleic Acids Res. 2009;37(13), e91. Epub 2009/05/29.", "journal-title": "Nucleic Acids Res"}, {"issue": "4", "key": "14_CR114", "doi-asserted-by": "crossref", "first-page": "866", "DOI": "10.1016/j.bbrc.2008.01.025", "volume": "367", "author": "WP Tong", "year": "2008", "unstructured": "Tong WP, Zhou Y, Wang X, Yang F, Wu KL, Wu J, et al. An accurate quantitative method for screening effective siRNA probes targeting a hepatitis B virus transcript in single living cells. Biochem Biophys Res Commun. 2008;367(4):866\u201373. Epub 2008/01/19.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "14_CR115", "unstructured": "Tseng TC, Liu CJ, Yang HC, Chen CL, Yang WT, Tsai CS, et al. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 2014. Epub 2014/04/26."}, {"issue": "1", "key": "14_CR116", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.1007/s12072-012-9343-x", "volume": "7", "author": "P Marcellin", "year": "2013", "unstructured": "Marcellin P, Bonino F, Yurdaydin C, Hadziyannis S, Moucari R, Kapprell HP, et al. Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients. Hepatol Int. 2013;7(1):88\u201397. Epub 2013/03/23.", "journal-title": "Hepatol Int"}, {"issue": "3", "key": "14_CR117", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1034/j.1600-0676.2001.021003207.x", "volume": "21", "author": "AB Nunen van", "year": "2001", "unstructured": "van Nunen AB, Baumann M, Manns MP, Reichen J, Spengler U, Marschner JP, et al. Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patients. Liver. 2001;21(3):207\u201312. Epub 2001/06/26.", "journal-title": "Liver"}, {"key": "14_CR118", "author": "AML Lever", "year": "1988", "unstructured": "Lever AML, Waters AJ, Brook MG, Karayiannis P. Treatment of Chronic Hepatitis B Virus Infection With Monoclonal Antibody to the Hepatitis B Virus Surface Antigen in Two Patients With Hypogammaglobuinaemia. In: Zuckerman AJ, editor. Viral hepatitis and liver disease. New York, NY: Alan R Liss; 1988.", "volume-title": "Viral hepatitis and liver disease"}, {"issue": "6", "key": "14_CR119", "doi-asserted-by": "crossref", "first-page": "797", "DOI": "10.3851/IMP1294", "volume": "14", "author": "AJ Thompson", "year": "2009", "unstructured": "Thompson AJ, Colledge D, Rodgers S, Wilson R, Revill P, Desmond P, et al. Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro. Antivir Ther. 2009;14(6):797\u2013808. Epub 2009/10/09.", "journal-title": "Antivir Ther"}, {"issue": "1", "key": "14_CR120", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1124/jpet.113.207878", "volume": "348", "author": "A Fosdick", "year": "2014", "unstructured": "Fosdick A, Zheng J, Pflanz S, Frey CR, Hesselgesser J, Halcomb RL, et al. Pharmacokinetic and pharmacodynamic properties of GS-9620, a novel Toll-like receptor 7 agonist, demonstrate interferon-stimulated gene induction without detectable serum interferon at low oral doses. J Pharmacol Exp Ther. 2014;348(1):96\u2013105. Epub 2013/10/18.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "14_CR121", "unstructured": "Menne S, Tumas DB, Liu KH, Thampi L, AlDeghaither D, Baldwin BH, et al. Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B. J Hepatol. 2015. Epub 2015/01/07.", "DOI": "10.1016/j.jhep.2014.12.026", "doi-asserted-by": "crossref"}, {"key": "14_CR122", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1016/j.ijid.2014.07.015", "volume": "29", "author": "Y Wang", "year": "2014", "unstructured": "Wang Y, Chen K, Wu Z, Liu Y, Liu S, Zou Z, et al. Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic mice. Int J Infect Dis. 2014;29:31\u20136. Epub 2014/12/03.", "journal-title": "Int J Infect Dis"}, {"key": "14_CR123", "doi-asserted-by": "crossref", "first-page": "5533", "DOI": "10.2741/3097", "volume": "13", "author": "G Sommer", "year": "2008", "unstructured": "Sommer G, Heise T. Posttranscriptional control of HBV gene expression. Front Biosci. 2008;13:5533\u201347. Epub 2008/05/30.", "journal-title": "Front Biosci"}, {"key": "14_CR124", "unstructured": "Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X, et al. Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science. 2014. Epub 2014/02/22."}, {"issue": "10", "key": "14_CR125", "doi-asserted-by": "crossref", "first-page": "e499", "DOI": "10.1111/j.1365-2893.2011.01484.x", "volume": "18", "author": "R Wilson", "year": "2011", "unstructured": "Wilson R, Warner N, Ryan K, Selleck L, Colledge D, Rodgers S, et al. The hepatitis B e antigen suppresses IL-1beta-mediated NF-kappaB activation in hepatocytes. J Viral Hepat. 2011;18(10):e499\u2013507. Epub 2011/09/15.", "journal-title": "J Viral Hepat"}, {"issue": "5", "key": "14_CR126", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1089/vim.2010.0042", "volume": "23", "author": "S Wu", "year": "2010", "unstructured": "Wu S, Kanda T, Imazeki F, Arai M, Yonemitsu Y, Nakamoto S, et al. Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines. Viral Immunol. 2010;23(5):467\u201376. Epub 2010/10/05.", "journal-title": "Viral Immunol"}, {"issue": "1", "key": "14_CR127", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/j.virol.2009.10.043", "volume": "397", "author": "LA Gaither", "year": "2010", "unstructured": "Gaither LA, Borawski J, Anderson LJ, Balabanis KA, Devay P, Joberty G, et al. Multiple cyclophilins involved in different cellular pathways mediate HCV replication. Virology. 2010;397(1):43\u201355. Epub 2009/11/26.", "journal-title": "Virology"}, {"issue": "4", "key": "14_CR128", "doi-asserted-by": "crossref", "first-page": "647", "DOI": "10.1016/j.bbrc.2012.07.024", "volume": "424", "author": "D Zhou", "year": "2012", "unstructured": "Zhou D, Mei Q, Li J, He H. Cyclophilin A and viral infections. Biochem Biophys Res Commun. 2012;424(4):647\u201350. Epub 2012/07/21.", "journal-title": "Biochem Biophys Res Commun"}, {"issue": "2", "key": "14_CR129", "doi-asserted-by": "crossref", "first-page": "403", "DOI": "10.1053/j.gastro.2014.10.004", "volume": "148", "author": "S Phillips", "year": "2015", "unstructured": "Phillips S, Chokshi S, Chatterji U, Riva A, Bobardt M, Williams R, et al. Alisporivir inhibition of hepatocyte cyclophilins reduces HBV replication and hepatitis B surface antigen production. Gastroenterology. 2015;148(2):403\u201314 e7. Epub 2014/10/12.", "journal-title": "Gastroenterology"}, {"key": "14_CR130", "unstructured": "Matthews et al., Clin Infect. Dis. 56 (9). e87-94."}], "container-title": ["Molecular and Translational Medicine", "Hepatitis B Virus in Human Diseases"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-22330-8_14", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 31]], "date-time": "2019-05-31T14:24:10Z", "timestamp": 1559312650000}, "score": 29.813854, "issued": {"date-parts": [[2016]]}, "ISBN": ["9783319223292", "9783319223308"], "references-count": 130, "URL": "http://dx.doi.org/10.1007/978-3-319-22330-8_14", "relation": {"cites": []}, "ISSN": ["2197-7852", "2197-7860"], "issn-type": [{"value": "2197-7852", "type": "print"}, {"value": "2197-7860", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T11:43:15Z", "timestamp": 1576755795422}, "reference-count": 223, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 5, 1]], "date-time": "2015-05-01T00:00:00Z", "timestamp": 1430438400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2016, 5, 1]], "date-time": "2016-05-01T00:00:00Z", "timestamp": 1462060800000}, "delay-in-days": 366, "content-version": "vor"}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.com.au", "clinicalkey.fr", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Virology"], "published-print": {"date-parts": [[2015, 5]]}, "DOI": "10.1016/j.virol.2015.02.031", "type": "journal-article", "created": {"date-parts": [[2015, 3, 7]], "date-time": "2015-03-07T13:47:38Z", "timestamp": 1425736058000}, "page": "672-686", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 255, "title": ["Molecular biology of hepatitis B virus infection"], "prefix": "10.1016", "volume": "479-480", "author": [{"ORCID": "http://orcid.org/0000-0002-3602-5256", "authenticated-orcid": false, "given": "Christoph", "family": "Seeger", "sequence": "first", "affiliation": []}, {"given": "William S.", "family": "Mason", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Virology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S004268221500077X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S004268221500077X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 21]], "date-time": "2019-08-21T19:14:16Z", "timestamp": 1566414856000}, "score": 29.74138, "issued": {"date-parts": [[2015, 5]]}, "references-count": 223, "alternative-id": ["S004268221500077X"], "URL": "http://dx.doi.org/10.1016/j.virol.2015.02.031", "ISSN": ["0042-6822"], "issn-type": [{"value": "0042-6822", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Molecular biology of hepatitis B virus infection", "name": "articletitle", "label": "Article Title"}, {"value": "Virology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.virol.2015.02.031", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2015 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T05:23:30Z", "timestamp": 1574227410738}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2006, 1, 1]], "date-time": "2006-01-01T00:00:00Z", "timestamp": 1136073600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Clinical Virology"], "published-print": {"date-parts": [[2006, 1]]}, "DOI": "10.1016/s1386-6532(06)80303-3", "type": "journal-article", "created": {"date-parts": [[2006, 8, 29]], "date-time": "2006-08-29T12:37:22Z", "timestamp": 1156855042000}, "page": "S98", "source": "Crossref", "is-referenced-by-count": 0, "title": ["P.123 Characterisation of a mouse monoclonal and rabbit polyclonal antibody against the hepatitis B precore protein"], "prefix": "10.1016", "volume": "36", "author": [{"given": "S.C.", "family": "Rodgers", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Locarnini", "sequence": "additional", "affiliation": []}, {"given": "P.", "family": "Revill", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Journal of Clinical Virology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1386653206803033?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1386653206803033?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 1, 13]], "date-time": "2019-01-13T20:20:32Z", "timestamp": 1547410832000}, "score": 29.680904, "issued": {"date-parts": [[2006, 1]]}, "references-count": 0, "alternative-id": ["S1386653206803033"], "URL": "http://dx.doi.org/10.1016/s1386-6532(06)80303-3", "ISSN": ["1386-6532"], "issn-type": [{"value": "1386-6532", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T13:06:11Z", "timestamp": 1574168771668}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "16", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Virology"], "published-print": {"date-parts": [[2003, 8, 15]]}, "DOI": "10.1128/jvi.77.16.8882-8892.2003", "type": "journal-article", "created": {"date-parts": [[2003, 7, 28]], "date-time": "2003-07-28T21:36:47Z", "timestamp": 1059428207000}, "page": "8882-8892", "source": "Crossref", "is-referenced-by-count": 58, "title": ["Endocytosis of Hepatitis B Immune Globulin into Hepatocytes Inhibits the Secretion of Hepatitis B Virus Surface Antigen and Virions"], "prefix": "10.1128", "volume": "77", "author": [{"given": "R.", "family": "Schilling", "sequence": "first", "affiliation": []}, {"given": "S.", "family": "Ijaz", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Davidoff", "sequence": "additional", "affiliation": []}, {"given": "J. Y.", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Locarnini", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Williams", "sequence": "additional", "affiliation": []}, {"given": "N. V.", "family": "Naoumov", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[2003, 7, 28]]}, "container-title": ["Journal of Virology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/JVI.77.16.8882-8892.2003", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T09:40:39Z", "timestamp": 1482486039000}, "score": 29.4629, "issued": {"date-parts": [[2003, 7, 28]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 8, 15]]}, "issue": "16"}, "URL": "http://dx.doi.org/10.1128/jvi.77.16.8882-8892.2003", "ISSN": ["0022-538X"], "issn-type": [{"value": "0022-538X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:09:04Z", "timestamp": 1574107744858}, "reference-count": 17, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1997, 2, 1]], "date-time": "1997-02-01T00:00:00Z", "timestamp": 854755200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Trends in Microbiology"], "published-print": {"date-parts": [[1997, 2]]}, "DOI": "10.1016/s0966-842x(96)30043-7", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T01:51:05Z", "timestamp": 1027648265000}, "page": "45-47", "source": "Crossref", "is-referenced-by-count": 4, "title": ["The attachment receptor for hepatitis A virus"], "prefix": "10.1016", "volume": "5", "author": [{"given": "Stephen", "family": "Locarnini", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Trends in Microbiology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0966842X96300437?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0966842X96300437?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T08:30:08Z", "timestamp": 1555317008000}, "score": 29.40177, "issued": {"date-parts": [[1997, 2]]}, "references-count": 17, "journal-issue": {"published-print": {"date-parts": [[1997, 2]]}, "issue": "2"}, "alternative-id": ["S0966842X96300437"], "URL": "http://dx.doi.org/10.1016/s0966-842x(96)30043-7", "ISSN": ["0966-842X"], "issn-type": [{"value": "0966-842X", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}